Nurses Revision

Nurses Revision

nursesrevision@gmail.com

Bipolar Affective Disorder

Bipolar Affective Disorder

Bipolar Affective Disorder

Bipolar Affective Disorder is formerly called manic-depressive illness (MDI). B.A.D is a severe and persistent condition that causes serious lifelong struggle and challenge.

Bipolar affective disorder is a mental health condition characterized by mood swings, from deep and prolonged low mood (profound depression) to extreme euphoria (mania), with intervening normal periods.

Episodes of mood swings may occur rarely or multiple times a year. While some people will experience some emotional symptoms between episodes, some may not experience any.

Differentiating Bipolar Affective Disorder (BPAD) in children and adolescents from other psychiatric conditions is one of the most challenging aspects of pediatric psychopathology. The overlapping symptoms, developmental variability, and comorbidity make accurate diagnosis difficult but crucial for appropriate treatment.

Distinguishing Feature of BAD: Episodes of Mania/Hypomania

The defining characteristic of BAD, distinguishing it from unipolar depression, is the presence of at least one manic or hypomanic episode.

  • Mania: A distinct period of abnormally and persistently elevated, expansive, or irritable mood and abnormally and persistently increased goal-directed activity or energy, lasting at least one week (or any duration if hospitalization is necessary).
  • Hypomania: Similar symptoms to mania but less severe, of shorter duration (at least 4 consecutive days), and not causing marked functional impairment or requiring hospitalization.

Without evidence of these episodic mood elevations, a diagnosis of BAD cannot be made. They are of three kinds i.e.

  • Mixed bipolar disorder that is both manic and depressive episodes intermixed.
  • Manic bipolar disorder; here there is predominant elation of mood, irritability, excessive motor activity and evident psychotic features.
  • Depressed bipolar disorder; symptoms are characteristic of major depression with a history of at least one manic episode.

Differentiation from Major Depressive Disorder (MDD)

This is the most fundamental differentiation.

Feature Major Depressive Disorder (MDD) in Youth Bipolar Affective Disorder (BPAD) in Youth
Defining Characteristic Presence of one or more Major Depressive Episodes (MDE) without any manic or hypomanic episodes. Presence of at least one manic episode (BP-I) or at least one hypomanic episode and one MDE (BP-II). Cyclothymic Disorder involves numerous hypomanic and depressive symptoms over at least one year that don't meet full criteria for hypomanic or MDE.
Mood Episodes Only depressive episodes. Episodes of depression and mania/hypomania. Mood can be unstable, cycling between states, or present as mixed features (co-occurring manic and depressive symptoms).
Irritability Common, often chronic, and pervasive during a depressive episode. Can be extreme, explosive, and episodic, particularly during manic/hypomanic phases. Often comes with increased energy and agitation.
Energy Levels Persistently low energy, fatigue, psychomotor retardation. Fluctuates: Very low during depression, abnormally high during mania/hypomania (restlessness, decreased need for sleep, goal-directed activity).
Grandiosity/Euphoria Absent. Hallmark of manic/hypomanic episodes. Children might express exaggerated abilities, magical thinking, or an inflated sense of self-importance.
Sleep Increased sleep (hypersomnia) or decreased sleep (insomnia) with difficulty falling/staying asleep. During mania/hypomania: Decreased need for sleep (e.g., feeling rested after only a few hours), but without feeling tired.
During depression: Similar to MDD.
Psychosis Can occur in severe MDD with mood-congruent psychotic features (e.g., delusions of guilt/worthlessness). More common in BPAD, especially during manic episodes. Can be mood-congruent or mood-incongruent.
Family History Family history of MDD. Stronger family history of BPAD is a significant risk factor.
Treatment Response Antidepressants are the primary pharmacological treatment. Mood stabilizers (e.g., lithium, valproate) and atypical antipsychotics are first-line. Antidepressants used alone can sometimes induce mania/hypomania in vulnerable individuals with BPAD, necessitating careful monitoring.

Differentiation from Attention-Deficit/Hyperactivity Disorder (ADHD)

ADHD is one of the most common comorbidities with BAD, and its symptoms often overlap, making differentiation particularly challenging.

Feature Attention-Deficit/Hyperactivity Disorder (ADHD) in Youth Bipolar Affective Disorder (BPAD) in Youth (Manic/Hypomanic Phase)
Mood Chronic irritability, frustration, emotional dysregulation common as a secondary feature due to difficulties with executive function. Mood is generally reactive to external stimuli. Episodic mood shifts between distinct states (e.g., euphoric, expansive, extremely irritable, agitated) that are out of proportion to external circumstances. These mood states are qualitatively different from typical frustration or reactivity.
Energy Level Chronic hyperactivity, restlessness, difficulty sitting still. Generally present across settings. Episodic surge of energy, often described as "boundless," "wired," or "driven." Associated with decreased need for sleep. This energy often has a goal-directed (albeit often disorganized) quality that is distinct from ADHD's chronic restlessness.
Sleep Difficulty falling asleep due to an active mind, but generally needs sleep. Decreased need for sleep is a core manic symptom; the child feels rested after very little sleep. During depressive phases, can have insomnia or hypersomnia.
Distractibility Chronic difficulty sustaining attention, easily diverted by external stimuli. During mania/hypomania: Severe distractibility, often due to internal flight of ideas and racing thoughts, rather than solely external stimuli. Easily shifts from one activity or topic to another.
Impulsivity Chronic difficulty waiting turn, interrupting, acting without thinking. During mania/hypomania: Reckless impulsivity with potentially severe consequences (e.g., spending sprees, sexually inappropriate behavior, substance abuse, dangerous stunts) driven by grandiosity or impaired judgment. Differs in severity and consequences.
Grandiosity Absent. Present during manic/hypomanic episodes (e.g., exaggerated self-importance, belief in special powers/abilities, invincibility).
Onset Typically early childhood (before age 12). Symptoms are usually chronic. More commonly adolescent-onset, though can occur in childhood. Characterized by discrete episodes with periods of relative remission (though residual symptoms or rapid cycling are common in youth).
Family History Family history of ADHD. Stronger family history of BPAD.
Treatment Stimulants are first-line. Mood stabilizers/atypical antipsychotics are first-line. Stimulants can exacerbate manic symptoms or induce mania in children with underlying BPAD, so caution is needed if both are present.

Differentiation from Disruptive Mood Dysregulation Disorder (DMDD)

DMDD was introduced in DSM-5 to address concerns about overdiagnosis of BPAD in children with severe, chronic irritability.

Feature Disruptive Mood Dysregulation Disorder (DMDD) Bipolar Affective Disorder (BPAD) in Youth
Key Symptom Chronic, severe, persistent irritability (mood is irritable or angry most of the day, nearly every day) and frequent, severe temper outbursts (at least 3 times/week) inconsistent with developmental level. Episodic mood shifts with distinct periods of elevated, expansive, or euphoric mood, or periods of extreme, explosive irritability that are clearly demarcated from baseline. Irritability in BPAD is episodic and distinct, whereas in DMDD, it's chronic.
Mood State Mood is persistently irritable or angry between outbursts. No distinct non-depressed, non-irritable elevated mood periods. Mood can be irritable during a manic/hypomanic episode, but this is accompanied by other manic symptoms (decreased need for sleep, grandiosity, racing thoughts). There are also periods of distinct elevated/expansive mood, or periods of depression.
Episodic Nature Not episodic. The core feature is chronic irritability. Characterized by distinct episodes of mania/hypomania and/or depression. Between episodes, mood may return to baseline, although rapid cycling or residual symptoms are common.
Age of Onset/Diagnosis Symptoms must be present before age 10, diagnosis made between ages 6 and 18. Cannot be diagnosed before age 6 or after age 18. Can be diagnosed at any age, though often presents in adolescence. Onset can be earlier, but manic/hypomanic symptoms must meet criteria.
Manic/Hypomanic Episodes Absence of full manic or hypomanic episodes. If a child meets criteria for a manic/hypomanic episode lasting more than 1 day, then DMDD cannot be diagnosed. Requires the presence of at least one manic or hypomanic episode.
Prognosis Children with DMDD are more likely to develop unipolar depression or anxiety disorders as adults, not BPAD. Children with BPAD are at risk for recurrent mood episodes, functional impairment, and a lifelong course of illness if untreated.

Clinical presentations of Bipolar Affective Disorder in children and adolescents

The clinical presentation of Bipolar Affective Disorder (BAD) in children and adolescents is characterized by variability based on developmental stage, individual differences, and the specific phase of the illness (manic, hypomanic, depressive, or mixed).

I. General Characteristics of Pediatric BPAD

  1. More Irritability than Euphoria: While adult mania often features classic euphoria, children and adolescents with BPAD frequently present with prominent, explosive, and intense irritability during manic/hypomanic episodes, sometimes without any discernible period of elevated mood. This makes it easily mistaken for ODD or DMDD.
  2. Rapid Cycling: A significant proportion of youth with BPAD experience rapid cycling (four or more mood episodes within a year). These shifts can be very quick, sometimes within hours or days, rather than weeks or months.
  3. Mixed Features: Co-occurrence of manic/hypomanic and depressive symptoms within the same episode is very common and can make diagnosis challenging. For example, a child might be extremely agitated and grandiose while simultaneously expressing feelings of worthlessness and suicidal ideation.
  4. Comorbidity: High rates of co-occurring conditions, especially ADHD, anxiety disorders, oppositional defiant disorder (ODD), conduct disorder (CD), and substance use disorders, complicate the clinical picture and diagnosis.
  5. Less Discrete Episodes: In younger children, mood states may not be as clearly demarcated as in adults; rather, there can be a chronic, underlying mood dysregulation with superimposed mood swings.
  6. Psychotic Features: Psychotic symptoms (hallucinations, delusions) are more common in pediatric mania than in adult mania, often manifesting as bizarre or fantastic delusions.

II. Age-Specific Manifestations

A. Preschool/Early Childhood (Ages 3-6):

  • Manic/Hypomanic Episodes:
    • Mood: Intense, prolonged temper tantrums (lasting hours), severe irritability, aggression, inconsolable rage. Can appear "wound up" or "out of control."
    • Energy/Activity: Increased energy and activity that is qualitatively different from typical childhood play; appears driven, relentless, and non-stop. Decreased need for sleep (e.g., needing only 2-3 hours but still appearing rested).
    • Grandiosity: May express grandiose ideas, believe they have special powers, or engage in magical thinking far beyond typical developmental norms (e.g., believing they can fly, superhero fantasies that are acted upon with disregard for safety).
    • Impulsivity: Extreme impulsivity and risk-taking behavior (e.g., running into traffic, climbing to dangerous heights without fear).
    • Speech: Pressured speech, talking very rapidly, constant chatter.
    • Sexualized Behaviors: Inappropriate sexualized language or behavior (rare but can occur).
  • Depressive Episodes:
    • Mood: Persistent sadness, apathy, anhedonia (lack of interest in play), social withdrawal.
    • Physical: Changes in appetite (overeating or undereating), sleep disturbances (hypersomnia or insomnia), low energy, psychomotor retardation.
    • Cognitive: Feelings of worthlessness, guilt (e.g., "I'm a bad kid"), frequent crying spells.
    • Developmental Regression: May regress in toilet training or self-care skills.

    • B. School-Age Children (Ages 7-12):

  • Manic/Hypomanic Episodes:
    • Mood: Marked irritability, anger, lability (rapid shifts between euphoria, irritability, and tearfulness). May be verbally aggressive, defiant, or explosive.
    • Energy/Activity: Excessive energy, hyperactivity, restlessness, agitation. Decreased need for sleep (feeling rested on minimal sleep).
    • Grandiosity: Exaggerated self-esteem, inflated sense of abilities, belief in special talents or invincibility, often leading to arguments with authority figures about rules.
    • Impulsivity: Engaging in risky behaviors (e.g., running away, shoplifting, dangerous dares) without considering consequences.
    • Speech: Pressured speech, flight of ideas, rapid shifts between topics.
    • Distractibility: Easily distracted, difficulty sustaining attention, poor concentration.
    • School Impact: Significant academic decline, difficulty following rules, peer conflicts.
  • Depressive Episodes:
    • Mood: Persistent sadness, hopelessness, anhedonia, tearfulness, irritability.
    • Physical: Changes in appetite/weight, sleep disturbances, fatigue, somatic complaints (headaches, stomachaches).
    • Cognitive: Feelings of worthlessness, guilt, self-blame, poor concentration, difficulty making decisions.
    • Behavioral: Social withdrawal, decline in school performance, increased defiant behavior, self-injurious behavior.
    • Suicidal Ideation: Increased risk of suicidal thoughts or attempts.

    • C. Adolescents (Ages 13-18):

  • Manic/Hypomanic Episodes:
    • Mood: Can present with classic euphoria, expansiveness, or intense, sustained irritability and anger. Mood lability is common.
    • Energy/Activity: High energy, restlessness, agitation, decreased need for sleep (often staying up all night for days, but not feeling tired).
    • Grandiosity: Inflated self-esteem, unrealistic beliefs about talents, power, or wealth. May believe they don't need to follow rules, engage in delusional thinking.
    • Impulsivity/Risk-Taking: Reckless driving, promiscuous sexual behavior, substance abuse (alcohol, illicit drugs), spending sprees, gambling, running away, engaging in illegal activities. This can lead to legal issues.
    • Speech: Pressured speech, racing thoughts, flight of ideas, tangentiality.
    • Psychotic Features: More common than in adults (e.g., persecutory delusions, grandiose delusions, hallucinations).
    • School Impact: Severe academic decline, truancy, expulsion.
    • Social: Alienation from peers, family conflict, inappropriate social behaviors.
  • Depressive Episodes:
    • Mood: Profound sadness, hopelessness, anhedonia, loss of interest in hobbies/friends, irritability.
    • Physical: Significant changes in appetite/weight, chronic fatigue, sleep disturbances (insomnia or hypersomnia).
    • Cognitive: Poor concentration, indecisiveness, feelings of worthlessness, guilt, rumination, difficulty with schoolwork.
    • Behavioral: Social isolation, withdrawal from family, substance abuse, self-harm (cutting, burning), increased somatic complaints.
    • Suicidal Ideation/Attempts: Extremely high risk during depressive episodes.

    • Etiology Of Bipolar Affective Disorder

    Bipolar Affective Disorder (BPAD) is a complex neurodevelopmental illness with a significant biological basis. While psychosocial stressors can trigger episodes, the underlying vulnerability is strongly linked to genetic factors and abnormalities in brain structure, function, and neurochemistry.

    I. Genetic Predispositions:

    Genetics play a powerful role in the etiology of BPAD, particularly in early-onset cases.

    1. High Heritability: BPAD is one of the most heritable psychiatric disorders, with heritability estimates ranging from 60-85%. This means that a significant portion of the risk for developing BPAD is passed down through genes.
    2. Family History: Children and adolescents with a first-degree relative (parent, sibling) who has BPAD are at a significantly higher risk (up to 10-fold) of developing the disorder themselves compared to the general population. The risk increases with the number of affected relatives.
    3. Polygenic Risk: BPAD is not caused by a single gene but rather by the cumulative effect of multiple genes, each contributing a small amount to the overall risk.
    4. Overlap with Other Disorders: Genetic research suggests some shared genetic susceptibility between BPAD and other psychiatric conditions, such as schizophrenia, ADHD, and major depressive disorder. This genetic overlap can help explain the high rates of comorbidity seen in pediatric BPAD.
    5. Specific Genes/Pathways: While no single "bipolar gene" has been identified, research points to genes involved in various neuronal functions, including:
      • Neurotransmitter systems: Genes affecting the synthesis, reuptake, and receptor sensitivity of dopamine, serotonin, and norepinephrine.
      • Ion channels: Genes regulating calcium and sodium channels, which are crucial for neuronal excitability and mood stabilization (relevant to the mechanism of action of some mood stabilizers).
      • Intracellular signaling pathways: Genes involved in pathways like the GSK-3 pathway, which is targeted by lithium.
      • Circadian rhythm genes: Genes that regulate the sleep-wake cycle, given the prominent sleep disturbances in BPAD.

    II. Brain Structure and Functional Differences:

    Neuroimaging studies (MRI, fMRI, PET) have revealed consistent structural and functional abnormalities in the brains of individuals with BAD, even in pediatric populations. These differences are often more pronounced or develop differently in early-onset BPAD compared to adult-onset.

    1. Structural Differences (Volume and Connectivity):
      • Amygdala: Often shows increased volume in youth with BPAD, particularly the left amygdala. The amygdala is a key region involved in processing emotions, fear, and aggression. Dysregulation here can contribute to mood lability and exaggerated emotional responses.
      • Hippocampus: Some studies report reduced hippocampal volume, a region critical for memory and emotion regulation, especially in those with more severe illness or repeated episodes.
      • Prefrontal Cortex (PFC): The PFC, especially the ventrolateral and orbitofrontal regions, is crucial for executive functions, decision-making, impulse control, and emotional regulation. In pediatric BPAD, reduced gray matter volume or altered cortical thickness in these areas has been observed, potentially explaining difficulties with judgment and impulsivity.
      • White Matter Integrity: Alterations in white matter tracts, which connect different brain regions, particularly those connecting the prefrontal cortex with limbic structures, have been found. These altered connections can disrupt efficient communication between emotion-generating and emotion-regulating networks.
      • Basal Ganglia: Abnormalities in the basal ganglia, involved in motor control, motivation, and reward processing, have also been reported.
    2. Functional Differences (Neural Circuitry and Activation Patterns):
      • Dysfunctional Emotion Regulation Networks: This is a core finding. During emotional tasks, individuals with BPAD often show:
        • Increased Amygdala Activity: Over-activation of the amygdala, suggesting heightened emotional reactivity.
        • Decreased Prefrontal Cortex (PFC) Activity: Under-recruitment of the PFC (ventrolateral and dorsolateral PFC), indicating impaired top-down control over emotional responses. This imbalance leads to difficulty modulating strong emotions.
      • Reward Circuitry Dysfunction: Alterations in the brain's reward system (e.g., ventral striatum, nucleus accumbens) lead to exaggerated responses to rewards during manic episodes (e.g., heightened pursuit of pleasurable activities) and diminished responses during depressive episodes (anhedonia).
      • Default Mode Network (DMN): Abnormalities in the DMN, a network active during resting states and self-referential thought, have been implicated, suggesting altered self-processing and introspection, which could contribute to mood disturbances.
      • Abnormal Connectivity: Reduced functional connectivity between the PFC and subcortical limbic regions (amygdala, hippocampus) suggests a "disconnect" in the brain's ability to regulate emotion effectively.

    III. Neurotransmitter Dysregulation:

    Neurotransmitters are chemical messengers that transmit signals across brain cells. Imbalances in these systems are thought to underpin the extreme mood swings in BPAD.

    1. Dopamine: Often considered a key player in mania.
      • Mania: Excessive dopamine activity in reward pathways is hypothesized to drive increased energy, goal-directed behavior, grandiosity, and psychotic symptoms.
      • Depression: Reduced dopamine activity might contribute to anhedonia, low motivation, and fatigue.
    2. Serotonin: Involved in mood, sleep, appetite, and impulse control.
      • Mania/Depression: Dysregulation of serotonin (both excess and deficiency) can contribute to mood instability. Reduced serotonin activity is associated with depression and increased impulsivity.
    3. Norepinephrine (Noradrenaline): Involved in arousal, attention, and the fight-or-flight response.
      • Mania: Elevated norepinephrine levels contribute to increased energy, agitation, and racing thoughts.
      • Depression: Reduced norepinephrine is associated with low energy and difficulty concentrating.
    4. Glutamate and GABA: These are the primary excitatory (glutamate) and inhibitory (GABA) neurotransmitters in the brain.
      • Imbalance: An imbalance between glutamate and GABA can lead to neuronal hyperexcitability (associated with mania) or hypoexcitability (associated with depression). Mood stabilizers like lithium and valproate are thought to modulate these systems.
    5. Other Neurotransmitters/Neuropeptides: Research is also exploring the role of acetylcholine, histamine, and various neuropeptides in BPAD.

    Comprehensive diagnostic process for Bipolar Affective Disorder

    A. Thorough History-Taking (Clinical Interview):

    This is the cornerstone of diagnosis and should be conducted with the child/adolescent and primary caregivers separately, then together.

    1. Presenting Problem: Detailed description of current symptoms, their onset, frequency, intensity, duration, and impact on functioning.
    2. Past Psychiatric History:
      • Previous episodes of depression, mania, hypomania, or mixed symptoms.
      • Any prior diagnoses (e.g., ADHD, ODD, anxiety) and response to treatments.
      • History of self-harm, suicidal ideation/attempts, aggression, impulsivity.
      • Psychiatric hospitalizations or emergency room visits.
    3. Developmental History:
      • Pregnancy and birth complications.
      • Developmental milestones (motor, language, social).
      • Temperament in infancy/early childhood (e.g., difficult temperament, excessive tantrums).
    4. Family Psychiatric History: Critically important for BPAD.
      • History of BPAD, major depression, anxiety disorders, substance use, suicide in first- and second-degree relatives.
      • Early-onset mood disorders in parents.
    5. Medical History:
      • Current and past medical conditions, neurological conditions (e.g., head injury, epilepsy).
      • Current medications (prescription, over-the-counter, supplements) and any illicit substance use.
      • Sleep patterns, appetite changes.
    6. Social/Environmental History:
      • School performance, academic struggles, disciplinary issues.
      • Peer relationships (social isolation, conflicts).
      • Family dynamics, significant stressors (e.g., parental divorce, abuse, neglect, trauma).
      • Substance use history (including nicotine, alcohol, marijuana, illicit drugs).
      • Home environment and safety concerns.

    B. Multi-Informant Assessment:

    Information from various sources provides a more complete and objective picture of the child's functioning across different settings.

    1. Child/Adolescent Interview:
      • Assess their subjective experience of mood, energy, thoughts, and behaviors.
      • Evaluate insight, judgment, and safety (e.g., suicidal/homicidal ideation).
      • Use developmentally appropriate language and techniques.
    2. Parent/Caregiver Interview:
      • Crucial for obtaining historical information, developmental context, and observations of symptoms at home.
      • May use structured interviews or checklists (e.g., Parent-Rated Young Mania Rating Scale, Child Behavior Checklist).
    3. Teacher Reports:
      • Provide invaluable information on symptoms in the school environment (e.g., attention, hyperactivity, irritability, social difficulties, academic performance).
      • May use standardized rating scales (e.g., Conners Rating Scales, Vanderbilt ADHD Diagnostic Parent and Teacher Rating Scales) that can help differentiate ADHD-like symptoms from BPAD.
    4. Other Informants:
      • If applicable, obtain information from other treatment providers (e.g., therapists, previous psychiatrists), coaches, or extended family members.
      • Review previous medical/psychiatric records.

    C. Application of DSM-5 Criteria:

    The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) provides the official diagnostic criteria. For pediatric BPAD, particular attention is paid to:

    1. Manic Episode:
      • A distinct period of abnormally and persistently elevated, expansive, or irritable mood and abnormally and persistently increased goal-directed activity or energy, lasting at least 1 week and present most of the day, nearly every day (or any duration if hospitalization is necessary).
      • Three (or more) of the following symptoms (four if mood is only irritable) are present to a significant degree and represent a noticeable change from usual behavior:
        1. Inflated self-esteem or grandiosity.
        2. Decreased need for sleep (e.g., feels rested after only 3 hours of sleep).
        3. More talkative than usual or pressure to keep talking.
        4. Flight of ideas or subjective experience that thoughts are racing.
        5. Distractibility (i.g., attention too easily drawn to unimportant or irrelevant external stimuli).
        6. Increase in goal-directed activity (either socially, at school or work, or sexually) or psychomotor agitation.
        7. Excessive involvement in activities that have a high potential for painful consequences (e.g., engaging in unrestrained buying sprees, sexual indiscretions, foolish business investments).
      • The mood disturbance is severe enough to cause marked impairment in social or occupational functioning or to necessitate hospitalization to prevent harm to self or others, or there are psychotic features.
      • The episode is not attributable to the physiological effects of a substance or another medical condition.
    2. Hypomanic Episode: Similar symptoms to a manic episode but lasting at least 4 consecutive days, less severe, and not causing marked functional impairment or necessitating hospitalization.
    3. Major Depressive Episode: Five (or more) symptoms present during the same 2-week period and represent a change from previous functioning; at least one symptom is either (1) depressed mood or (2) loss of interest or pleasure.
    4. Bipolar I Disorder: Criteria met for at least one manic episode. Major depressive and hypomanic episodes may precede or follow the manic episode.
    5. Bipolar II Disorder: Criteria met for at least one hypomanic episode AND at least one major depressive episode. There has NEVER been a manic episode.
    6. Cyclothymic Disorder: Numerous periods with hypomanic symptoms and numerous periods with depressive symptoms for at least 1 year in children/adolescents (2 years in adults). Symptoms do not meet full criteria for hypomanic or major depressive episodes.
    7. "With Rapid Cycling": Specifies four or more mood episodes (manic, hypomanic, or major depressive) within 1 year.
    8. "With Mixed Features": Specifies that full criteria are met for a mood episode (manic, hypomanic, or depressive) AND at least three symptoms of the opposite pole are present.

    D. Diagnostic Tools and Rating Scales:

    While not diagnostic on their own, these tools can aid in gathering information, tracking symptom severity, and supporting clinical judgment.

    • Mood Disorder Questionnaire-Adolescent Version (MDQ-A): A brief screening tool for BPAD symptoms.
    • Child Mania Rating Scale (CMRS): Parent- or child-rated scale to assess manic symptoms.
    • Young Mania Rating Scale (YMRS): Clinician-rated scale to assess manic symptoms.
    • Children's Depression Inventory (CDI) / PHQ-9-Adolescent: To assess depressive symptoms.
    • Vanderbilt ADHD Diagnostic Parent and Teacher Rating Scales: To help differentiate from ADHD.
    • Semi-structured Diagnostic Interviews: (e.g., Kiddie Schedule for Affective Disorders and Schizophrenia - Present and Lifetime Version (K-SADS-PL)) often used in research and highly specialized clinical settings.

    Nursing diagnoses for children and adolescents experiencing Bipolar Affective Disorder

    I. Related to Mood Instability:

    1. Impaired Emotional Regulation related to neurobiological dysregulation and mood lability, as evidenced by rapid, extreme shifts in mood (e.g., euphoria to severe irritability/anger), difficulty modulating emotional responses, and disproportionate reactions to stressors.
      Rationale: This diagnosis captures the core mood instability characteristic of BPAD, often manifesting as lability and difficulty controlling emotional expression, particularly during manic, hypomanic, or mixed episodes.
    2. Disturbed Thought Processes related to racing thoughts, flight of ideas, and distractibility secondary to manic/hypomanic episodes, as evidenced by disorganized speech, difficulty concentrating, impaired judgment, and illogical thinking.
      Rationale: During manic phases, cognitive processes are significantly altered, impacting a child's ability to focus, think logically, and communicate coherently.
    3. Risk for Suicide related to depressed mood, hopelessness, mixed features (agitation with depression), impulsivity, and prior self-harm history, as evidenced by verbalizations of suicidal ideation, past attempts, or engaging in self-injurious behaviors (e.g., cutting, burning).
      Rationale: The risk of suicide is significantly elevated in youth with BPAD, particularly during depressive or mixed episodes, and in the presence of impulsivity.
    4. Ineffective Coping related to immature coping mechanisms, overwhelming mood symptoms, and lack of adaptive problem-solving skills, as evidenced by withdrawal, aggression, self-harm, or substance use in response to emotional distress.
      Rationale: Mood instability often overwhelms a child's coping abilities, leading to maladaptive behaviors.
    5. Disturbed Sleep Pattern related to decreased need for sleep during manic/hypomanic episodes or insomnia/hypersomnia during depressive episodes, as evidenced by reports of feeling rested on minimal sleep, difficulty falling/staying asleep, or excessive sleeping.
      Rationale: Sleep disturbance is a hallmark symptom of BPAD, varying across mood states and significantly impacting functioning.

    II. Related to Impulsivity and Risk-Taking Behaviors:

    1. Risk for Injury related to poor judgment, impulsivity, increased psychomotor activity, and disregard for consequences during manic/hypomanic episodes, as evidenced by engaging in dangerous activities (e.g., reckless driving, climbing, running away), aggression, or self-harm.
      Rationale: Manic grandiosity, decreased need for sleep, and poor impulse control drastically increase the likelihood of accidents and harm.
    2. Impaired Social Interaction related to intrusive, irritable, or grandiose behaviors, difficulty with empathy, and rapid mood shifts, as evidenced by peer rejection, conflicts with authority figures, and lack of age-appropriate social skills.
      Rationale: Impulsive and grandiose behaviors, coupled with irritability, can severely disrupt social relationships and lead to isolation.
    3. Ineffective Impulse Control related to neurobiological dysregulation (e.g., prefrontal cortex dysfunction) and manic/hypomanic symptoms, as evidenced by acting without thinking, interrupting others, physical aggression, or engaging in inappropriate sexual behaviors.
      Rationale: This is a direct consequence of the neurological changes in BPAD, especially prominent during elevated mood states.
    4. Risk for Other-Directed Violence related to extreme irritability, low frustration tolerance, impulsivity, and poor anger management, as evidenced by verbal threats, physical aggression towards others, property destruction, or history of outbursts.
      Rationale: Severe irritability and agitation during manic or mixed states can lead to violent or aggressive outbursts.
    5. Risk for Substance Abuse related to impulsivity, desire for mood alteration/self-medication, and peer pressure, as evidenced by reported or observed experimentation with drugs/alcohol, or family history of substance abuse.
      Rationale: Adolescents with BPAD are at significantly higher risk for substance use, which can exacerbate mood symptoms and complicate treatment.

    III. Related to Family Dynamics:

    1. Compromised Family Coping related to the chronic, unpredictable nature of BPAD, emotional burden, stigma, and lack of understanding of the illness, as evidenced by family conflict, caregiver exhaustion, social isolation of the family, and difficulty maintaining routines.
      Rationale: BPAD profoundly impacts the entire family system, demanding significant adjustments and often leading to stress and dysfunction.
    2. Impaired Family Processes related to the child's mood instability, challenging behaviors, communication breakdowns, and inconsistent parenting strategies, as evidenced by lack of clear boundaries, ineffective conflict resolution, and parental guilt/blame.
      Rationale: The child's symptoms can disrupt family roles, communication patterns, and overall family functioning.
    3. Deficient Knowledge related to the nature, symptoms, course, and management of pediatric BPAD, as evidenced by verbalized questions, unrealistic expectations for recovery, non-adherence to treatment plan, or inappropriate responses to symptoms.
      Rationale: Parents and children often lack accurate information about BPAD, which is crucial for engagement in treatment and effective management.
    4. Caregiver Role Strain related to the demands of caring for a child with a chronic, complex mental illness, difficulty accessing resources, and managing challenging behaviors, as evidenced by reports of stress, fatigue, anxiety, depression, or feeling overwhelmed.
      Rationale: The intense, long-term nature of caring for a child with BPAD places immense strain on caregivers.

    Specific nursing care for a child/adolescent with BPAD

    It requires a collaborative, interdisciplinary approach, with the nurse playing a central role in coordination, education, and direct care. The plan prioritizes safety, effective symptom management, and fostering resilience and adaptive coping skills.

    Goals for the Child/Adolescent with BPAD:

    1. Achieve and maintain mood stability.
    2. Ensure safety (self and others) and prevent injury.
    3. Improve functioning in home, school, and social environments.
    4. Develop adaptive coping and emotion regulation skills.
    5. Enhance family understanding and support.
    6. Promote adherence to treatment.

    A. Safety Management (Highest Priority)

    Nursing Diagnosis Interventions
    Risk for Suicide; Risk for Injury; Risk for Other-Directed Violence.
    • Continuous Assessment: Regularly assess for suicidal ideation, intent, plan, and access to means. Assess for homicidal ideation or aggressive impulses.
    • Environmental Safety:
      • Remove all potential means of self-harm (sharp objects, ropes, medications, firearms, ligatures) from the patient's environment.
      • Supervise patient closely, especially during periods of agitation, impulsivity, or depression. Implement 1:1 observation if risk is high.
      • Maintain a calm and structured environment to reduce stimulation and agitation.
    • Behavioral De-escalation:
      • Use verbal de-escalation techniques (calm tone, non-confrontational stance, offering choices) for agitation or escalating behaviors.
      • Implement behavioral contracts or safety plans with the patient (if developmentally appropriate) and family.
      • Teach the patient to identify triggers and early warning signs of escalating mood states.
    • Medication Management: Administer prescribed medications (e.g., mood stabilizers, antipsychotics, anxiolytics) as ordered to reduce acute symptoms of mania, aggression, or psychosis. Monitor for effectiveness and side effects.
    • Limit Setting & Structure: Clearly communicate behavioral expectations and consequences. Provide consistent boundaries.
    • Family Education: Educate family on safety precautions, recognizing warning signs, and how to respond during crises. Develop an emergency plan.

    B. Pharmacological Interventions & Management

    Nursing Diagnosis Interventions
    Impaired Emotional Regulation; Disturbed Thought Processes; Disturbed Sleep Pattern.
    • Administer Medications: Accurately administer prescribed psychotropic medications (mood stabilizers like Lithium, Valproate; atypical antipsychotics like Olanzapine, Risperidone, Quetiapine; sometimes antidepressants, but with extreme caution and always with a mood stabilizer).
    • Monitor for Therapeutic Effects: Observe and document changes in mood, energy, sleep, thought processes, and behavior. Collaborate with the prescriber regarding medication efficacy.
    • Monitor for Side Effects: Assess for common and serious side effects (e.g., weight gain, metabolic syndrome, extrapyramidal symptoms, tremors, nausea, sedation). Conduct regular vital signs, labs (e.g., Lithium levels, LFTs, renal function, CBC, glucose, lipids), and physical assessments.
    • Medication Education: Educate patient and family about:
      • Purpose, dose, frequency, and expected effects of each medication.
      • Common and serious side effects and what to report immediately.
      • Importance of adherence, even when feeling better.
      • Potential interactions with other medications, OTCs, or substances.
      • Never abruptly stopping medications.

    C. Psychotherapeutic Interventions (Nurse's Role in Supporting & Facilitating)

    Nursing Diagnosis Interventions
    Ineffective Coping; Impaired Emotional Regulation; Impaired Social Interaction; Disturbed Thought Processes.
    • Therapeutic Communication: Establish a trusting relationship. Use active listening, empathy, and validation.
    • Cognitive Behavioral Therapy (CBT) Skills:
      • Cognitive Restructuring: Help the patient identify and challenge negative or grandiose thought patterns.
      • Problem-Solving: Guide the patient through a systematic approach to problem identification and solution generation.
      • Mindfulness/Relaxation: Teach techniques to manage anxiety and promote emotional regulation.
    • Dialectical Behavior Therapy (DBT) Skills (adapted for youth):
      • Emotion Regulation: Teach skills to identify, understand, and manage intense emotions.
      • Distress Tolerance: Teach strategies to cope with painful emotions and urges without engaging in maladaptive behaviors.
      • Interpersonal Effectiveness: Help improve communication and relationship skills.
    • Behavioral Management:
      • Develop clear behavioral plans with rewards and consequences.
      • Encourage participation in structured activities to provide routine and reduce boredom/idle time.
    • Social Skills Training: Role-play social interactions, teach appropriate communication, and conflict resolution skills.
    • Support Groups: Refer patient and family to peer support groups.

    D. Psychoeducational Interventions

    Nursing Diagnosis Interventions (for patient and family)
    Deficient Knowledge; Compromised Family Coping.
    • Illness Education: Provide clear, age-appropriate information about BPAD:
      • What it is (brain-based illness, not a choice).
      • Common symptoms (mania, depression, mixed states, rapid cycling).
      • Genetic and neurobiological factors (to reduce blame/stigma).
      • Chronic nature and episodic course of the illness.
    • Symptom Recognition & Early Warning Signs: Teach patient and family to identify individual triggers, prodromal symptoms, and early warning signs of escalating mood (e.g., changes in sleep, energy, irritability, thoughts).
    • Relapse Prevention Plan: Develop a personalized plan including:
      • Action steps for early symptom recognition.
      • Contact information for emergency support.
      • Strategies for managing stressors.
      • Importance of maintaining routine sleep-wake cycles.
    • Stress Management: Teach relaxation techniques, healthy coping strategies, and effective communication skills to manage family stress.
    • Advocacy: Educate parents on how to advocate for their child in school and community settings (e.g., 504 plans, IEPs).
    • Lifestyle Management: Emphasize regular sleep, healthy diet, regular exercise, and avoidance of alcohol/substances.
    • Treatment Adherence: Reinforce the importance of consistent medication use and therapy attendance.

    E. Family Support and System Interventions

    Nursing Diagnosis Interventions
    Compromised Family Coping; Impaired Family Processes; Caregiver Role Strain.
    • Family Therapy: Facilitate family therapy sessions to improve communication, resolve conflicts, and establish consistent expectations and boundaries.
    • Support for Caregivers:
      • Assess for caregiver burden, stress, and signs of burnout.
      • Provide resources for caregiver support groups, respite care, or individual counseling.
      • Encourage caregivers to practice self-care.
    • Role Definition: Help family members understand their roles and responsibilities in supporting the patient.
    • Environmental Adjustments: Collaborate with the family to create a structured, predictable, and low-stimulus home environment.
    • Resource Navigation: Assist families in connecting with school services, community mental health programs, and financial assistance if needed.

    Mania

    Mania is a core feature of Bipolar I Disorder, characterized by a distinct period of abnormally and persistently elevated, expansive, or irritable mood and abnormally and persistently increased goal-directed activity or energy.

    I. Core Characteristics

    • Elevated Mood: Ranges from cheerfulness and euphoria to extreme elation. This can quickly switch to irritability, anger, or hostility, especially when the individual's grandiose plans are thwarted or they are challenged.
    • Increased Activity/Energy: A profound and persistent increase in goal-directed activity (socially, at work/school, sexually) or psychomotor agitation.

    II. Types of Manic/Hypomanic Episodes

    1. Hypomania: A milder form of mania. The symptoms are similar but less severe and of shorter duration (at least 4 consecutive days).
      • Impact: Does not cause marked impairment in social or occupational functioning and typically does not require hospitalization. Psychotic features are absent. While individuals in a hypomanic state may feel unusually productive or well, they often receive negative feedback from others due to their altered behavior.
    2. Acute Mania: A severe and full-blown manic episode.
      • Impact: Symptoms are intense, causing significant impairment in functioning, and often necessitating hospitalization due to risk of harm to self or others, or severe psychotic features.
    3. Delirious Mania: An extreme form of mania characterized by profound excitement, severe psychomotor agitation, confusion, disorientation, and often florid psychotic symptoms (e.g., delusions, hallucinations).
      • Context: While you mention "mainly found in organic psychoses," it can also occur in severe functional mania, representing a psychiatric emergency.
    4. Chronic Mania: A manic state that has persisted for an extended period, often years, and has proven resistant to various forms of treatment.
      • Demographics: As you note, it is often seen in individuals aged 40 years and above, potentially reflecting a more entrenched or treatment-refractory illness course.

    III. Etiology (Causes of Mania)

    Mania is understood to arise from a complex interplay of genetic, neurobiological, and psychosocial factors.

    1. Genetic Factors:
      • Heritability: Strong evidence indicates a significant genetic predisposition; mania "runs in families." Individuals with a first-degree relative with BPAD have a substantially higher risk.
    2. Neurobiological Factors (Neurotransmitter Dysregulation):
      • Norepinephrine: Increased levels of norepinephrine metabolites are associated with the heightened energy, arousal, and psychomotor agitation seen in mania.
      • Dopamine: Elevated dopamine levels, particularly in reward pathways, are strongly implicated in the euphoric mood, increased goal-directed behavior, grandiosity, and sometimes psychotic symptoms of mania.
      • Serotonin: Imbalances in serotonin levels contribute to overall mood dysregulation. While often associated with depression, serotonin plays a complex role in mood stability, and its dysregulation can contribute to both poles of BPAD.
    3. Cyclothymic Personality:
      • Definition: A temperament characterized by chronic, fluctuating mood states that don't meet full criteria for hypomania or depression.
      • Role: While not a cause per se, a cyclothymic temperament is considered a significant risk factor or a prodromal state that can predispose an individual to developing full-blown BPAD, including manic episodes.
    4. Body Physic (Temperament/Constitution): This likely refers to inherent temperamental traits that might interact with other factors, though modern psychiatry focuses more on specific neurobiological and genetic markers.
    5. Psychosocial Factors:
      • Stressors: Significant life stressors (e.g., divorce, bereavement, job loss, interpersonal conflict) can act as triggers for manic episodes, especially in genetically vulnerable individuals. These stressors often interact with biological predispositions (stress-diathesis model).
      • Sleep Deprivation: Can be a potent trigger for mania or hypomania in susceptible individuals.

    IV. Clinical Features of Mania (Symptoms)

    The symptoms of mania are profound and affect mood, cognition, behavior, and physical functioning.

    1. Mood:
      • Elation/Euphoria: Excessive happiness, joy, or high spirits.
      • Irritability: Can rapidly shift from euphoria to extreme irritability, anger, or hostility, especially when thwarted.
    2. Behavioral/Activity:
      • Boundless Energy/Restlessness: A significant increase in energy levels, leading to restlessness and incessant activity.
      • Increased Goal-Directed Activity: Engaging in multiple activities simultaneously, often with excessive enthusiasm and poor planning (e.g., starting numerous projects, engaging in social events, excessive work).
      • Psychomotor Agitation: Non-goal-directed motor activity (e.g., pacing, fidgeting).
      • Excessive Involvement in Pleasurable Activities: Engaging in activities with a high potential for painful consequences (e.g., reckless spending, sexual indiscretions, foolish business investments, gambling).
      • Increased Urge for Sex (High Libido): Often accompanied by disinhibition.
      • Inappropriate Dressing: Selection of bright, clashing colors, excessive makeup, and jewelry, reflecting grandiosity or disinhibition.
    3. Cognitive/Thought Processes:
      • Racing Thoughts: Subjective experience that thoughts are moving too quickly.
      • Flight of Ideas: Rapidly shifting from one topic to another, often with discernible connections, but the pace makes it difficult to follow.
      • Pressure of Speech/Over-talkativeness: Speaking rapidly, loudly, and often continuously, difficult to interrupt.
      • Distractibility: Poor concentration, attention easily drawn to unimportant external stimuli.
      • Delusions of Grandeur: Exaggerated beliefs about one's own importance, power, knowledge, or identity (e.g., believing oneself to be a celebrity, deity, or having special abilities). These are more pronounced in severe mania.
      • Ideas of Reference: Belief that unrelated events, objects, or people have a particular and unusual significance to oneself.
      • Lost Insight: Lack of awareness that one is ill or that one's behavior is problematic.
    4. Physical:
      • Decreased Need for Sleep: Feeling rested after only a few hours of sleep, or experiencing total insomnia, without feeling fatigued.
      • High Appetite/Lack of Time to Eat: Despite increased appetite, individuals may neglect eating due to hyperactivity, leading to weight loss and dehydration.
    5. Perceptual (in severe cases):
      • Auditory Hallucinations: Hearing voices or sounds that are not present, common in acute mania with psychotic features.

    V. Diagnosis of Mania (DSM-5 Criteria Highlights)

    The diagnosis of a manic episode requires the presence of:

    1. Abnormally and persistently elevated, expansive, or irritable mood.
    2. Abnormally and persistently increased goal-directed activity or energy.
    3. Duration: Lasting at least 1 week and present most of the day, nearly every day (or any duration if hospitalization is necessary).
    4. Significant Impairment: Severe enough to cause marked impairment in social or occupational functioning, or to necessitate hospitalization, or there are psychotic features.
    5. Three (or more) of the following symptoms (four if mood is only irritable):
      • Grandiosity (overrating one's self).
      • Decreased need for sleep.
      • Over-talkativeness/Pressure of speech.
      • Flight of ideas/Racing thoughts.
      • Distractibility.
      • Increase in goal-directed activity or psychomotor agitation (Boundless energy, over activity).
      • Excessive involvement in pleasurable activities with high potential for painful consequences.

    VI. Management of Mania

    The management of mania is multifaceted, aiming to stabilize the patient, ensure safety, and prevent recurrence.

    A. Environmental and Supportive Interventions:

    1. Hospitalization:
      • Indications: Essential for patients who are too excited, pose a risk to self or others, are severely disinhibited, unable to care for themselves (e.g., not eating, drinking, or sleeping), or are experiencing psychotic features.
      • Benefits: Provides a safe, structured, and low-stimulus environment, facilitating close observation and medication management.
    2. Therapeutic Relationship:
      • Foundation: Establishing a calm, consistent, and empathetic therapeutic relationship is paramount. It forms the basis for all nursing care and enhances patient cooperation.
    3. De-escalation and Restraint:
      • Initial Approach: For agitated or restless patients, verbal de-escalation with a calm, firm, and direct approach should be attempted.
      • Pharmacological Intervention: If verbal de-escalation is ineffective, rapid tranquilization with sedatives/antipsychotics (e.g., chlorpromazine 100-200mg IM, haloperidol 5-10mg IM) may be necessary to ensure safety. Dosages are adjusted as symptoms subside.
    4. Low Stimulus Environment:
      • Rationale: Reducing environmental stimulation (noise, bright lights, excessive activity) helps to decrease agitation, promote calm, and reduce distractibility.
      • Implementation: Quiet room, soft lighting, minimal visitors, avoidance of overstimulating activities.
    5. Safety Precautions:
      • Remove Dangerous Objects: Crucial to remove any potential weapons or items for self-harm (e.g., sharp instruments, glass, ligatures, easily portable heavy objects).
      • Constant Supervision: Close observation, sometimes 1:1, is essential, especially during acute phases.
    6. Physical Care:
      • Nutrition and Hydration:
        • Challenge: Patients are often too busy/hyperactive to eat or drink adequately, risking weight loss and dehydration.
        • Intervention: Provide frequent, high-calorie, high-protein, easily portable finger foods and ample fluids. Supervise meals. Supplementation may be necessary.
      • Hygiene: Supervise and assist with personal hygiene (bathing, oral care, dressing) as patients may neglect these due to preoccupation or disorganization.
      • Sleep: Promote rest by creating a calm environment and administering sedating medications as prescribed.
    7. Communication:
      • Style: Use short, simple, direct sentences. Avoid complex explanations or arguments.
      • Consistency: All staff should approach the patient with a consistent plan.
    8. Observation: Continuously observe and document patient behavior, mood, sleep patterns, eating habits, and toilet habits, reporting any significant changes.
    9. Injury Management: Attend to any injuries sustained due to hyperactivity or impulsivity.

    B. Drug Treatment (Pharmacotherapy):

    Pharmacotherapy is the cornerstone of acute mania management and relapse prevention.

    1. Antipsychotics (for acute symptom control):
      • Mechanism: Used to rapidly control agitation, aggression, psychosis, and severe sleep disturbance.
      • Examples:
        • Chlorpromazine (CPZ): 100-1200mg in divided doses. Can be sedating.
        • Thioridazine: 100-600mg in divided doses. Also noted for potentially lowering libido.
        • Haloperidol: 5-15mg nocte (often 5-15mg/day, but can be given acutely as 5-10mg IM). Effective for severe agitation and psychosis.
      • Note: Antipsychotics are often used acutely to stabilize the patient, and then mood stabilizers are used for long-term management.
    2. Mood Stabilizers (for long-term management and prophylaxis):
      • Lithium Carbonate:
        • First-line: Often considered the drug of choice, especially for classic euphoria-driven mania.
        • Dosage: 250-550mg (this is usually a starting dose, titrated based on blood levels and clinical response, typical maintenance levels are 0.6-1.2 mEq/L).
        • Monitoring: Requires regular blood level monitoring due to a narrow therapeutic window.
      • Anticonvulsants (with mood-stabilizing properties):
        • Sodium Valproate (Valproic Acid): 100-1500mg in divided doses (often given as Divalproex Sodium). Highly effective for mixed episodes and rapid cycling.
        • Carbamazepine: 100-400mg in divided doses. Used for acute mania and maintenance.
      • Other:
        • Benzhexol (Artane): An anticholinergic medication, often prescribed to counteract extrapyramidal side effects of antipsychotics, not a primary treatment for mania itself.

    C. Electroconvulsive Therapy (ECT):

    • Indications: Highly effective for severe manic excitement, especially when rapid response is needed (e.g., severe self-harm risk, catatonia, unresponsiveness to medication) or when medications are contraindicated.
    • Protocol: Typically 1-2 shocks per week for 6-9 weeks.
    • Combination: Most effective when used in combination with pharmacotherapy.

    D. Other Therapies:

    1. Occupational Therapy:
      • Purpose: Helps recovering patients reintegrate into daily routines, develop vocational skills, and engage in meaningful activities.
      • Individualized: The type of occupation varies based on the individual's interests and abilities.
    2. Psychotherapy:
      • Family Psychotherapy: Crucial for helping families understand the illness, improve communication, manage stress, and develop coping strategies.
      • Individual Therapy: For the patient, focusing on psychoeducation, coping skills, relapse prevention, and addressing underlying psychological issues.
    3. Resettlement and Follow-up:
      • Continuity of Care: Essential for long-term stability. Involves coordinating with community resources, ensuring medication adherence, and facilitating ongoing therapy.

    VII. Nursing Care of Manic Patients

    This section reiterates and emphasizes the practical aspects of nursing care during a manic episode, integrating the points discussed above.

    1. Prioritize Safety: Remove dangerous objects, ensure supervision, and manage agitation effectively.
    2. Maintain Physical Health: Ensure adequate nutrition, hydration, sleep, and hygiene.
    3. Environmental Management: Create a low-stimulus, structured, and consistent environment.
    4. Therapeutic Communication: Use calm, direct, and simple language. Assign one nurse for consistency if possible.
    5. Medication Management: Administer medications, monitor effects and side effects, and provide education.
    6. Observation and Documentation: Continuously monitor and record changes in behavior, mood, and physical status.
    7. Address Injuries: Provide care for any physical injuries.

    VIII. Prognosis

    • Acute Episode Resolution: With appropriate treatment, most manic episodes resolve within three months, rarely lasting beyond six months.
    • Risk of Recurrence: There is a significant risk of recurrence, especially if the disorder begins before 30 years of age. BPAD is a chronic, episodic illness.
    • Sequential Episodes: Studies indicate that 10-20% of individuals with BPAD may experience multiple depressive episodes before their first manic episode.
    • Compared to Schizophrenia: The prognosis for BPAD is generally better than for schizophrenia, particularly concerning functional outcomes.

    Bipolar Affective Disorder Read More »

    Mood Disorders in Children and Adolescents

    Mood Disorders in Children and Adolescents

    Mood Disorders In Children and Adolescents

    In psychiatry, mood disorders (also known as affective disorders) are a group of mental health conditions characterized by a significant disturbance in a person's emotional state or mood.

    This disturbance is severe enough to cause considerable distress and impair functioning in various aspects of life, such as school, family, social relationships, and daily activities.

    For children and adolescents, these mood disturbances are often expressed differently than in adults, making diagnosis challenging. While adults might overtly express sadness or euphoria, youth might present with irritability, somatic complaints, behavioral problems, or school refusal.

    The key feature is a sustained change in mood that represents a departure from the individual's typical emotional baseline and is not attributable to a transient situation or normal emotional fluctuations.

    Primary Mood Disorders in Children and Adolescents:

    The primary mood disorders we focus on are depressive disorders and bipolar disorders.

    A. Depressive Disorders:

    These are characterized by persistent sadness, loss of interest or pleasure (anhedonia), and a range of associated emotional, cognitive, behavioral, and physical symptoms.

    1. Major Depressive Disorder (MDD): Characterized by one or more Major Depressive Episodes. A Major Depressive Episode involves a period of at least two consecutive weeks where an individual experiences five or more of the following symptoms, with at least one symptom being either (1) depressed mood or (2) loss of interest or pleasure:
      • Depressed mood most of the day, nearly every day (often irritable mood in children/adolescents).
      • Markedly diminished interest or pleasure in all, or almost all, activities most of the day, nearly every day.
      • Significant unintentional weight loss or gain, or decrease/increase in appetite.
      • Insomnia or hypersomnia nearly every day.
      • Psychomotor agitation or retardation nearly every day.
      • Fatigue or loss of energy nearly every day.
      • Feelings of worthlessness or excessive or inappropriate guilt nearly every day.
      • Diminished ability to think or concentrate, or indecisiveness, nearly every day.
      • Recurrent thoughts of death, recurrent suicidal ideation without a specific plan, or a suicide attempt or a specific plan for committing suicide.
      In Youth: Depressed mood is often manifested as irritability, anger, or temper outbursts rather than overt sadness. Other common presentations include social withdrawal, academic decline, somatic complaints (headaches, stomachaches), and an increase in disruptive behaviors.
    2. Persistent Depressive Disorder (PDD) / Dysthymia:
      • Core Feature: A chronic form of depression, characterized by a depressed mood (or irritable mood in children/adolescents) for most of the day, for more days than not, for at least one year (for children and adolescents; two years for adults).
      • Symptoms: While less severe than MDD, individuals experience at least two additional depressive symptoms (e.g., poor appetite/overeating, insomnia/hypersomnia, low energy/fatigue, low self-esteem, poor concentration/difficulty making decisions, feelings of hopelessness).
      • In Youth: Can be insidious in onset and often perceived as part of the child's "personality," leading to delayed diagnosis. Impairs functioning over a prolonged period.

    B. Bipolar Disorders:

    These are characterized by significant mood swings that include episodes of both depression and abnormally elevated, expansive, or irritable mood (mania or hypomania).

    1. Bipolar I Disorder: Defined by the occurrence of at least one Manic Episode. A Manic Episode is a distinct period of abnormally and persistently elevated, expansive, or irritable mood and abnormally and persistently increased goal-directed activity or energy, lasting at least one week and present most of the day, nearly every day.
      • Symptoms: During this period, three or more of the following symptoms (four if the mood is only irritable) are present to a significant degree and represent a noticeable change from usual behavior:
        • Inflated self-esteem or grandiosity.
        • Decreased need for sleep.
        • More talkative than usual or pressure to keep talking.
        • Flight of ideas or subjective experience that thoughts are racing.
        • Distractibility.
        • Increase in goal-directed activity or psychomotor agitation.
        • Excessive involvement in activities that have a high potential for painful consequences (e.g., unrestrained buying sprees, sexual indiscretions, foolish business investments).
      • In Youth: Manic episodes in children and adolescents often present with severe irritability, explosive temper outbursts, aggressive behavior, rapid mood shifts, and distractibility rather than classic euphoria. Grandiosity might involve exaggerated claims of ability or possessions. Psychotic features can occur. Depressive episodes also typically occur.
    2. Bipolar II Disorder: Defined by at least one Hypomanic Episode and at least one Major Depressive Episode. A Hypomanic Episode is similar to a manic episode but is less severe and shorter in duration (at least four consecutive days). It does not cause marked impairment in social or occupational functioning or necessitate hospitalization.
      In Youth: Often presents with chronic or recurrent depression punctuated by episodes of elevated energy, decreased need for sleep, and irritability. Hypomanic episodes can be easily missed or misinterpreted as normal "highs" or behavioral problems.
    3. Cyclothymic Disorder: A chronic, fluctuating mood disturbance involving numerous hypomanic symptoms and numerous depressive symptoms for at least one year (for children and adolescents; two years for adults), that do not meet the full criteria for a hypomanic or major depressive episode.
      • In Youth: Characterized by recurrent mood swings that are less extreme but more persistent than those in Bipolar I or II.
    4. Premenstrual Dysphoric Disorder (PMDD): This includes depressive symptoms, irritability, and tension before menstruation.
      Consideration for Children/Adolescents: PMDD is primarily diagnosed in post-menarcheal adolescents and adult women. While it can certainly affect adolescent females, especially after the onset of regular menstrual cycles, it's generally considered a diagnosis for individuals who are experiencing regular menstruation. Its symptoms are specifically timed to the luteal phase of the menstrual cycle and remit shortly after the onset of menses. It would be an important consideration for adolescent girls presenting with cyclical mood symptoms.
    5. Mood Disorder Due to a General Medical Condition: Many medical illnesses, including cancer, injuries, and chronic medical illnesses, can trigger symptoms of depression.
      Consideration for Children/Adolescents: This is absolutely critical in pediatric and adolescent psychiatry. Any child or adolescent presenting with mood symptoms must undergo a thorough medical workup to rule out underlying medical causes.

      Examples include:

      • Endocrine disorders: Thyroid dysfunction, diabetes.
      • Neurological conditions: Epilepsy, traumatic brain injury, multiple sclerosis.
      • Chronic illnesses: Autoimmune diseases (e.g., lupus), cancer, chronic pain conditions, inflammatory bowel disease.
      • Nutritional deficiencies: Vitamin D, B12 deficiency.
      • Infections: Post-viral syndromes.

      The key here is that the mood disturbance is judged to be a direct physiological consequence of another medical condition.

    6. Substance-Induced Mood Disorder: Symptoms of depression due to drug use, the effects of a medication, or exposure to toxins.
      Consideration for Children/Adolescents: Highly relevant for adolescents. Substance use (alcohol, cannabis, stimulants, opioids, hallucinogens, etc.) can both induce mood symptoms (depressive or manic-like) and exacerbate pre-existing mood disorders. Certain prescribed medications (e.g., corticosteroids, some acne medications like isotretinoin, certain antihypertensives) can also cause mood side effects. Exposure to environmental toxins is less common but possible. A thorough substance use history and medication review are essential during assessment. The mood disturbance must develop during or soon after substance intoxication or withdrawal, or after exposure to a medication/toxin, and the involved substance must be capable of producing the symptoms.

    Differentiating Primary Mood Disorders from Mood Dysregulation:

    This distinction is particularly important with the introduction of a new diagnosis in DSM-5.

    1. Disruptive Mood Dysregulation Disorder (DMDD):

    DMDD was introduced in DSM-5 to address concerns about the overdiagnosis of Bipolar Disorder in children, especially those with chronic, severe irritability and temper outbursts, who did not experience distinct, episodic mania/hypomania.

    • Core Features:
      • Severe Recurrent Temper Outbursts: Outbursts are grossly out of proportion in intensity or duration to the situation or provocation, occur frequently (three or more times per week), and are inconsistent with developmental level.
      • Persistent Irritable or Angry Mood: Present most of the day, nearly every day, between temper outbursts.
      • Duration: Symptoms must be present for at least 12 months, without a period of 3 or more consecutive months without all symptoms.
      • Onset: Onset before age 10, with diagnosis not made before age 6 or after age 18.
      • Exclusivity: The diagnosis cannot coexist with Bipolar Disorder or Oppositional Defiant Disorder (ODD), though it can coexist with MDD, anxiety disorders, and ADHD.
    • Key Differentiation from Bipolar Disorder: DMDD is characterized by chronic, inter-episode irritability and non-episodic temper outbursts, not distinct periods of mania or hypomania. Children with DMDD do not have the classic "mood cycling" of bipolar disorder, nor do they typically experience the same degree of grandiosity, decreased need for sleep, or racing thoughts that characterize mania/hypomania. The mood is persistently negative, not episodically elevated.
    • Key Differentiation from ODD: While both involve irritability and defiance, DMDD's temper outbursts are more severe, more frequent, and more pervasive, with persistent severe irritability between outbursts that is not seen in ODD.

    Manifestations of Depressive Disorders and Bipolar Disorders as they present in children and adolescents.

    The symptoms of mood disorders in children and adolescents are often age-dependent and can be masked by developmental stage, making them difficult to recognize. Unlike adults who might articulate feelings of sadness or euphoria, youth often express their distress through behavioral changes, irritability, or physical complaints.

    Depressive disorders (Major Depressive Disorder, Persistent Depressive Disorder/Dysthymia) in youth are characterized by a pervasive low mood and/or loss of pleasure, accompanied by a range of emotional, cognitive, behavioral, and physical symptoms.

    A. Emotional Manifestations:

    1. Irritability/Anger (Most Common in Youth): This is perhaps the most significant difference from adult depression. Instead of sadness, children and adolescents often present with persistent crankiness, short temper, rage outbursts, or an inability to tolerate minor frustrations. They might seem constantly annoyed or easily provoked.
    2. Persistent Sadness/Unhappiness: While often masked by irritability, children may express feelings of sadness, being down, or tearfulness. They might report feeling "empty" or "nothing matters."
    3. Loss of Interest or Pleasure (Anhedonia): A decrease in enjoyment from activities previously found pleasurable (e.g., hobbies, sports, playing with friends, video games). They might seem bored, withdrawn, or uninterested in anything.
    4. Feelings of Hopelessness/Worthlessness/Guilt: Children may express negative self-perception, feeling like a failure, blaming themselves for problems, or believing things will never get better.
    5. Anxiety Symptoms: Increased worry, nervousness, or fearfulness often co-occurs with depression.

    B. Behavioral Manifestations:

    1. Social Withdrawal/Isolation: Avoiding friends, family activities, or social events. Spending more time alone in their room.
    2. Changes in Activity Level: Can be either psychomotor retardation (slowing down, lack of energy, lethargy) or psychomotor agitation (restlessness, inability to sit still, fidgeting).
    3. Academic Decline: Decreased concentration, difficulty focusing, forgetfulness, lower grades, missing assignments, or school refusal.
    4. Behavioral Problems/Acting Out: Increased defiance, aggression, oppositional behavior, or substance use (especially in adolescents) can sometimes be a manifestation of underlying depression.
    5. Increased Sensitivity/Tearfulness: Crying easily or becoming upset over minor issues.
    6. Self-Harm/Suicidal Behavior: Non-suicidal self-injury (e.g., cutting, burning) or suicidal ideation, threats, gestures, or attempts are serious manifestations and require immediate attention.

    C. Cognitive Manifestations:

    1. Difficulty Concentrating/Indecisiveness: Problems paying attention in class, reading, or making simple decisions.
    2. Memory Problems: Forgetfulness, difficulty retaining new information.
    3. Negative Thinking: Pervasive pessimistic outlook, catastrophic thinking, focusing on failures.
    4. Preoccupation with Death/Dying: Thoughts about death, their own mortality, or wishing they weren't alive.

    D. Physical (Somatic) Manifestations:

    1. Changes in Appetite/Weight: Can be either decreased appetite leading to weight loss (or failure to gain weight as expected) or increased appetite leading to weight gain.
    2. Sleep Disturbances: Insomnia (difficulty falling or staying asleep, early morning waking) or hypersomnia (sleeping excessively, difficulty waking up).
    3. Fatigue/Low Energy: Persistent tiredness, lack of motivation, feeling physically drained even after rest.
    4. Unexplained Physical Complaints: Frequent headaches, stomachaches, or other body aches without a clear medical cause.

    II. Core Manifestations of Bipolar Disorders in Children and Adolescents:

    Bipolar disorders involve distinct periods of elevated mood (mania or hypomania) and often periods of depression. The manifestation of mania/hypomania in youth is particularly challenging to differentiate from severe ADHD or ODD.

    A. Manic/Hypomanic Episodes (Often Present as Irritability/Explosiveness in Youth):

    1. Severe Irritability/Explosiveness (Most Common): Instead of classic euphoria, manic episodes in children and adolescents are often characterized by persistent, severe irritability, rage, violent outbursts, and extreme defiance. This can be episodic or more continuous during an episode.
    2. Elevated/Expansive Mood: Less common, but can include periods of excessive cheerfulness, giddiness, silliness, or inappropriate euphoria, sometimes out of context.
    3. Grandiosity/Inflated Self-Esteem: Exaggerated beliefs about one's abilities, talents, or importance. May make unrealistic plans, believe they have special powers, or feel invulnerable.
    4. Decreased Need for Sleep: Significant reduction in sleep duration (e.g., sleeping only 2-3 hours) without feeling tired, feeling rested after very little sleep. This is a classic and highly diagnostic symptom.
    5. Pressured Speech/Increased Talkativeness: Talking excessively, very rapidly, loudly, or about multiple topics simultaneously, difficult to interrupt.
    6. Flight of Ideas/Racing Thoughts: Subjective experience that thoughts are moving too quickly, jumping from one idea to another, difficulty staying on topic.
    7. Distractibility: Easily sidetracked by irrelevant stimuli, difficulty focusing attention.
    8. Increased Goal-Directed Activity/Psychomotor Agitation: Excessive involvement in multiple activities, starting many projects but not finishing them, restlessness, fidgeting, pacing, impulsively engaging in risky behaviors.
    9. Reckless/Risky Behavior: Engaging in actions with high potential for negative consequences without considering the risks (e.g., sexual promiscuity, substance use, shoplifting, driving recklessly, excessive spending).
    10. Rapid Mood Swings: Abrupt and frequent shifts between intense emotions (e.g., from rage to giddiness to sadness). This is often referred to as "affective lability."
    11. Psychotic Features (Severe Cases, Bipolar I): Hallucinations (seeing/hearing things that aren't there) or delusions (false, fixed beliefs, e.g., believing they have special powers or are being targeted).

    B. Depressive Episodes:

    • As described above for depressive disorders. Children and adolescents with bipolar disorder will experience periods that meet criteria for Major Depressive Episodes, which can be particularly debilitating. The cycling between these states (manic/hypomanic and depressive) is characteristic.

    C. Cyclothymic Disorder:

    • Persistent Mood Swings: Less severe but more chronic fluctuations between mild depressive symptoms and mild hypomanic symptoms. These do not meet full criteria for major depressive or hypomanic episodes but are noticeably different from the child's typical mood.
    • Irritability and Dysphoria: Often present with chronic grumpiness, discontent, and fluctuating periods of increased energy and restlessness, interspersed with periods of low mood and fatigue.

    Etiology and Risk Factors Associated with Mood Disorders

    Mood disorders in children and adolescents are complex, multifactorial conditions resulting from an interplay of various biological, psychological, and social factors.

    No single cause explains their development; rather, a vulnerability-stress model is often applied, suggesting that individuals with certain predisposing vulnerabilities are more likely to develop a disorder when exposed to specific stressors.

    I. Genetic Contributors:

    Genetics play a significant role in increasing susceptibility to mood disorders.

    1. Family History: A strong family history of depression, bipolar disorder, or other mood disorders significantly increases a child's risk.
      • Children with a parent who has Major Depressive Disorder have a 2-4 times higher risk of developing depression themselves.
      • The risk for bipolar disorder is even higher; children with one parent with bipolar disorder have a 15-30% chance of developing a mood disorder (often bipolar disorder), and the risk increases to 50-75% if both parents are affected.
    2. Heritability: Twin and adoption studies consistently demonstrate a substantial heritable component for both depressive and bipolar disorders. However, it's important to note that specific genes are not solely responsible; rather, polygenic inheritance (multiple genes acting together) is suspected, contributing to a predisposition rather than a deterministic outcome.

    II. Neurobiological Contributors:

    Advances in neuroimaging and neurochemistry have identified several brain-based factors associated with mood disorders.

    1. Neurotransmitter Dysregulation: Imbalances or dysregulation in key neurotransmitter systems are implicated.
      • Serotonin: Involved in mood regulation, sleep, appetite, and impulse control. Lower levels or dysregulation are commonly linked to depression.
      • Norepinephrine: Affects alertness, energy, and attention. Dysregulation can contribute to both depressive and manic symptoms.
      • Dopamine: Associated with pleasure, reward, motivation, and motor control. Implicated in both depression (low levels leading to anhedonia, low energy) and mania (excessive activity leading to euphoria, grandiosity).
    2. Brain Structure and Function: Differences in certain brain regions and their connectivity have been observed.
      • Limbic System: (e.g., Amygdala, Hippocampus) Involved in emotion processing and memory. Dysregulation can lead to altered emotional responses.
      • Prefrontal Cortex: (PFC) Involved in executive functions (planning, decision-making, impulse control, emotional regulation). Reduced activity or altered connectivity in the PFC can impair these functions, contributing to symptoms of depression and the impulsivity seen in mania.
      • Neural Circuitry: Alterations in neural circuits that regulate emotion, reward, and cognition are increasingly recognized as contributing factors.
    3. Hormonal Imbalances: Dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis, which controls the stress response, is often seen in mood disorders. Elevated cortisol levels can impact brain function and lead to depressive symptoms. Pubertal hormonal changes may also play a role, particularly in adolescent-onset mood disorders.

    III. Psychosocial Contributors:

    These factors relate to an individual's psychological makeup and their interactions within social environments.

    1. Temperament and Personality Traits:
      • Negative Affectivity: A predisposition to experience negative emotions (anxiety, sadness, irritability).
      • Behavioral Inhibition: A tendency to be shy, withdrawn, and fearful in novel situations.
      • Neuroticism: A personality trait characterized by emotional instability, anxiety, and worry.
      • Perfectionism: Can lead to excessive self-criticism and feelings of inadequacy.
    2. Cognitive Distortions: Maladaptive thought patterns, such as negative self-talk, catastrophic thinking, hopelessness, and learned helplessness, can perpetuate or exacerbate depressive symptoms.
    3. Poor Coping Skills: Inadequate strategies for managing stress, emotions, and challenges can increase vulnerability.
    4. Low Self-Esteem: A pervasive negative self-view can contribute to and be maintained by depressive episodes.

    IV. Environmental Contributors (Stressors):

    Exposure to adverse environmental experiences and stressors can precipitate mood disorders, especially in genetically vulnerable individuals.

    1. Adverse Childhood Experiences (ACEs):
      • Trauma: Physical, emotional, or sexual abuse.
      • Neglect: Physical or emotional neglect.
      • Household Dysfunction: Exposure to domestic violence, parental substance abuse, parental mental illness, parental separation/divorce, or incarceration of a household member.
      • High ACE scores are strongly linked to an increased risk of mood disorders.
    2. Family Environment:
      • Parental Psychopathology: Parents with mental health disorders, especially mood disorders, can create a less supportive or more chaotic home environment.
      • Parent-Child Conflict: High levels of conflict, lack of warmth, or critical parenting styles.
      • Family Instability: Frequent moves, financial difficulties, or disruptions in family structure.
      • Poor Attachment: Insecure attachment patterns with primary caregivers.
    3. Peer Relationships:
      • Bullying/Victimization: Being subjected to physical, verbal, or social aggression by peers.
      • Social Isolation/Rejection: Feeling lonely or excluded by peers.
      • Peer Pressure: Pressure to engage in risky behaviors, especially when coupled with low self-esteem.
    4. Academic Stress: High academic demands, school-related failures, or learning difficulties.
    5. Life Stressors: Significant life changes (moving, changing schools), loss of a loved one, chronic illness (personal or family member), relationship breakups (in adolescence).
    6. Substance Use: As discussed in Objective 1, substance abuse can induce or exacerbate mood symptoms. Self-medication with substances is also common in youth struggling with underlying mood disorders.

    Diagnostic Process for Mood Disorders in Children and Adolescents

    There is no single "test" for mood disorders; instead, diagnosis relies on a comprehensive clinical assessment.

    1. Multimodal/Multi-informant Assessment: Information should be gathered from various sources:
      • Child/Adolescent Interview: Direct assessment of symptoms, feelings, thoughts, and perception of functioning. Rapport building is key.
      • Parent/Caregiver Interview: Crucial for developmental history, family history, home behavior, onset/duration of symptoms, and impact on family life.
      • Teacher/School Reports: Essential for understanding behavior, mood, and academic functioning in the school setting, often providing objective observations.
      • Other Relevant Informants: (e.g., coaches, therapists, previous providers) if applicable and with consent.
    2. Developmental Sensitivity: Symptoms must be evaluated in the context of the child's age and developmental stage. What is problematic for a 15-year-old might be normal for a 5-year-old.
    3. Longitudinal Perspective: Mood disorders are not static. Symptoms often fluctuate, and a comprehensive history helps understand the course of the illness, including onset, duration, severity, and previous episodes.
    4. Emphasis on Functional Impairment: Symptoms must cause clinically significant distress or impairment in social, academic, occupational, or other important areas of functioning.
    5. Rule-Out Approach (Differential Diagnosis): Before concluding a mood disorder, other conditions that could mimic or explain the symptoms must be systematically considered and ruled out.

    Components of the Diagnostic Assessment:

    A. Detailed History Taking:

    1. Presenting Problem: Detailed description of current symptoms, including onset, frequency, intensity, duration, triggers, and what makes them better or worse.
    2. Developmental History: Pregnancy and birth complications, developmental milestones, temperament, early childhood experiences, significant traumas.
    3. Psychiatric History: Previous episodes of mood disturbance, psychiatric diagnoses, hospitalizations, previous treatments (medications, therapy), response to treatment, self-harm or suicide attempts.
    4. Family Psychiatric History: History of mood disorders, anxiety disorders, substance use, suicide in first-degree relatives. This helps assess genetic risk.
    5. Medical History: Past and current medical illnesses, hospitalizations, surgeries, current medications (prescription, OTC, supplements), allergies. Rule out medical conditions that could cause mood symptoms.
    6. Substance Use History: For adolescents, inquire about alcohol, tobacco, illicit drug use, and prescription medication misuse.
    7. Social History: Peer relationships, bullying, social skills.
    8. Academic History: School performance, learning difficulties, disciplinary issues, school attendance, relationships with teachers.
    9. Trauma History: Exposure to abuse (physical, emotional, sexual), neglect, domestic violence, significant losses, natural disasters.
    10. Cultural and Spiritual Factors: Understanding the family's cultural background, beliefs about mental illness, and spiritual practices can influence how symptoms are expressed and perceived.

    B. Mental Status Examination (MSE):

  • A systematic observation and evaluation of the individual's current mental state, including:
    • Appearance: Grooming, hygiene, age appropriateness.
    • Behavior: Psychomotor activity (agitation, retardation), eye contact, tics, mannerisms.
    • Speech: Rate, rhythm, volume, clarity, spontaneity.
    • Mood: Subjective report of emotional state (e.g., "sad," "angry," "upbeat").
    • Affect: Objective observation of emotional expression (e.g., "flat," "constricted," "labile," "irritable," "appropriate to mood").
    • Thought Process: Organization, logic, coherence (e.g., "linear," "flight of ideas," "loose associations").
    • Thought Content: Presence of delusions, obsessions, suicidal/homicidal ideation, paranoia. Crucially, assess for suicidal ideation, intent, plan, and access to means.
    • Perceptual Disturbances: Hallucinations (auditory, visual, etc.).
    • Cognition: Orientation, attention, concentration, memory, general knowledge.
    • Insight: Understanding of their condition.
    • Judgment: Ability to make sound decisions.

    • C. Use of Standardized Rating Scales and Screening Tools:

  • These are adjuncts to clinical assessment, not diagnostic tools themselves. They can help quantify symptom severity, track changes over time, and screen for potential diagnoses.
    • Depression Scales: Children's Depression Inventory (CDI), Beck Depression Inventory (BDI), PHQ-9 (modified for adolescents), Center for Epidemiologic Studies Depression Scale for Children (CES-DC).
    • Mania/Bipolar Scales: Mood Disorder Questionnaire (MDQ), Child Mania Rating Scale (CMRS), Young Mania Rating Scale (YMRS).
    • General Symptom Checklists: Child Behavior Checklist (CBCL), Strengths and Difficulties Questionnaire (SDQ).
    • Suicide Risk Scales: Columbia-Suicide Severity Rating Scale (C-SSRS).

    • D. Physical Examination and Laboratory Tests:

  • A thorough physical exam by a physician is essential to rule out medical conditions that can present with mood symptoms.
  • Laboratory tests may include:
    • Complete Blood Count (CBC).
    • Thyroid Function Tests (TFTs) to rule out hypo/hyperthyroidism.
    • Electrolyte Panel.
    • Vitamin D and B12 levels.
    • Urine toxicology screen (especially for adolescents) to rule out substance-induced mood symptoms.
    • Other tests as indicated by clinical presentation (e.g., EEG for seizure disorders, neuroimaging if neurological concerns).

    • Differential Diagnosis

    This is the process of distinguishing a particular disease or condition from others that present with similar symptoms. For mood disorders in youth, this often involves differentiating from:

    1. Normal Developmental Fluctuations: Mood swings and irritability are common during adolescence. The key is the intensity, persistence, and impact on functioning.
    2. Anxiety Disorders: Can co-occur, but primary anxiety disorders might present with irritability, poor sleep, and concentration difficulties.
    3. Attention-Deficit/Hyperactivity Disorder (ADHD): Hyperactivity, impulsivity, and inattention can mimic manic/hypomanic symptoms, especially irritability and distractibility. Differentiation often lies in the episodic nature of bipolar symptoms versus the chronic presentation of ADHD.
    4. Oppositional Defiant Disorder (ODD)/Conduct Disorder (CD): Chronic irritability, defiance, and behavioral outbursts can resemble DMDD or symptoms within a depressive or manic episode.
    5. Substance Use Disorders: Can cause or exacerbate mood symptoms. A comprehensive toxicology screen and history are essential.
    6. Psychotic Disorders: Early stages of schizophrenia or other psychotic disorders can sometimes present with mood symptoms, especially with disorganized thought processes.
    7. Trauma-Related Disorders (PTSD, Adjustment Disorders): Symptoms of depression or anxiety can arise in response to traumatic events.
    8. Medical Conditions: As discussed in Objective 1 (e.g., thyroid disease, neurological conditions, anemia, chronic pain).
    9. Medication Side Effects: Some medications (e.g., corticosteroids, anticonvulsants) can induce mood symptoms.

    Nursing Diagnoses for Children and Adolescents

    1. Risk for Suicide
      • Related Factors: Depressed mood, feelings of hopelessness/worthlessness, previous suicide attempts, family history of suicide, access to means, substance abuse, chronic illness, social isolation, impulsive behavior (especially in adolescents).
      • Defining Characteristics: (Not directly observed, as it's a risk diagnosis, but inferred from risk factors and verbal/behavioral cues) Verbalization of suicidal ideation, making plans, giving away possessions, sudden improvement in mood after prolonged depression, self-harm gestures.
      • Priority: This is often the highest priority nursing diagnosis in depression.
    2. Hopelessness
      • Related Factors: Chronic pain or illness, long-term stress, deteriorating physical condition, perceived loss of control, social isolation, feelings of worthlessness, lack of support system.
      • Defining Characteristics: Verbal cues (e.g., "I give up," "What's the use?"), decreased affect, lack of initiative, passivity, sleep disturbance, decreased appetite, withdrawal, decreased problem-solving ability.
    3. Low Self-Esteem (Situational or Chronic)
      • Related Factors: Lack of positive feedback, perceived failure (academic, social), dysfunctional family dynamics, negative self-talk, body image disturbance, social isolation, peer rejection/bullying.
      • Defining Characteristics: Self-negating verbalizations (e.g., "I'm stupid," "I can't do anything right"), expressions of shame/guilt, social withdrawal, lack of eye contact, indecisiveness, excessive need for reassurance, aggressive behavior (as a compensatory mechanism).
    4. Social Isolation
      • Related Factors: Depression, anxiety, perceived rejection, immature interests, developmental delay, inadequate social skills, withdrawal behaviors, family conflict.
      • Defining Characteristics: Absence of supportive significant others, expressions of loneliness, withdrawal from social activities, preoccupation with own thoughts, sad/dull affect.
    5. Inadequate protein energy nutritional intake
      • Related Factors: Depressed mood, loss of appetite, anhedonia, poor oral intake, inadequate knowledge of nutritional needs.
      • Defining Characteristics: Weight loss (or failure to gain weight appropriate for age), aversion to eating, poor muscle tone, pale conjunctiva and mucous membranes, verbal report of inadequate food intake.
    6. Disrupted Sleep Pattern
      • Related Factors: Psychological stress, internalizing behaviors (anxiety, depression), worry, environmental disturbances, medication side effects.
      • Defining Characteristics: Verbal complaints of difficulty falling asleep, frequent awakenings, early morning awakening, not feeling rested, changes in mood/irritability, lethargy, dark circles under eyes.
    7. Ineffective Coping
      • Related Factors: Inadequate coping skills, emotional distress, poor impulse control, trauma history, low self-esteem, lack of problem-solving skills, unsupportive environment.
      • Defining Characteristics: Verbalization of inability to cope, inability to meet basic needs, destructive behavior towards self or others, use of maladaptive coping mechanisms (e.g., substance abuse, self-harm), changes in usual behavior patterns.
    8. Risk for Delayed Development (especially for younger children with chronic, severe depression)
      • Related Factors: Chronic illness, poor social interaction, lack of environmental stimulation, impaired primary caregiver, physical/emotional neglect.
      • Defining Characteristics: (Inferred from risk factors) Regression in developmental milestones, difficulty learning new skills, apathy, lack of initiative.
    9. Risk for Injury
      • Related Factors: Extreme psychomotor agitation, poor judgment, impulsivity, grandiosity, decreased need for sleep, aggressive behavior, engagement in risky activities, environmental hazards.
      • Defining Characteristics: (Inferred from risk factors) Restlessness, hyperactivity, inability to control impulses, engaging in high-risk behaviors without regard for consequences, self-neglect.
      • Priority: Often the highest priority during acute manic phases.

    Specific Nursing Interventions for Children and Adolescents with Mood Disorders

    Nursing interventions for children and adolescents aiming to promote safety, stabilize mood, improve functioning, enhance coping skills, and support overall well-being.

    Principles Guiding Nursing Interventions:

    1. Safety First: Prioritize interventions that address immediate risks, especially suicide, self-harm, and aggression.
    2. Therapeutic Relationship: Establish a trusting, empathetic, and non-judgmental relationship with the child/adolescent and their family.
    3. Individualized Care: Tailor interventions to the specific needs, developmental stage, and cultural background of the child/adolescent and family.
    4. Family-Centered Care: Involve parents/caregivers as active partners in the treatment plan, providing education and support.
    5. Interdisciplinary Collaboration: Work closely with psychiatrists, psychologists, social workers, teachers, and other healthcare professionals.
    6. Psychoeducation: Provide comprehensive information about the disorder, treatment options, symptom management, and relapse prevention.
    7. Skill Building: Help the child/adolescent develop coping mechanisms, problem-solving skills, emotional regulation strategies, and social skills.
    8. Least Restrictive Environment: Strive to provide care in the least restrictive setting possible while ensuring safety and effectiveness.

    Nursing Interventions Across Settings:

    A. Inpatient Setting (Acute Stabilization, High-Risk Situations):

  • Safety Monitoring (Continuous):
    • Suicide/Self-Harm Precautions: Implement constant observation (1:1 sitter) or frequent checks, remove all dangerous objects (sharps, ligatures), ensure tamper-proof environment.
    • Aggression Management: Monitor for escalation, use de-escalation techniques, implement least restrictive restraints (verbal, chemical, physical) as per policy and only when absolutely necessary, followed by debriefing.
  • Medication Management:
    • Administration & Monitoring: Administer prescribed psychotropic medications (antidepressants, mood stabilizers, antipsychotics) accurately.
    • Side Effect Monitoring: Closely observe and document side effects (e.g., akathisia, sedation, weight changes, suicidal ideation with SSRIs in some youth). Educate about side effects.
    • Therapeutic Efficacy: Monitor for therapeutic effects and report to the prescriber.
  • Structured Environment:
    • Routine and Predictability: Establish consistent daily schedules for activities, meals, and sleep to provide a sense of security and structure.
    • Limit Setting: Consistently enforce clear, fair, and firm boundaries to manage behavior and provide a sense of control and safety.
  • Therapeutic Communication & Engagement:
    • Active Listening & Validation: Listen to concerns, validate feelings, even if behavior is maladaptive.
    • Individual & Group Therapy Participation: Encourage and facilitate participation in therapeutic activities (e.g., CBT, DBT, art therapy).
    • Psychoeducation: Begin educating the patient and family about the diagnosis, medication, and coping skills.
  • Promoting Self-Care:
    • ADLs Assistance: Assist with activities of daily living (hygiene, grooming) if self-care deficits are present.
    • Nutrition & Hydration: Monitor intake, offer nutritional supplements if needed, encourage regular meals.
    • Sleep Promotion: Implement sleep hygiene practices (quiet environment, consistent bedtime, no electronics).

    • B. Outpatient Setting (Ongoing Management, Prevention, Skill Building):

  • Medication Management:
    • Adherence Education: Educate child/adolescent and family about medication purpose, dosage, administration, importance of adherence, and potential side effects.
    • Side Effect Monitoring: Assess for and manage side effects in collaboration with the prescriber.
    • Relapse Prevention: Emphasize the importance of continued medication use even when feeling better.
  • Psychoeducation (Comprehensive):
    • Disease Education: Explain the specific mood disorder, its etiology, symptoms, and prognosis.
    • Coping Strategies: Teach stress management, relaxation techniques (deep breathing, progressive muscle relaxation), problem-solving skills, and emotional regulation.
    • Communication Skills: Improve assertive communication and conflict resolution.
    • Relapse Recognition & Prevention: Help identify early warning signs of worsening mood and develop an action plan.
  • Therapeutic Support:
    • Referrals: Facilitate referrals to individual, family, and group therapy (e.g., CBT, DBT, interpersonal therapy).
    • Support Groups: Suggest age-appropriate peer support groups.
  • Life Style Interventions:
    • Nutrition & Exercise: Promote a balanced diet and regular physical activity.
    • Sleep Hygiene: Reinforce healthy sleep habits.
    • Stress Reduction: Encourage hobbies, mindfulness, and healthy leisure activities.
  • Monitoring & Follow-up:
    • Symptom Tracking: Use symptom rating scales to monitor progress and adjust treatment.
    • Safety Planning: Review and update safety plans (for suicide/self-harm risk).
    • Appointment Adherence: Encourage attendance at all appointments.

    • C. School Setting (Support, Integration, Early Identification):

  • Collaboration with School Staff:
    • IEP/504 Plans: Advocate for and participate in the development and implementation of individualized education plans (IEPs) or 504 plans to accommodate academic needs (e.g., reduced workload, extended time, preferential seating, quiet testing environment).
    • Communication: Liaison between family, healthcare team, and school staff to ensure consistent support.
  • Behavioral Support:
    • Behavioral Plans: Help develop and implement classroom management strategies tailored to the student's needs.
    • Social Skills Training: Facilitate opportunities for social skill development and positive peer interactions.
  • Academic Support:
    • Tutoring/Extra Help: Suggest academic accommodations or support services.
    • Monitoring Attendance & Performance: Track school attendance and academic progress, noting changes that may indicate worsening symptoms.
  • Crisis Preparedness:
    • Emergency Protocols: Ensure school staff are aware of emergency protocols for mental health crises, including suicide risk.
    • Referrals: Assist with referrals to school counselors or external mental health services.
  • Psychoeducation:
    • Staff Education: Educate teachers and school personnel on recognizing signs of mood disorders and appropriate responses.
    • Peer Education: Promote anti-stigma initiatives and understanding among peers (age-appropriate).

    • D. Community Setting (Prevention, Advocacy, Resource Connection):

  • Resource Navigation:
    • Connecting Families to Resources: Provide information and referrals to community mental health services, support groups, advocacy organizations, and financial assistance programs.
    • Advocacy: Advocate for policies that support mental health services for youth.
  • Public Health Education:
    • Awareness Campaigns: Participate in or initiate community-wide campaigns to reduce stigma and increase awareness of mental health issues in youth.
    • Early Identification: Educate community groups (e.g., youth sports coaches, scout leaders) on recognizing early signs of mood disorders.
  • Crisis Services:
    • Emergency Planning: Inform families about local crisis hotlines, walk-in clinics, and emergency services.
  • Promoting Healthy Lifestyles:
    • Youth Programs: Support and encourage participation in positive youth development programs that foster resilience, self-esteem, and social connections.

    • Evaluation of the Effectiveness of Nursing Interventions and Treatment Plan.

    Evaluation is an ongoing and systematic process that determines the effectiveness of nursing interventions and the overall treatment plan.

    I. Principles of Evaluation:

    1. Continuous Process: Evaluation is not a one-time event but an ongoing cycle that occurs throughout the entire care trajectory, from initial assessment to discharge and follow-up.
    2. Client-Centered: Outcomes should reflect improvements that are meaningful to the child/adolescent and their family.
    3. Objective and Subjective Data: Utilize both measurable data (e.g., symptom scores, school attendance) and the client's/family's subjective reports of well-being.
    4. Multimodal Approach: Gather evaluative data from multiple sources (child/adolescent, parents, teachers, other providers).
    5. Interdisciplinary Collaboration: Share evaluation findings and collaborate with the entire treatment team to make informed decisions.
    6. Documentation: Clearly document all evaluation findings, adjustments to the care plan, and the rationale behind those changes.

    II. Key Areas for Evaluation:

    A. Symptom Severity and Frequency:

    • Tools: Re-administer standardized rating scales (e.g., PHQ-9, CDI for depression; CMRS, YMRS for mania) at regular intervals to track changes in symptom severity.
    • Observation: Nurses' ongoing observation of behaviors, mood, and affect for improvement or worsening.
    • Self-Report/Parent Report: Ask the child/adolescent and parents to rate symptom severity (e.g., on a 0-10 scale) and note any changes.
    • Specific Symptoms: Monitor specific target symptoms identified during assessment (e.g., frequency of rage outbursts, duration of sleep, presence of anhedonia, suicidal ideation).

    B. Functional Impairment:

    • Academic Performance: Monitor grades, school attendance, completion of homework, participation in class, and reports from teachers.
    • Social Functioning: Observe and inquire about peer interactions, participation in extracurricular activities, social withdrawal, and family relationships.
    • Activities of Daily Living (ADLs): Assess for improvements in self-care, hygiene, and age-appropriate responsibilities.
    • Behavioral Regulation: Note changes in impulsivity, aggression, defiance, and overall behavioral control.

    C. Safety:

    • Suicide Risk: Continuously assess for suicidal ideation, intent, plan, and behaviors. Any increase in risk necessitates immediate intervention and care plan adjustment.
    • Self-Harm: Monitor for cessation or reduction of non-suicidal self-injury, and the use of healthy coping strategies instead.
    • Aggression/Violence: Track the frequency and intensity of aggressive outbursts and the effectiveness of de-escalation strategies.

    D. Medication Adherence and Side Effects:

    • Adherence: Ask the child/adolescent and parents about consistent medication taking.
    • Side Effects: Routinely assess for the presence and severity of medication side effects.
    • Therapeutic Efficacy: Determine if the medication is achieving its intended therapeutic effect on mood and behavior.

    E. Coping Skills and Resilience:

    • Observed Use: Note whether the child/adolescent is actively using taught coping strategies (e.g., relaxation techniques, problem-solving, communication skills) in stressful situations.
    • Self-Report: Ask the child/adolescent about their perceived ability to cope with challenges.
    • Stress Management: Assess their ability to manage daily stressors without significant decompensation.

    F. Family Functioning and Support:

    • Family Communication: Observe and inquire about improvements in family communication patterns.
    • Parental Coping: Assess parents' ability to cope with the child's illness and their engagement in the treatment plan.
    • Support System: Evaluate the adequacy of the family's formal and informal support systems.

    G. Client and Family Satisfaction:

    • Feedback: Obtain feedback from the child/adolescent and family regarding their satisfaction with the care received, their perception of progress, and any unmet needs.

    III. Adjusting the Care Plan:

    Based on the evaluation findings, the nursing care plan, and the broader treatment plan, will be adjusted as follows:

    1. If Goals Are Met:
      • Reinforce Success: Acknowledge and celebrate the child/adolescent's progress and efforts.
      • Set New Goals: Establish new, more advanced goals to continue progress, focusing on relapse prevention and further skill development.
      • Transition Care: Consider stepping down to a less intensive level of care if appropriate and safe.
      • Discharge Planning: Prepare for discharge, ensuring adequate follow-up and community resources.
    2. If Goals Are Partially Met or Not Met:
      • Reassessment: Conduct a thorough reassessment to identify new or persistent problems, changes in circumstances, or barriers to progress.
      • Review Diagnoses: Re-evaluate the accuracy and relevance of existing nursing diagnoses.
      • Modify Interventions: Adjust nursing interventions. This might involve:
        • Increasing the intensity or frequency of an intervention.
        • Introducing new interventions.
        • Modifying the approach (e.g., trying a different teaching method).
        • Addressing previously overlooked barriers.
      • Collaborate with Team: Discuss findings with the interdisciplinary team to consider changes in medication, therapy type, or other aspects of the overall treatment plan.
      • Family Engagement: Re-engage the family to ensure their understanding and participation in any revised plan.
      • Problem-Solve Barriers: Identify and problem-solve any identified barriers to treatment (e.g., transportation issues, financial constraints, lack of motivation).
    3. Emergence of New Problems/Risks:
      • Immediate Action: Address any new safety concerns (e.g., increased suicidal ideation) or significant symptom worsening with immediate, appropriate interventions.
      • Re-prioritize: Adjust priorities in the care plan to reflect the most pressing needs.
      • Escalate Care: Consider a higher level of care (e.g., inpatient hospitalization) if the current setting cannot adequately manage the new risks or symptoms.

    BIPOLAR AFFECTIVE DISORDER click here

    Mood Disorders in Children and Adolescents Read More »

    Attention-deficit/hyperactivity disorder

    Attention-Deficit/Hyperactivity Disorder

    Attention-Deficit/Hyperactivity Disorder (ADHD)
    Attention-Deficit/Hyperactivity Disorder (ADHD)
    Table of Contents (Click to Expand) ▼

    Attention-Deficit/Hyperactivity Disorder (ADHD) is a neurodevelopmental disorder characterized by a persistent pattern of inattention and/or hyperactivity-impulsivity that interferes with functioning or development.

    Key Definitions:
    • Inattention means a person wanders off task, lacks persistence, has difficulty sustaining focus and is disorganized and these problems are not due to defiance or lack of comprehension.
    • Hyperactivity means a person seems to move about constantly, including in situations in which it is not appropriate or excessively fidgets, taps, or talks.
    • Impulsivity means a person makes hasty actions that occur in the moment without first thinking about them and that may have high potential for harm or a desire for immediate rewards or inability to delay gratification. An impulsive person may be socially intrusive and excessively interrupt others to make important decisions without considering the long-term consequences.

    It is one of the most common neurodevelopmental disorders of childhood and often persists into adulthood.

    Key characteristics of ADHD:
    • Neurodevelopmental: This classification emphasizes that ADHD is a disorder of brain development and function, rather than solely a behavioral or psychological issue. It involves differences in brain structure, function, and connectivity, particularly in areas related to executive functions such as attention, impulse control, and regulation of activity level.
    • Persistent Pattern: The symptoms are not transient; they are ongoing, lasting for at least six months, and are inconsistent with the individual's developmental level.
    • Interferes with Functioning or Development: The symptoms must cause significant impairment in at least two settings (e.g., home, school, work, social situations). This impairment can affect academic performance, occupational success, social relationships, and overall quality of life.
    Primary Presentations (Subtypes) of ADHD (as per DSM-5 criteria):

    The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), specifies three primary presentations, or subtypes, of ADHD based on the predominant symptoms experienced by the individual over the past six months:

    1. Predominantly Inattentive Presentation:
      • Individuals primarily exhibit symptoms of inattention, with fewer hyperactive-impulsive symptoms.
      • Symptoms often include: Difficulty sustaining attention in tasks or play activities, being easily distracted, not seeming to listen when spoken to directly, often losing things necessary for tasks or activities, difficulty organizing tasks and activities, avoiding or disliking tasks that require sustained mental effort, and being forgetful in daily activities.
    2. Predominantly Hyperactive-Impulsive Presentation:
      • Individuals primarily exhibit symptoms of hyperactivity and impulsivity, with fewer inattentive symptoms.
      • Symptoms often include: Fidgeting or squirming, often leaving seat in situations when remaining seated is expected, running about or climbing in situations where it is inappropriate, difficulty playing or engaging in leisure activities quietly, often "on the go" or acting as if "driven by a motor," talking excessively, blurting out answers before questions have been completed, difficulty waiting their turn, and often interrupting or intruding on others.
    3. Combined Presentation:
      • Individuals meet the criteria for both inattention and hyperactivity-impulsivity.
      • This is the most common presentation of ADHD.
    Etiology and Risk Factors for ADHD

    The etiology of Attention-Deficit/Hyperactivity Disorder (ADHD) is complex involving a significant interplay of genetic, neurobiological, and environmental factors. It is not caused by poor parenting, too much sugar, or excessive screen time, although these factors can exacerbate symptoms or influence management.

    I. Genetic Factors (The Strongest Link):
    • High Heritability: Genetic factors are considered the strongest contributors to ADHD. Studies, particularly twin and family studies, show that ADHD is highly heritable, with heritability estimates ranging from 70% to 80%. This means that if a parent has ADHD, their child has a significantly higher chance of also having it.
    • Polygenic Disorder: ADHD is not typically linked to a single gene but rather to the combined effect of multiple genes, each contributing a small amount to the overall risk. Many of these genes are involved in the regulation of neurotransmitters (especially dopamine and norepinephrine) and brain development.
    • Neurotransmitter System Genes: Research often points to genes involved in dopamine regulation (e.g., dopamine receptor genes DRD4 and DRD5, and dopamine transporter gene DAT1) and norepinephrine regulation as key players, affecting brain circuits related to reward, motivation, attention, and executive function.
    II. Neurobiological Factors:
  • Brain Structure and Function: Individuals with ADHD often show differences in brain structure and function, particularly in areas of the brain responsible for executive functions (e.g., planning, organizing, self-regulation, inhibition). These areas include:
    • Prefrontal Cortex: Involved in attention, decision-making, impulse control, and working memory. Studies often show reduced activity or smaller volume in certain areas of the prefrontal cortex in individuals with ADHD.
    • Basal Ganglia: Important for regulating movement, reward, and motivation.
    • Cerebellum: Involved in motor control, timing, and cognitive functions.
    • Default Mode Network (DMN): Differences in the connectivity and activity of the DMN, which is active when the brain is at rest, have been observed.
  • Neurotransmitter Dysregulation: As mentioned under genetic factors, there is evidence of dysregulation in neurotransmitter systems, primarily dopamine and norepinephrine. These neurotransmitters play critical roles in:
    • Dopamine: Reward, motivation, pleasure, attention, and executive control.
    • Norepinephrine: Alertness, arousal, attention, and decision-making.
    • Imbalances or inefficiencies in these systems are thought to contribute to the core symptoms of ADHD.
    • III. Environmental Factors (Risk Factors, not direct causes):

    While not primary causes, certain environmental factors can increase the risk of developing ADHD or exacerbate its symptoms.

  • Prenatal Exposures:
    • Maternal Smoking, Alcohol, or Drug Use during Pregnancy: Exposure to toxins during crucial periods of fetal brain development can increase the risk.
    • Maternal Stress/Anxiety during Pregnancy: Emerging research suggests a potential link, though more studies are needed.
  • Perinatal and Early Childhood Complications:
    • Premature Birth / Low Birth Weight: Babies born significantly premature or with very low birth weight have a higher risk of developing ADHD.
    • Brain Injury: Traumatic brain injury in early development can sometimes lead to ADHD-like symptoms.
    • Exposure to Environmental Toxins: Lead exposure in early childhood has been linked to an increased risk of ADHD symptoms.
  • Psychosocial Factors:
    • Severe Early Deprivation: Extreme neglect or institutionalization in early childhood, although rare, can lead to attention and hyperactivity problems that mimic ADHD.
    • Note: While family stress, chaotic home environments, or poor parenting do not cause ADHD, they can significantly worsen symptoms and make management more challenging.
    • Clinical Manifestations and Common Comorbidities of ADHD

    Attention-Deficit/Hyperactivity Disorder (ADHD) is characterized by a persistent pattern of inattention and/or hyperactivity-impulsivity. core manifestations significantly interfere with an individual's functioning in multiple areas of life.

    I. Manifestations of ADHD (DSM-5 Criteria):

    The core symptoms of ADHD are categorized into two main domains: Inattention and Hyperactivity-Impulsivity. To meet diagnostic criteria, an individual must display a certain number of symptoms in one or both domains, with onset before age 12, present in two or more settings, and causing significant impairment.

    A. Inattention:

    (At least six symptoms for children up to age 16, or five for adolescents 17 and older and adults; symptoms must have been present for at least 6 months)

    1. Often fails to give close attention to details or makes careless mistakes in schoolwork, at work, or during other activities (e.g., overlooks or misses details, work is inaccurate).
    2. Often has difficulty sustaining attention in tasks or play activities (e.g., has difficulty remaining focused during lectures, conversations, or lengthy reading).
    3. Often does not seem to listen when spoken to directly (e.g., mind seems elsewhere, even in the absence of any obvious distraction).
    4. Often does not follow through on instructions and fails to finish schoolwork, chores, or duties in the workplace (e.g., starts tasks but quickly loses focus and is easily sidetracked).
    5. Often has difficulty organizing tasks and activities (e.g., difficulty managing sequential tasks; difficulty keeping materials and belongings in order; messy, disorganized work; has poor time management; fails to meet deadlines).
    6. Often avoids, dislikes, or is reluctant to engage in tasks that require sustained mental effort (e.g., schoolwork or homework; for older adolescents and adults, preparing reports, completing forms, reviewing lengthy papers).
    7. Often loses things necessary for tasks or activities (e.g., school materials, pencils, books, tools, wallets, keys, paperwork, eyeglasses, mobile telephones).
    8. Is often easily distracted by extraneous stimuli (for older adolescents and adults, may include unrelated thoughts).
    9. Is often forgetful in daily activities (e.g., doing chores, running errands; for older adolescents and adults, returning calls, paying bills, keeping appointments).
    B. Hyperactivity and Impulsivity:

    (At least six symptoms for children up to age 16, or five for adolescents 17 and older and adults; symptoms must have been present for at least 6 months)

    Hyperactivity:
    1. Often fidgets with or taps hands or feet or squirms in seat.
    2. Often leaves seat in situations when remaining seated is expected (e.g., leaves his or her place in the classroom, in the office or other workplace, or in other situations that require remaining in place).
    3. Often runs about or climbs in situations where it is inappropriate (Note: In adolescents or adults, may be limited to feeling restless).
    4. Often unable to play or engage in leisure activities quietly.
    5. Is often "on the go" acting as if "driven by a motor" (e.g., is uncomfortable being still for extended time, as in restaurants, meetings; may be experienced by others as restless or difficult to keep up with).
    6. Often talks excessively.
    Impulsivity:
    1. Often blurts out an answer before a question has been completed (e.g., completes people's sentences; cannot wait for turn in conversation).
    2. Often has difficulty waiting his or her turn (e.g., while waiting in line).
    3. Often interrupts or intrudes on others (e.g., butts into conversations, games, or activities; may start using other people's things without asking or receiving permission; for adolescents and adults, may intrude into or take over what others are doing).
    II. Common Comorbidities of ADHD:

    Comorbidity is the rule rather than the exception in ADHD, with many individuals having at least one other mental health or learning disorder. These co-occurring conditions can significantly impact the presentation of ADHD symptoms, complicate diagnosis, and require integrated treatment approaches.

    1. Oppositional Defiant Disorder (ODD) and Conduct Disorder (CD): ODD involves a pattern of angry/irritable mood, argumentative/defiant behavior, or vindictiveness. CD involves a more severe pattern of antisocial behavior, aggression, destruction of property, deceitfulness, or serious rule violations.
    2. Anxiety Disorders: Generalized anxiety disorder, social anxiety, separation anxiety, panic disorder.: Can lead to internalizing behaviors, perfectionism, or avoidance, and can make ADHD symptoms (e.g., inattention due to worry) worse.
    3. Depressive Disorders (Major Depressive Disorder, Persistent Depressive Disorder): Can be difficult to differentiate from ADHD symptoms (e.g., fatigue, lack of motivation). ADHD can increase the risk of depression due to chronic challenges and low self-esteem.
    4. Specific Learning Disorders (SLDs): Difficulties in learning and using academic skills (e.g., reading/dyslexia, written expression/dysgraphia, mathematics/dyscalculia).
    5. Autism Spectrum Disorder (ASD): Both disorders involve challenges with attention, social interaction, and sensory processing. ADHD symptoms can be present in individuals with ASD, and vice versa.
    6. Tourette's Syndrome and Chronic Tic Disorders: Involuntary, repetitive movements or vocalizations (tics).
    7. Substance Use Disorders (SUDs): Individuals with untreated ADHD, especially the combined type, have a significantly higher risk of developing SUDs, particularly nicotine and alcohol.
    8. Sleep Disorders: Insomnia, restless legs syndrome, sleep apnea.
    Diagnostic Process for ADHD

    The process is conducted by a trained healthcare professional, such as a pediatrician, child psychiatrist, psychologist, or neurologist, and often involves a multidisciplinary team approach.

    1. No Single Test: There is no blood test, brain scan, or single psychological test that can definitively diagnose ADHD.
    2. Clinical Evaluation: Diagnosis is based on a careful clinical assessment of symptoms and their impact on functioning, using established diagnostic criteria (DSM-5).
    3. Multisource Information: Information is gathered from various settings and multiple informants (e.g., parents, teachers, caregivers, the individual themselves).
    4. Developmental area: Symptoms must be inconsistent with the individual's developmental level.
    5. Pervasiveness and Impairment: Symptoms must be present in two or more settings (e.g., home, school, work, social situations) and cause significant impairment in major life activities.
    6. Exclusion of Other Conditions: Other medical or psychological conditions that could explain the symptoms must be considered and ruled out.
    Components of the Diagnostic Process:
    1. Initial Clinical Interview and History Taking:
      • Patient Interview: For adolescents and adults, a detailed interview to understand their current symptoms, their impact, and their history.
      • Parent/Caregiver Interview: For children and younger adolescents, interviews with parents or primary caregivers are essential to gather information about:
        • Developmental History: Milestones, early behaviors, temperament.
        • Symptom Onset and Duration: When symptoms first appeared, how long they have been present, and their course over time (DSM-5 requires symptoms to be present before age 12, though this can be recalled retrospectively).
        • Symptom Severity and Pervasiveness: How severe the symptoms are, and in which settings they occur (e.g., home, school, daycare, social gatherings).
        • Impact on Functioning: How symptoms affect academic performance, social relationships, family life, self-care, and daily activities.
        • Family Medical and Psychiatric History: To identify any genetic predispositions or co-occurring family conditions.
        • Past Medical History: Including pregnancy and birth history, illnesses, injuries, and medication use.
    2. Information from Multiple Informants:
      • Teacher Reports: For school-aged children, information from teachers is critical as they observe behavior in a structured, demanding environment. Teachers can provide insights into inattention, hyperactivity, impulsivity, academic performance, and social interactions in the classroom.
      • Other Caregivers: Reports from daycare providers, coaches, or tutors can also be valuable.
    3. Standardized Rating Scales (Behavior Rating Scales):
      • Purpose: These are questionnaires completed by parents, teachers, and often the individual themselves (for older children/adults) to systematically assess ADHD symptoms and related behaviors. They compare the individual's behavior to age and gender norms.
      • Common Scales:
        • Conners 3rd Edition (Conners 3): Widely used for children and adolescents, with parent, teacher, and self-report forms.
        • ADHD Rating Scale-5 (ADHD-RS-5): Directly maps to DSM-5 criteria.
        • Vanderbilt ADHD Diagnostic Teacher and Parent Rating Scales: Popular in educational and clinical settings.
        • Adult ADHD Self-Report Scale (ASRS): For adults.
      • Interpretation: Scores are typically compared to normative data to indicate the likelihood and severity of ADHD symptoms.
    4. Observation:
      • Clinical Observation: The clinician observes the individual's behavior during the evaluation, noting attention span, activity level, impulsivity, and social interaction.
      • Naturalistic Observation (less common): Sometimes, a professional may observe the child in a classroom or home setting, though this is often impractical.
    5. Psychological and Educational Testing (Optional but often recommended):
      • Neuropsychological Testing: Can assess specific cognitive functions often impacted by ADHD, such as executive functions (working memory, inhibitory control, planning), attention, and processing speed. This helps identify specific areas of strength and weakness and rule out other conditions.
      • Achievement Testing: To screen for specific learning disorders, which frequently co-occur with ADHD.
      • Intellectual Assessment (IQ Testing): To ensure symptoms are not better explained by intellectual disability.
    III. DSM-5 Diagnostic Criteria (Summary):
    • Six (or more) symptoms of inattention and/or six (or more) symptoms of hyperactivity-impulsivity for at least 6 months.
    • Several inattentive or hyperactive-impulsive symptoms were present before age 12 years.
    • Several symptoms are present in two or more settings.
    • There is clear evidence that the symptoms interfere with, or reduce the quality of, social, academic, or occupational functioning.
    • The symptoms do not occur exclusively during the course of schizophrenia or another psychotic disorder and are not better explained by another mental disorder.
    Management Strategies for ADHD

    Evidence consistently supports a combination of medication and behavior therapy as the most effective approach, especially for children.

    I. Pharmacological Interventions:

    Medication do not offer permanent cure for ADH but may help someone with the condition to concentrate better, be less impulsive, fell calmer and learn to practice new skills. Drugs licensed for treatment of ADHD include;

    • Methylphenidate one tablet once a day
    • Lisdexamfetamine once capsule once a day
    • Dexamfetamine one tablet once or twice a day
    • Atomoxetine one capsule once or twice a day
    • Guanfacine one tablet once a day
    • tricyclic antidepressants
    • Antipsychotics
    • serotonin specific reuptake inhibitors

    Medications do not cure ADHD but can significantly reduce core symptoms, allowing individuals to benefit more from behavioral and educational interventions.

    1. Stimulants (First-line for most ages):
      • Mechanism of Action: Increase the availability of dopamine and norepinephrine in the brain, primarily by blocking their reuptake and, to a lesser extent, by promoting their release. This enhances signaling in brain regions responsible for attention, focus, and impulse control (e.g., prefrontal cortex).
      • Examples:
        • Methylphenidate-based: Ritalin, Concerta, Daytrana (patch), Focalin, Quillivant XR, Adhansia XR.
        • Amphetamine-based: Adderall, Vyvanse, Dexedrine, Mydayis.
      • Forms: Available in short-acting (taken 2-3 times/day) and long-acting (once daily) formulations. Long-acting forms are often preferred for convenience and smoother symptom control.
      • Efficacy: Highly effective in reducing core symptoms (inattention, hyperactivity, impulsivity) in approximately 70-80% of individuals.
      • Common Side Effects: Decreased appetite/weight loss, sleep disturbances (insomnia), headache, stomachache, irritability, increased heart rate and blood pressure (usually minor).
      • Nursing Considerations: Monitor growth, weight, blood pressure, and heart rate. Educate on administration (e.g., timing to avoid sleep issues), potential side effects, and importance of adherence. Assess for effectiveness and adjust dose as prescribed.
    2. Non-Stimulants (Alternatives or adjuncts):
      • Mechanism of Action: Work differently than stimulants, often by selectively targeting norepinephrine or other neurotransmitter systems.
      • Examples:
        • Atomoxetine (Strattera): Selective norepinephrine reuptake inhibitor (SNRI). Takes several weeks for full effect.
        • Guanfacine (Intuniv) and Clonidine (Kapvay): Alpha-2 adrenergic agonists. Can be particularly helpful for hyperactivity, impulsivity, tics, and sleep disturbances.
        • Bupropion (Wellbutrin): A dopamine and norepinephrine reuptake inhibitor, sometimes used off-label, especially with comorbid depression.
      • Efficacy: Less rapid and generally less potent in symptom reduction compared to stimulants, but effective for many, especially those who don't respond to or tolerate stimulants.
      • Common Side Effects:
        • Atomoxetine: Nausea, stomach upset, fatigue, dry mouth, suicidal ideation (rare).
        • Guanfacine/Clonidine: Drowsiness, fatigue, low blood pressure, dizziness.
      • Nursing Considerations: Educate on delayed onset of action for atomoxetine. Monitor blood pressure and heart rate for alpha-2 agonists, especially during initiation and discontinuation.
    II. Behavioral Interventions and Psychotherapy:

    These strategies teach skills, modify behaviors, and create supportive environments.

    1. Behavior Therapy (Parent Training in Behavior Management for Children): Teaches parents specific skills to reinforce desired behaviors and reduce unwanted ones.
      • Key Strategies:
        • Positive Reinforcement: Praising, rewarding, or providing privileges for target behaviors (e.g., following instructions, completing tasks).
        • Consistent Consequences: Implementing clear, predictable consequences for problematic behaviors (e.g., time-out, loss of privileges).
        • Token Economy: Using a system of earning points or tokens for positive behaviors that can be exchanged for rewards.
        • Structuring the Environment: Creating predictable routines, minimizing distractions, providing clear rules.
      • Efficacy: Highly effective, especially for younger children, in improving behavior, parent-child relationships, and reducing ADHD symptoms. Often considered first-line for preschoolers with ADHD.
    2. Behavioral Interventions in the School Setting: Classroom management techniques (e.g., daily report cards, positive reinforcement, clear rules), preferential seating, frequent breaks, reduced workload, use of organizational aids, peer tutoring.
      • Efficacy: Improves academic performance, on-task behavior, and social interactions in school.
    3. Organizational Skills Training (for Older Children, Adolescents, and Adults): Teaches explicit strategies for time management, planning, organization, and problem-solving.
      • Strategies: Using planners, calendars, checklists, breaking down large tasks, decluttering, managing distractions.
      • Efficacy: Helps improve academic performance, reduce procrastination, and enhance daily functioning.
    4. Cognitive Behavioral Therapy (CBT) (for Adolescents and Adults): Helps individuals identify and change unhelpful thought patterns and behaviors.
      • Strategies: Addressing negative self-talk, developing problem-solving skills, improving emotional regulation, managing impulsivity, stress management.
      • Efficacy: Particularly useful for managing comorbid conditions (anxiety, depression), improving self-esteem, and developing coping strategies for ADHD-related challenges. Does not directly treat core ADHD symptoms but helps manage their impact.
    5. Social Skills Training: Explicitly teaches social cues, communication skills, conflict resolution, and empathy. Improves social interactions and peer relationships.
    III. Educational Interventions and Accommodations:
    • Individualized Education Programs (IEPs) or 504 Plans: Legally mandated plans in schools to provide accommodations (e.g., extended time on tests, quiet testing environment, preferential seating, reduced distractions, use of technology) and specialized instruction to meet academic needs.
    • Parent and Patient Education: Crucial for understanding ADHD, treatment options, potential side effects, and strategies for managing symptoms at home and in school/work.
    IV. Lifestyle Modifications and Complementary Approaches:
    • Regular Exercise: Can improve focus, reduce hyperactivity, and boost mood.
    • Healthy Diet: While diet doesn't cause ADHD, balanced nutrition supports overall brain health. Some individuals report sensitivity to certain foods, though evidence for widespread dietary changes is limited.
    • Adequate Sleep: Essential for managing symptoms; sleep hygiene strategies are critical.
    • Mindfulness and Meditation: Can help improve attention regulation and emotional control in some individuals.
    V. Nursing interventions

    Children with ADHD need guidance and understanding from their parents, families, and teachers to reach their full potential and to succeed. For school age children, frustration, blame and anger may hinder recovery in other wards children need special help to overcome negative feeling and to develop new skills and attitudes.

    • Social skills training; this will help the child learn how to behave in social situations by learning how their behaviours affect others
    • Parenting skills training (behavioural parent management training) this teaches parents the skills to encourage and reward positive behaviours in their children. It helps parents learn how to use a system of rewards and consequences to change a child’s behaviour
    • Stress management techniques, these can benefit parents of children with ADHD by increasing their ability to deal with frustration so that they can respond calmly to their child’s behaviour
    • Support groups; these help parents and families connect with others who have similar problems and concerns. Groups often meet regularly to share frustration and successes to exchange information about recommended specialists and strategies and to talk with experts
    • Diet; sugar, food colourings and additives as well as caffeine should be excluded in the patients diet as they aggravate hyperactivity

    Help the child with ADHD to stay organised and stay organised by;

    • Keeping a routine and a schedule. Keep the same routine every day from wake-up time to bedtime. Include times of homework, outdoor play and indoor activities. Write all changes on the schedule in advance as possible
    • Organizing everyday items; have a place for everything and keep everything in its place. This includes clothing, backpacks and toys
    • Using homework and notebook organizers. Stress to the child the importance of writing down assignments and bringing home necessary books
    • Being clear and consistent. Children with ADHD need consistent rules they can understand and follow
    • Giving praise or rewards when rules are followed. Children with ADHD often receive and expect criticism. Look for good behaviour and praise it.
    • Develop a trusting relationship with the child that conveys acceptance of the child separate from unacceptable behaviour
    • Ensure patient has a safe environment free from dangerous objects that can injure him due to random hyperactive movements
    • Keep the child in an environment that is free from distractions to help him comply on given tasks
    • Ensure child’s attention by calling his name and maintain an eye contact before giving instructions
    • Ask patient to repeat instructions before beginning the task
    • establish goals that allow the patient to complete part of the task, rewarding each step completion with a break for physical activity
    • Provide assistance on one-to-one basis beginning with simple concrete instructions
    • Gradually decrease the amount of assistance given to task performance while assuring patient that assistance is available if still needed
    • Offer recognition for successful attempts and positive reinforcement for attempts made
    • Provide quiet environment, self-contained classrooms an small group activities
    • Help the patient to learn how to take his turn, wait in line and follow rules
    • Provide information an materials related to the child’s disorder and effective parenting techniques
    • Explain and demonstrate positive parenting techniques to parents such as being vigilant in identifying the child’s behaviour and responding positively to that behaviour
    • Co-ordinate overall treatment plan with schools, child and family
    Nursing Diagnoses for Individuals with ADHD
    1. Impaired Attention
      • Related to: Neurotransmitter imbalance (e.g., dopamine, norepinephrine dysregulation) affecting executive function, difficulty processing multiple stimuli, inconsistent processing of information.
      • As evidenced by: Difficulty sustaining focus on tasks, frequent distractibility, difficulty following instructions, losing belongings, making careless errors, poor academic/work performance, difficulty with organization.
      • Rationale: This is a direct reflection of the inattentive symptoms, impacting learning, task completion, and safety.
    2. Impaired Organizational Ability
      • Related to: Deficits in executive function (e.g., planning, sequencing, prioritizing), difficulty with time management, chronic inattention.
      • As evidenced by: Disorganized living/work space, difficulty completing multi-step tasks, frequently missing deadlines, misplacing items, poor planning for future events.
      • Rationale: Directly addresses the functional impact of inattention and executive dysfunction on daily living and responsibilities.
    3. Deficient Knowledge (e.g., of effective study strategies, time management, disease process)
      • Related to: Impaired attention, difficulty with information processing, lack of prior education on condition.
      • As evidenced by: Verbalization of unfamiliarity, inappropriate or inefficient performance of tasks, frequent academic/work difficulties despite effort, questions about ADHD.
      • Rationale: Individuals and families often lack comprehensive understanding of ADHD and effective coping strategies.
    4. Risk for Injury
      • Related to: Impulsive behavior, hyperactivity, reduced hazard perception, restless motor activity, difficulty inhibiting responses.
      • As evidenced by: (This is a "risk for" diagnosis, so it doesn't have "as evidenced by" statements, but rather risk factors like:) Frequent accidents or near-misses, engaging in dangerous activities, difficulty adhering to safety rules, tendency to rush tasks.
      • Rationale: Hyperactivity and impulsivity increase the likelihood of accidents and unsafe behaviors.
    5. Impaired Impulse Control
      • Related to: Neurotransmitter dysregulation affecting inhibitory control, difficulty delaying gratification, underdeveloped prefrontal cortical function.
      • As evidenced by: Interrupting others, blurting out answers, difficulty waiting turns, making hasty decisions, engaging in risky behaviors, frequent social conflicts.
      • Rationale: Directly addresses the core impulsive symptom, impacting social interactions and decision-making.
    6. Disrupted Sleep Pattern
      • Related to: Hyperactivity, restlessness, difficulty winding down, medication side effects (stimulants), comorbid anxiety.
      • As evidenced by: Difficulty falling asleep, frequent awakenings, non-restorative sleep, daytime fatigue, irritability.
      • Rationale: Sleep disturbances are common in ADHD and can exacerbate symptoms.
    7. Low Self-Esteem
      • Related to: Chronic academic/social difficulties, negative feedback from peers/adults, perception of personal failures, co-occurring anxiety/depression.
      • As evidenced by: Negative self-talk, withdrawal from social situations, difficulty accepting compliments, expression of feelings of worthlessness, avoidance of new challenges.
      • Rationale: Repeated failures and criticisms can significantly erode self-worth.
    8. Impaired Social Interaction
      • Related to: Impulsivity (e.g., interrupting), difficulty with turn-taking, inattention to social cues, difficulty regulating emotions, peer rejection.
      • As evidenced by: Few close friendships, reports of being disliked, difficulty maintaining conversations, conflicts with peers, misinterpreting social cues.
      • Rationale: Core symptoms of ADHD can interfere with developing and maintaining healthy social relationships.
    9. Ineffective Coping (Individual or Family)
      • Related to: Inadequate problem-solving skills, overwhelming demands of managing ADHD symptoms, insufficient support systems, presence of co-occurring conditions, caregiver burden.
      • As evidenced by: Verbalization of inability to cope, difficulty with decision-making, maladaptive behaviors, strained family relationships, exacerbation of symptoms.
      • Rationale: Addresses the challenges individuals and families face in managing a chronic condition.
    10. Risk for Inadequate protein energy nutritional intake (especially relevant with stimulant medication)
      • Related to: Anorectic side effects of stimulant medication, decreased appetite.
      • As evidenced by: (Risk diagnosis) Reports of decreased appetite, weight loss, verbalization of food aversion after starting medication.
      • Rationale: Stimulants can suppress appetite, necessitating monitoring of nutritional intake.
    Role of the Nurse in the Care of Individuals with ADHD

    Given the chronic nature of the condition, its varied presentations across age groups, and the complexity of multimodal treatment, nurses are often at the forefront of assessment, education, advocacy, and coordination of care.

    I. Assessment and Early Identification:
    • Screening: Nurses in various settings (pediatric clinics, schools, primary care) are often the first to screen for ADHD symptoms during routine visits. They can administer standardized screening tools and observe behaviors indicative of ADHD.
    • Detailed History Taking: Collecting comprehensive developmental, medical, family, and psychosocial histories from patients and families.
    • Symptom Evaluation: Systematically assessing for core ADHD symptoms (inattention, hyperactivity, impulsivity) and their impact on functioning across multiple settings (home, school, work, social).
    • Comorbidity Assessment: Identifying potential co-occurring conditions (e.g., anxiety, depression, learning disabilities, ODD, sleep disorders) that frequently accompany ADHD and can complicate diagnosis and treatment.
    • Differential Diagnosis Support: Gathering information to help rule out other medical or psychiatric conditions that might mimic ADHD symptoms.
    II. Education and Counseling:
    • Psychoeducation: Providing individuals and families with accurate, evidence-based information about ADHD, including its neurobiological basis, symptoms, course, and treatment options. Dispelling myths and reducing stigma.
    • Treatment Rationale: Explaining the purpose, expected benefits, potential side effects, and administration guidelines for both pharmacological and non-pharmacological interventions.
    • Behavior Management Strategies: Teaching parents and caregivers effective behavioral techniques (e.g., positive reinforcement, consistent consequences, token economies, establishing routines) to manage challenging behaviors and promote desired ones.
    • Organizational and Study Skills: Counseling older children, adolescents, and adults on strategies for time management, planning, organization, note-taking, and reducing distractions.
    • Lifestyle Modifications: Educating on the importance of healthy diet, regular exercise, adequate sleep, and stress management in mitigating ADHD symptoms.
    • Coping Strategies: Helping individuals develop effective coping mechanisms for frustration, emotional dysregulation, and low self-esteem often associated with ADHD.
    III. Medication Management and Monitoring:
    • Administration Education: Instructing patients/families on the correct dosage, timing, and method of administration for prescribed medications (e.g., stimulants, non-stimulants).
    • Side Effect Monitoring: Assessing for and educating about common and serious side effects of ADHD medications (e.g., appetite suppression, sleep disturbances, cardiovascular changes for stimulants; GI upset for atomoxetine; sedation for alpha-agonists).
    • Therapeutic Response Evaluation: Monitoring the effectiveness of medication in reducing target symptoms and improving functioning, often using rating scales and patient/family reports.
    • Growth Monitoring: For children on stimulant medication, regularly monitoring height and weight to track growth.
    • Cardiovascular Monitoring: Taking baseline and regular blood pressure and heart rate measurements, especially for individuals on stimulant or alpha-agonist medications.
    • Adherence Promotion: Addressing barriers to medication adherence and promoting consistent medication use as prescribed.
    IV. Care Coordination and Advocacy:
    • Collaboration with Multidisciplinary Team: Working closely with physicians, psychiatrists, psychologists, social workers, teachers, and other specialists to ensure integrated and comprehensive care.
    • School Liaison: Communicating with school personnel (teachers, counselors, special education staff) to facilitate academic accommodations (IEPs, 504 plans), behavioral interventions in the classroom, and exchange of information.
    • Referrals: Facilitating referrals to specialists (e.g., occupational therapy for sensory issues, tutoring for learning disabilities, therapy for mental health comorbidities).
    • Advocacy: Advocating for the individual's needs within healthcare systems, educational settings, and the community. Empowering patients and families to advocate for themselves.
    • Resource Navigation: Connecting families to support groups, community resources, and reliable information sources.
    V. Supporting Across the Lifespan:
    • Children and Adolescents: Focus on psychoeducation for parents, behavior management strategies, school collaboration, medication monitoring, and supporting social skill development.
    • Adults: Emphasis on medication adherence, organizational skills, stress management, coping with comorbidities (anxiety, depression), workplace accommodations, and managing the impact of ADHD on relationships and daily responsibilities.
    • Geriatric Population: While less common for initial diagnosis, nurses might encounter older adults managing lifelong ADHD, focusing on medication interactions, cognitive changes, and maintaining functional independence.

    Attention-Deficit/Hyperactivity Disorder Read More »

    Standards of Care

    Standards of Care

    Standards of Care in Mental Health Nursing
    Standards of Care in Mental Health Nursing

    Standard of care refers to the degree of care that a reasonably prudent and competent mental health nurse would exercise under similar circumstances.

    It is a benchmark against which nursing actions are judged. These standards include both clinical competence and ethical conduct, reflecting the nature of caring for individuals with mental health conditions.

    Sources of Standards:

    They were enunciated by the American Nurses Association (ANA) in 1973.

    • Professional Organizations: Bodies such as the American Nurses Association (ANA) or country-specific nursing councils publish detailed standards of psychiatric-mental health nursing practice. These are often the primary source.
    • Legislation and Regulations: Laws like the Mental Treatment Act, Nurse Practice Acts, and patient rights legislation set legal mandates that directly influence nursing standards.
    • Institutional Policies and Procedures: Each healthcare facility develops its own policies and procedures, which must align with professional and legal standards and guide staff behavior within that specific environment.
    • Accrediting Bodies: Organizations that accredit healthcare institutions (e.g., The Joint Commission) set standards that influence care delivery and quality.
    • Published Literature and Research: Evidence-based practice guidelines, nursing textbooks, and peer-reviewed research contribute to defining optimal care.
    • Expert Consensus and Case Law: The opinions of expert witnesses in legal cases and previous court rulings (case law) can establish or clarify standards of care.
    Key Principles Guiding Mental Health Care:

    Underlying all standards of care are fundamental ethical and philosophical principles that are particularly salient in mental health:

    • Patient Safety: Paramount in all care, especially concerning risks like suicide, self-harm, or aggression.
    • Therapeutic Relationship: The development of a trusting, empathetic, and professional relationship is central to effective mental health nursing.
    • Autonomy: Respecting the patient's right to make decisions about their care, even when their capacity may be impaired, and supporting them to regain decision-making abilities.
    • Beneficence: Acting in the best interest of the patient, aiming to do good.
    • Non-Maleficence: The duty to do no harm.
    • Justice: Ensuring fair and equitable access to care, regardless of background or diagnosis.
    • Fidelity: Being faithful to promises and commitments made to patients.
    • Confidentiality: Protecting sensitive patient information, which is especially critical given the stigma often associated with mental illness.
    Legal Aspects in Psychiatric Nursing

    The practice of psychiatric nursing is influenced by law, particularly initial concern for the rights of patients and the quality of care they receive.

    • The client’s right to refuse a particular treatment, protection from confinement, intentional torts, informed consent, confidentiality and Promotion of research in mental health nursing.
    • The nurse contributes to nursing and the mental health field through innovations in theory and practice and participation in research.
    • Cost-effective nursing care: Studies need to be conducted to find out the viability in terms of cost involved in training a nurse and the quality of output in terms of nursing care rendered by her.
    • Focus of care: A psychiatric nurse has to focus care on certain target groups like the elderly, children, women, youth, mentally retarded and chronic mentally ill.
    • Record keeping are a few legal issues in which the nurse has to participate and gain quality knowledge.
    STANDARDS OF MENTAL HEALTH NURSING

    The purpose of Standards of Psychiatric and Mental Health Nursing practice is to fulfill the profession’s obligation to provide a means of improving the quality of care. The standards presented here are revision of the standards enunciated by the Division on Psychiatric and Mental Health Nursing Practice in 1973.

    Professional Practice Standards
    Standard I: Theory

    The nurse applies appropriate theory that is scientifically sound as basis for decisions regarding nursing practice. Psychiatric and mental health nursing is characterized by the application of relevant theories to explain phenomena of concern to nurses and to provide a basis for intervention.

    Standard II: Data Collection

    The nurse continuously collects data that are comprehensive, accurate and systematic. Effective interviewing, behavioral observation, physical and mental health assessment enable the nurse to reach sound conclusions and plan appropriate interventions with the client.

    Standard III: Diagnosis

    The nurse utilizes nursing diagnosis and/or standard classification of mental disorders to express conclusions supported by recorded assessment data and current scientific premises.

    Nursing logic basis for providing care rests on the recognition and identification of those actual or potential health problems that are within the scope of nursing practice.

    Standard IV: Planning

    The nurse develops a nursing care plan with specific goals and interventions delineating nursing actions unique to each client’s needs.

    The nursing care plan is used to guide therapeutic intervention and effectively achieve the desired outcomes.

    Standard V: Intervention

    The nurse intervenes as guided by the nursing care plan to implement nursing actions that promote, maintain or restore physical and mental health, prevent illness and effect rehabilitation.

    • (a) Psychotherapeutic interventions: The nurse uses psychotherapeutic interventions to assist clients in regaining or improving their previous coping abilities and to prevent further disability.
    • (b) Health teaching: The nurse assists clients, families and groups to achieve satisfying and productive patterns of living through health teaching.
    • (c) Activities of daily living: The nurse uses the activities of daily living in a goal directed way to foster adequate self-care and physical and mental well-being of clients.
    • (d) Somatic therapies: The nurse uses knowledge of somatic therapies and applies related clinical skills in working with clients.
    • (e) Therapeutic environment: The nurse provides structures and maintains a therapeutic environment in collaboration with the client and other health care providers.
    Standard VI: Evaluation

    The nurse evaluates client responses to nursing actions in order to revise the database, nursing diagnosis and nursing care plan.

    Professional Performance Standards
    Standard VII: Peer Review

    The nurse participates in peer review and other means of evaluation to assure quality of nursing care provided for clients.

    Standard VIII: Interdisciplinary Collaboration

    The nurse collaborates with other health care providers in assessing, planning, implementing and evaluating programs and other mental health activities.

    Standard IX: Utilization of Community Health Systems

    The nurse participates with other members of the community in assessing, planning, implementing and evaluating mental health services and community systems that include the promotion of the brand continuum of primary, secondary and tertiary prevention of mental illness.

    Standard X: Research

    The nurse contributes to nursing and the mental health field through innovations in theory and practice and participation in research.

    Impact of Standards on Practice:

    Adherence to these standards is fundamental to quality mental health nursing. It:

    • Minimizes Liability: By practicing within accepted standards, nurses significantly reduce their risk of negligence or malpractice claims.
    • Promotes Quality Outcomes: Consistent application of evidence-based standards leads to improved patient safety, more effective treatments, and better overall patient experiences and outcomes.
    • Enhances Professional Credibility: Upholding high standards reinforces the professionalism and trustworthiness of mental health nursing.
    • Guides Professional Development: Standards highlight areas for ongoing education, skill development, and specialization within mental health nursing.

    Standards of Care Read More »

    Law and Mental Illness

    Law and Mental Illness

    Law and Mental Illness
    Law and Mental Illness

    Law has relevance in nearly all aspects of nursing practice, but in no other area of nursing is the law more intimately involved than in psychiatric nursing.

    This is because psychiatric clients may;

    • be placed on treatment against their own will
    • pose a risk to themselves
    • have been charged to have committed crime while legally insane
    • be unable or unwilling to consent to treatment
    • be incapable of fully understanding medical risks
    • require constant restraints for their safety or others
    • make threats to others
    • undergo forensic evaluations that require nurses to testify in court
    Forensic Psychiatry

    Forensic psychiatry is a specialized branch of psychiatry that deals with the interface between mental health and the law.

    Forensic psychiatry is a branch of psychiatric nursing that deals with disorders of mind and their relationship with the legal principles.

    It is also concerned with the assessment, investigations, diagnosis and treatment of mental disorders among three broad categories of individuals i.e.;

    • individuals who are alleged to have committed an offence and face prosecution
    • convicted prisoners who develop mental illness in the course of serving their sentence
    • individuals who have not committed an offence but are at risk because of their mental capacity

    Under existing mental health legislation in Uganda, it is not expected that the primary health care provider will provide this service. It is however advised that a PHC provider knows something about prisoners’ mental health needs for the purpose of early and appropriate referrals to centres where a psychiatrist or other mental health professionals are available.

    The basic forensic psychiatry includes:
    • Crime and psychiatric disorders
    • Criminal responsibility
    • Civil responsibility
    • Laws relating to psychiatric disorders
    • Admission procedures of patients in psychiatric hospital
    • Civil rights of mentally ill
    • Psychiatrists and court
    I. Crime and Psychiatric Disorders

    There is a close association between crime and psychiatric disorders like schizophrenia, affective disorders, epilepsy, drug dependency, personality disorders, etc.

    Mentally ill people may commit crime because:

    • they do not understand the implication of their behaviour
    • due to delusions and hallucinations
    • abnormal mental states like confusion or excitements
    • drug related violence

    Instances when an individual facing prosecution may come to attention of a psychiatrist:

    • when police notices signs of mental disorder in individual under their custody
    • when the judge observes signs of mental disorder
    • when relatives raise issue of mental disorder
    • when prisoner reports history of treatment for psychiatric disorder
    • when suspect pleads insane during court proceedings

    Under any of the above, the magistrate may order assessment and observation of an individual to ascertain:

    • whether the individual is mentally disordered
    • the individual’s ability to stand trial if mentally disordered
    • whether the accused is criminally responsible for the offence he is charged with

    Responsibilities of a psychiatrist in order to find answers for the above questions:

    • hospitalize the accused for the purpose of observations and possible treatment or attend to matter as an out-patient case
    • take a full psychiatric history including history of previous episodes of illness and treatment
    • order an observation of patient by other nursing staff on daily basis
    • conduct laboratory, psychological and social investigations
    • make a report to the magistrate who will then decide on the best course of action on the basis of a psychiatric report
    II. Criminal Responsibility

    Criminal responsibility is a legal concept which refers to the extent to which an individual can be held liable for his or her offence.

    According to section 84 of the Indian penal code act of 1860, “Nothing is an offence which is done by a person who, at a time of doing it, by reason of unsoundness of mind, is incapable of knowing the nature of act, or that he is doing what is either wrong or contrary to the law”.

    A clinical test of responsibility may be used to determine whether an individual is responsible for an offence or not.

    III. Criteria for Criminal Responsibility

    Criteria for Criminal Responsibility (CCR) Score:

    SCORE Yes (1) / No (0)
    1. offence required careful planning
    2. offence was unrelated to symptoms of mental disorder
    3. identifiable motive for the crime was not a product of mental disorder
    4. mental capacity at a time of crime was unimpaired or did not impair rational judgement
    5. amnesia if present is incongruent with relevant key features of crime and mental state

    Score each item 1 for a Yes response and 0 for No response.

    The maximum score is 5. A score of 3 and more indicates that the individual is probably responsible for an alleged crime.

    IV. Other Criteria Used to Determine Criminal Responsibility
    • M’Naghten’s rule: This states that the individual at a time of the crime did not know the nature and quality of the act and if he did know what he was doing, he did not comprehend it to be wrong.
    • The Irresistible impulse act: According to this rule, a person may have known an act was illegal but as a result of mental impairment lost control of their actions.
    • The Durham test or Product rule: This states that an accused is not criminally responsible if his unlawful act was the product of mental disease or abnormality.
    • American law institute: This states that a person is not responsible for criminal conduct if at time of such conduct, as a result of mental disease or defect he lacks adequate capacity either to appreciate the criminality of his conduct or to conform his conduct to requirements of the law.
    V. Ability to Stand Trial

    An individual will not be expected to have an ability to stand trial under the following circumstances:

    • mentally ill with active signs of mental disorder
    • lacks ability to understand court proceedings

    In cases of the above, the psychiatrist may recommend that the individual receives relevant treatment for the mental disorder and after full recovery, the individual may then stand trial. However, in cases of severe psychotic illness like schizophrenia, the case might be disposed.

    Convicted prisoner: In case a prisoner who is serving sentence falls ill, he or she may be referred to a mental hospital under magistrates court Act for assessment, observation and treatment. Unfortunately, under existing laws, such an individual will not be excused from serving his prison sentence on ground of mental illness otherwise he will be released at the end of a prison sentence.

    VI. Aims of Management in Forensic Work
    • diagnose to form a basis for treatment and recommendations to court
    • make report and submit to court
    • rehabilitate as part of management
    • promote acceptance of individual in his community
    • resettle individual back in community
    • promote after care following discharge from court and hospital
    Civil Responsibilities and Rights of Mentally Ill Persons

    Beyond the criminal justice system, individuals with mental illness interact with the law concerning their civil responsibilities and fundamental human rights.

    I. Civil Responsibilities of a Mentally Ill Person:

    Mental illness can, under specific legal circumstances, impact an individual's capacity to exercise certain civil responsibilities. When a person is deemed of "unsound mind" to a degree that impairs their judgment or decision-making, the law provides mechanisms to protect their interests and the interests of others.

    1. Management of Property: "In case the court ascertain that a person is of unsound mind and incapable of managing his property, a manager is appointed by court of law to take care of his property which may include selling or disposal of property to settle debts or expenses." This highlights the legal provision for protecting the assets of individuals who lack the mental capacity to manage their own financial affairs. The appointed manager acts in the best interest of the person with mental illness.
    2. Marriage: "Hindu Marriage Act 1995" states that "marriage between any two individuals one of whom was of unsound mind at a time of marriage is considered null and void in the eyes of the law." Furthermore, "Unsoundness of mind for a continuous period can be sighted as a ground for obtaining divorce." If this unsoundness continues for a period of two years, the other party can file for divorce, though "divorce is granted with a precondition that one has to pay maintenance charges for the mentally ill."
    3. Testamentary Capacity (Making a Will): "Testamentary capacity or the mental ability of a person is a precondition for making a valid will." For a will to be legally binding, "The testator must be the major, free from coercion, understanding and displaying soundness of mind." This means that at the time of making a will, the individual must possess sufficient mental clarity to understand the nature of the document, the property they are disposing of, and the beneficiaries. Mental illness might invalidate a will if it demonstrably impaired this capacity.
    4. Right to Vote: "A person of unsound mind cannot contest for elections or exercise the privilege of voting." This is a civil responsibility directly tied to mental capacity, reflecting the legal requirement for electors and candidates to possess sound judgment in political processes.
    II. Rights of Psychiatric Patients:

    The legal framework, particularly within the context of mental health care, also aims to protect the fundamental human rights and dignity of individuals receiving psychiatric treatment.

    1. Right to wear their own clothes: Promotes dignity, personal expression, and normalization.
    2. Right to informed consent: Ensures patients understand and voluntarily agree to treatment, or have a legally authorized person consent on their behalf when capacity is compromised. This is a cornerstone of ethical medical practice.
    3. Right to habeas corpus: The right to challenge the legality of one's detention before a court, ensuring that involuntary hospitalization is subject to judicial review.
    4. Right to have individual storage space for their private use or right to privacy: Protects personal belongings and maintains a sense of autonomy and privacy within a treatment setting.
    5. Right to keep and use their own personal possessions: Allows patients to maintain connection to their identity and comfort items.
    6. Right to spend some of their money for their own expenses: Affirms financial autonomy and choice.
    7. Right to have reasonable access to all communication media like telephones: Maintains connection with the outside world, family, and legal counsel.
    8. Right to see visitors: Prevents social isolation and supports recovery through family and social connections.
    9. Right to treatment in the least restricted setting: Advocates for treatment environments that impose the fewest limitations on personal freedom, consistent with safety and effective care.
    10. Right to hold civil service status or enter into legal contracts e.g., marriage, personal last will etc.: These rights indicate that a diagnosis of mental illness alone does not automatically remove civil capacities. Such capacities are only removed if a court specifically determines an individual is of "unsound mind" to the extent that they cannot exercise these rights responsibly.
    11. Right to refuse treatment especially ECT: Acknowledges bodily autonomy and the patient's right to decline medical interventions, particularly those with significant implications like Electroconvulsive Therapy (ECT), unless there is a specific legal provision for compelled treatment in emergency situations or under court order.
    12. Right to manage and dispose of property and execute wills: Reaffirms that these civil responsibilities are generally retained unless a formal legal determination of incapacity has been made.
    Legal Responsibilities and Potential Liabilities for Nurses in Psychiatric Service

    Psychiatric nurses are confronted on daily basis with the interface of legal issues as they attempt to balance the rights of the patient with the rights of the society. Nurses and other health care providers should never in any way violate the rights of the mentally ill.

    I. Legal Responsibilities of a Nurse:

    Nurses, particularly in psychiatric care, bear specific legal responsibilities designed to protect both the patient and themselves from liability. These include:

    1. Adherence to Laws and Standards: Nurses must be intimately familiar with all relevant laws and regulations in their state or region of practice. This includes understanding mental health legislation, patient rights, and the criminal and civil responsibilities associated with mental illness. Practicing within the scope of state laws and the Nurse Practice Act is fundamental.
    2. Patient Rights Protection: Actively safeguarding patients' rights is a core responsibility. This involves ensuring patients are informed of their rights and that these rights are respected throughout their care.
    3. Documentation: Accurate, thorough, and timely legal documentation is crucial. Nurses must clearly and accurately maintain records of all assessment data, treatments given, interventions performed, and the patient's responses to care. These records must be kept safely and confidentially.
    4. Confidentiality: Maintaining strict confidentiality of all patient information is a paramount legal and ethical duty, given the sensitive nature of psychiatric diagnoses and treatments.
    5. Informed Consent: Obtaining informed consent from patients or their legal representatives for any procedure or treatment is a fundamental requirement. Explanations of procedures must be tailored to the patient's anxiety level, attention span, and capacity to make decisions.
    6. Collaboration: Working effectively with colleagues to determine the best course of action for patient care, ensuring a multidisciplinary approach.
    7. Ethical Practice: Always prioritizing patients’ rights and welfare and developing effective interpersonal relationships with patients and their families.
    8. Reporting: Recognizing and reporting instances of abuse, neglect, or any unsafe practices is a professional and legal obligation.
    II. Nursing Malpractice:

    Malpractice in nursing signifies a failure by a professional to provide the proper and competent care expected from members of their profession, leading to harm to the patient.

    To successfully argue a case of malpractice against a healthcare provider, three conditions typically must be proven by the patient:

    1. Established Standard of Care: There existed a recognized standard of care applicable to the situation.
    2. Breach of Responsibility: The nurse or physician breached their professional responsibility by failing to adhere to this established standard.
    3. Causation and Injury: This breach of responsibility directly caused injury or damage to the plaintiff (patient).

    If malpractice is proven, compensatory damages may be awarded to the patient to cover medical expenses, lost wages, and physical or emotional suffering. In cases of gross negligence or extreme carelessness, punitive damages may also be awarded, intended not to compensate the patient but to punish the negligent professional.

    III. Common Areas of Liability in Psychiatric Service:

    The unique aspects of psychiatric care create specific vulnerabilities for liability. Nurses must be particularly vigilant in these areas:

    1. Patient Committing Suicide: This remains a leading cause of liability. It involves inadequate risk assessment, failure to implement appropriate suicide precautions, or insufficient monitoring.
    2. Failure to Prevent Self-Inflicted Injury: This encompasses situations where patients cause harm to themselves (e.g., cutting, head-banging) without direct suicidal intent, often due to their mental state, and where supervision or protective measures were inadequate.
    3. Patient Assaults: Liability can arise from failure to prevent patients from assaulting other patients or staff. This often links to inadequate risk assessment, poor environmental management, or insufficient de-escalation skills.
    4. Misuse of Psychoactive Prescription Drugs: This includes medication errors (wrong drug, dose, route, time) or inappropriate administration leading to harm.
    5. Failure to Obtain Consent: Providing treatment without proper informed consent, particularly crucial in a setting where capacity to consent may fluctuate.
    6. Failure to Report Abuse: Neglecting to report suspected abuse of a patient is a serious legal and ethical failing.
    7. Inadequate Monitoring of Patients: Insufficient observation or supervision, especially for high-risk patients, leading to adverse events.
    8. Breach of Confidentiality: Unauthorized disclosure of sensitive patient information.
    9. Improper Use of Seclusion and Restraints: Applying these interventions without strict adherence to legal guidelines, clinical necessity, and monitoring protocols.
    10. Failure to Diagnose: While primarily a physician's role, nurses contribute to the diagnostic process through their observations and reporting. A failure to recognize and report critical symptoms that lead to a missed diagnosis and subsequent harm could involve nursing liability.
    IV. Steps to Avoid Liability in Psychiatric Nursing Services:

    Proactive measures are essential for psychiatric nurses to mitigate legal risks:

    1. Effective Communication: Reporting relevant patient information clearly and thoroughly to co-workers involved in patient care.
    2. Meticulous Documentation: Accurately and thoroughly documenting all assessment data, treatments given, interventions, and evaluations of patient responses.
    3. Confidentiality: Consistently maintaining the confidentiality of patient information.
    4. Scope of Practice: Practicing strictly within the defined scope of state laws and the Nurse Practice Act.
    5. Collaboration: Working collaboratively with colleagues and the interdisciplinary team to determine the best course of action for patient care.
    6. Standards of Practice: Utilizing established practice standards and guidelines to inform and direct clinical decisions and actions.
    7. Patient-Centered Care: Always prioritizing patients’ rights and welfare above all else.
    8. Therapeutic Relationships: Developing effective and professional interpersonal relationships with patients and their families.
    MENTAL TREATMENT ACT (MTA)

    Legal Documents And Admission Of Civil Patients.

    The Mental Treatment Act (MTA), enacted in 1964, is a piece of legislation governing the admission, treatment, and discharge of individuals with mental illness in psychiatric hospitals. It replaced the earlier Mental Treatment Ordinance of 1938, aiming to safeguard persons with unsound mind from harm, protect the public, and legally authorize mental hospitals to detain, treat, and discharge patients. The MTA primarily addresses civil patients, distinguishing them from forensic patients who enter the system via criminal justice proceedings.

    I. Orders for Admission of Civil Patients:

    The MTA outlines four primary orders under which civil patients can be admitted to mental hospitals, each with specific criteria and durations. While the Voluntary Order is not strictly under the MTA, it is legally accepted as a pathway to admission.

    1. Urgency Order (Section 7 of MTA):
    • Purpose: Designed for the rapid removal of an individual with mental illness from the public into a mental hospital, especially when there is an immediate need for intervention due to potential danger to themselves or others.
    • Authorization: Can be signed by a licensed medical practitioner (e.g., registered nurse, doctor), a police officer not below the rank of Assistant Inspector, or a gazetted chief (e.g., a Resident District Commissioner - RDC).
    • Duration: Remains in effect for a period of 10 days. It cannot be renewed; if further detention is required, a new order must be initiated. If the patient is not discharged or a new order is not signed after 10 days, the patient has the right to sue the hospital for illegal detention.
    2. Temporary Detention Order (Section 3 of MTA):
    • Purpose: This serves as the standard initial procedure for detaining patients requiring psychiatric hospitalization. The process begins with the "information of lunacy," which can be made by anyone aware of the patient's condition, though in practice, it is often initiated by the ward in charge.
    • Duration: Valid for 14 days. It can be renewed once for an additional 14 days, but no further renewals are permitted under this order.
    3. Reception Order (Section 5 of MTA):
    • Purpose: This order is sought if a patient's condition does not improve after the Temporary Detention Order and its renewal expire. It signifies a longer-term commitment to care.
    • Process: A magistrate appoints two medical practitioners (who are not related to the patient) to thoroughly investigate the patient's behavior and illness. Upon receiving and being satisfied with these medical reports, the magistrate signs the Reception Order.
    • Duration: Initially valid for one year. If the patient's condition has not improved, it can be renewed for another year. If improvement is still not observed, subsequent renewals are for three-year periods.
    • Implications: Patients under a Reception Order are considered "satisfied," implying a legal determination of diminished capacity. They are generally not permitted to sign a will, vote, stand as a witness in court, or marry, reflecting a curtailment of certain civil rights due to their mental state.
    4. Voluntary Order:
    • Status: Although not strictly under the MTA, this is a legally accepted pathway for admission.
    • Process: The patient voluntarily presents themselves to the hospital. The Medical Superintendent or Director examines the patient to confirm their mental health status. The patient agrees to abide by hospital rules and regulations.
    • Discharge: If a voluntary patient wishes to leave, they inform the ward in charge, who then informs the ward doctor and subsequently the Medical Director or Superintendent. There is typically a 72-hour period within which this notification and processing occurs, allowing for assessment of the patient's decision-making capacity and potential transition planning.
    II. Discharge of Civil Patients:

    The discharge process for civil patients under the MTA involves several sections, each catering to different circumstances, and nurses play a crucial role throughout.

    A. Role of a Nurse in Discharge Procedure:

    Nurses are instrumental in ensuring a safe and effective discharge by:

    • Identifying the patient's fitness for discharge and informing the psychiatrist.
    • Providing feedback and information about the discharge plan and seeking the patient's input.
    • Ensuring all paperwork and forms are completed, signed, and copies sent to medical records.
    • Confirming the patient has returned all hospital property to the ward manager.
    • Clearly communicating all necessary information, particularly regarding medications and follow-up appointments, to the patient.
    • Recognizing and addressing any mixed feelings the patient may have about leaving the hospital and returning to the community, offering support and coping strategies.
    • Preparing the patient's community (family, caregivers) to receive and support the patient, depending on the circumstances.
    • Escorting the patient out of the ward or hospital compound.
    B. Discharge Sections under the MTA:
    1. Section 18: For Recovered Patients:
      When a nurse assesses a patient as fit for discharge, they inform the ward doctor (psychiatrist), who then recommends the patient's fitness. The doctor writes to the Director for authorization to discharge the patient with treatment. For patients admitted under Temporary Detention or Reception Orders, the magistrate is informed and authorizes the discharge.
    2. Section 19: Discharge of a Patient Under the Care of Relatives:
      If relatives request to take the patient home, they must provide a written statement confirming they will care for the patient. If the patient becomes unmanageable within 28 days of discharge, they can be readmitted using the previous order. After 28 days, a new admission order would be required. In such cases, if the discharge is against medical advice, no medications are provided unless paid for.
    3. Section 20: Discharge for a Paying Patient:
      If relatives of a paying patient face increasing medical costs and request discharge, even if the patient is not fully recovered, the Medical Superintendent may grant it. This often comes with a condition that the hospital will not be held responsible for any subsequent incidents at home. Similar to Section 19, no medications are provided without payment if the discharge is against medical advice.
    4. Section 21: Discharge on Trial Leave:
      The Director of Medical Services authorizes the Medical Superintendent or ward doctor to discharge a patient on trial leave for a specified period (typically 28 days), during which the patient is expected to return for review. If the patient exceeds this 28-day period without returning, a fresh admission order would be required for readmission.
    5. Section 22: Discharge for Escaped Patients:
      If a patient escapes and does not return within 28 days, should they later be brought back, a fresh admission order must be obtained for readmission. This provision addresses safety and management concerns for the hospital.
    6. Section 23: Discharge of a Person of Sound Mind:
      If an individual of sound mind is detained against their will, a magistrate, in conjunction with a psychiatrist, will examine the person. If they are indeed found to be of sound mind, the Medical Superintendent or ward doctor will be directed to immediately discharge them.
    III. Transfer of Patients:

    The MTA also includes provisions for the transfer of patients:

    1. Section 36: Transfer of Patients: This section covers two types of transfers:
      • Intra-national Transfer: Allows for the transfer of a patient from one hospital to another within the same country if deemed necessary by the patient, relatives, or medical professionals.
      • Inter-national Transfer: Permits the transfer of a mental patient from a hospital in one country to a hospital in another country.
    2. Section 38: Transfer of a Foreigner Back to Their Own Country: This section specifically grants the authority to transfer a foreign mental patient back to their country of origin.
    Admission and Discharge Procedures for Criminal Mental Patients

    Criminal mental patients, also known as forensic patients, are individuals who interact with the mental health system due to their involvement with the criminal justice system. They are broadly classified into two categories: Remand patients and Class A, B, and C patients, each with distinct admission and discharge protocols governed by specific legal frameworks.

    I. Remand Patients (Penal Code Act 106):

    Remand patients are individuals who have been accused of an offense and charged, but during court proceedings, they are suspected of being of "unsound mind." They are referred to a mental hospital by a magistrate for observation, investigation, and the preparation of a medical report detailing their mental state, as requested by the court.

    A. Admission of a Remand Patient:

    Remand patients are admitted to a mental hospital under a warrant of commitment on remand. This warrant is signed by a judge or a magistrate and specifies either a fixed date or an open date for the patient to reappear in court.

    • Fixed Date Remand: The warrant explicitly states the date for the accused's next court appearance. When this date arrives, the patient is returned to court, accompanied by a medical report indicating their capacity to plead. If found capable, they may be sentenced immediately. If deemed incapable, they are typically returned to the hospital and reclassified as a Class B patient.
    • Open Date Remand: In this scenario, the warrant of commitment does not specify a date for the next hearing. The patient is recalled to court as needed, upon presentation of a production warrant signed by a magistrate.
    II. Class A Patients:

    Class A patients are prisoners who develop mental disorders while serving their sentences in a correctional facility.

    A. Admission of Class A Patients:

    These patients are transferred from prison to a mental hospital based on several orders:

    • A Temporary Detention Order or Reception Order, similar to those for civil patients, but applied within the context of their incarceration.
    • A warrant of commitment that specifies the offense they committed.
    • A warrant slip indicating the expiration date of their prison sentence.
    B. Discharge of Class A Patients:

    The discharge process for Class A patients depends on their recovery and sentence status:

    • Recovery Before Sentence Expiration: If a patient recovers while their sentence has not yet expired, they are returned to prison to complete their sentence. This transfer is facilitated by a production warrant signed by a magistrate.
    • Sentence Expiration While Hospitalized (Recovered): If the patient's sentence expires while they are in the mental hospital and they have recovered, they are discharged directly home under Section 18 of the Mental Treatment Act (which pertains to recovered patients).
    • Sentence Expiration While Hospitalized (Not Recovered): If the sentence expires but the patient has not shown signs of improvement, they are removed from the forensic register and transferred to a civil hospital, where their care continues under civil orders.
    III. Class B Patients:

    Class B patients are individuals admitted from court who have been deemed incapable of making their own defense or following court proceedings due to insanity.

    A. Admission of Class B Patients:

    They are admitted to a mental hospital for observation and treatment under specific warrants:

    • A warrant of detention for an accused person incapable of making a self-defense, signed by the Minister of Justice or the Attorney General.
    • Alternatively, a warrant of detention for an accused person incapable of making a self-defense, signed by a magistrate or judge, pending the Minister's order.
    B. Discharge of Class B Patients:

    When a Class B patient recovers and is deemed able to plead, a psychiatrist issues a certificate of mental fitness. This certificate is submitted to the Director of Public Prosecutions, who then arranges for a court hearing.

    • If, after pleading, the accused is found guilty, they are sentenced directly.
    • If found not guilty due to reasons of insanity, they are returned to the mental hospital and reclassified as a Class C patient.
    IV. Class C Patients:

    Class C patients are those admitted from court after being found not guilty of an offense due to reasons of insanity.

    A. Admission of Class C Patients:

    Their admission to a mental hospital is based on:

    • A warrant of detention signed by a judge or magistrate, pending the Minister's order.
    • A Minister's order, which will explicitly state "ORDER OF DETENTION of a person of unsound mind not found guilty due to reasons of insanity."
    B. Discharge of Class C Patients:

    Depending on the minister's order the patient after recovery is discharged directly home unless otherwise ordered by the minister.

    Law and Mental Illness Read More »

    Resuscitation of a newborn

    Resuscitation

    Neonatal Resuscitation Lecture Notes
    Neonatal Resuscitation Lecture Notes
    • Neonatal Resuscitation refers to a series of interventions initiated immediately after birth to support the establishment of breathing and circulation in a newborn who is not breathing effectively or has inadequate circulation.
    • Resuscitation is a means of restoring life to a baby from the state of asphyxia (Devi, Upendra, and Bard, 2017).

    Asphyxia in a newborn refers to a condition where there is impaired blood gas exchange, leading to a progressive decrease in oxygen (hypoxemia) and an increase in carbon dioxide (hypercarbia), often resulting in acidosis.

    • More simply, it is about "helping a baby to breathe," which is the most critical physiological adjustment required at birth.
    The Importance of Neonatal Resuscitation:
    1. High Vulnerability of the Neonatal Period: The first 28 days of life is called neonatal period and incontrovertibly, it is the most vulnerable and high risk time in life because of the highest mortality and morbidity that occur in this period. The day of birth is the riskiest time to a baby" (Sajjad, 2012; and WHO, 2015). A significant proportion of neonatal deaths occur on the first day of life, many of which are attributable to birth asphyxia.
    2. Prevention of Mortality: Effective and timely resuscitation can directly prevent death in newborns who fail to transition successfully from intrauterine to extrauterine life.
    3. Prevention of Morbidity and Long-Term Disability: Prevent brain injury and other organ damage resulting from prolonged oxygen deprivation. Timely resuscitation minimizes the duration of hypoxemia and acidosis, thereby reducing the risk of such devastating outcomes.
    4. Enabling Physiological Transition: Birth involves a physiological transition from relying on the placenta for gas exchange to establishing independent pulmonary respiration and circulatory changes. Approximately 85% of newborns transition successfully without intervention. However, about 10-15% require some assistance, and about 1% require extensive resuscitative measures. Resuscitation provides the necessary support for these babies to make this critical transition.
    5. Global Health Impact: Improving access to and quality of neonatal resuscitation services is a key strategy for achieving global maternal and child health targets, particularly in low-resource settings where the burden of birth asphyxia is highest.
    Goals of Neonatal Resuscitation (Aims of Management):
    1. Initiate and/or Restore Respiration/Breathing: This is the most immediate and primary goal, as establishing effective breathing is fundamental to oxygenation.
    2. Establish Adequate Circulation: While not explicitly listed as a separate aim in your text, it's intrinsically linked to respiration. Effective breathing improves oxygenation, which then supports heart function and systemic circulation.
    3. Prevent Infection: Although not a direct resuscitation step, ensuring aseptic technique during resuscitation and appropriate post-resuscitation care are vital to prevent secondary complications in a vulnerable neonate.
    4. Prevent Other Complications: This is a broad goal encompassing the prevention of brain injury (HIE), organ dysfunction, and ensuring overall physiological stability.
    5. Prevent Hypothermia: Maintaining the newborn's temperature is critical from birth, throughout resuscitation, and into post-resuscitation care, as hypothermia can worsen acidosis and impair resuscitation efforts.
    Risk Factors for Resuscitation
    I. Common Maternal Risk Factors:

    These factors are related to the mother's health, pregnancy complications, or circumstances surrounding the birth.

  • Advanced Maternal Age: (e.g., usually >35 years)
  • Maternal Illnesses/Conditions:
    • Diabetes (gestational or pre-existing)
    • Hypertension (e.g., pre-eclampsia, eclampsia, chronic hypertension)
    • Cardiac or renal disease
    • Thyroid disease
    • Anemia
    • Infections (e.g., Group B Streptococcus, herpes simplex virus, HIV)
  • Substance Abuse:
    • Opioid use (can cause neonatal abstinence syndrome)
    • Alcohol abuse
    • Smoking
  • Medications:
    • Maternal sedatives/analgesics administered close to delivery (can cause neonatal respiratory depression).
    • Magnesium sulfate administration (for pre-eclampsia, can cause neonatal respiratory and neuromuscular depression).
  • Lack of Antenatal Care: Poor or no antenatal care prevents the identification and management of potential risks.
    • II. Common Fetal/Intrapartum Risk Factors:

    These factors are directly related to the fetus or events occurring during labor and delivery.

  • Prematurity: The most significant risk factor. Premature infants have immature lungs, poor temperature control, and vulnerable brains.
    • Extremely preterm (<28 weeks)
    • Very preterm (28-32 weeks)
    • Moderate to late preterm (32-37 weeks)
  • Post-term Pregnancy: (>42 weeks gestation), associated with placental insufficiency.
  • Multiple Gestation: (Twins, triplets, etc.) increases the risk of prematurity, growth restriction, and delivery complications.
  • Abnormal Fetal Heart Rate (FHR) Pattern:
    • Persistent bradycardia
    • Repetitive late decelerations
    • Prolonged decelerations
    • Loss of variability, indicating fetal distress.
  • Meconium-Stained Amniotic Fluid: (especially thick meconium), indicates fetal stress and risk of meconium aspiration syndrome.
  • Prolonged Rupture of Membranes (PROM): Increases risk of infection.
  • Chorioamnionitis: (Infection of the amniotic fluid and membranes), leads to neonatal sepsis and respiratory distress.
  • Abnormal Presentation: (e.g., breech, transverse lie), often requires C-section and can be associated with birth trauma.
  • Placental Abnormalities:
    • Placenta previa
    • Abruptio placentae (premature separation of the placenta)
    • Vasa previa, leading to fetal hemorrhage and hypoxia.
  • Cord Complications:
    • Nuchal cord (cord around the neck)
    • Cord prolapse (cord falling through the cervix before the baby)
    • True knot in the cord.
  • Fetal Anomalies: Congenital malformations affecting respiratory, cardiac, or neurological systems.
  • Intrapartum Complications:
    • Prolonged labor
    • Precipitous labor (very rapid labor)
    • Forceps or vacuum extraction delivery
    • Cesarean section (especially elective C-section without labor, as it can be associated with transient tachypnea of the newborn).
    • Shoulder dystocia.
  • Fetal Growth Restriction (FGR) / Small for Gestational Age (SGA): Indicates placental insufficiency and compromised fetal reserves.
  • Lack of Fetal Movement: Reported by mother.
    • Initial Steps of Newborn Care and Assessment at Birth

    This objective focuses on the immediate actions taken when a baby is born, particularly during the critical first minute of life—often referred to as the "Golden Minute." This period is crucial for assessing the newborn's transition and initiating any necessary interventions quickly to prevent adverse outcomes.

    Principles of Management.
    • Temperature regulation. Ensure adequate warmth for the baby to prevent hypothermia which leads to decreased metabolic which cause additional stress to the baby.
    • Ensure adequate oxygenation to the baby to prevent hypoxia by administration of oxygen and monitoring oxygen perfusion. An endotracheal tube should be inserted and oxygen administered
    • Prevention of hypoglycemia by regular monitoring blood glucose and if risk for hypoglycemia is identified administer dextrose as per prescription.
    I. Preparation for Birth: Ensuring Readiness

    Before any birth, and especially when risk factors (as discussed previously) are present, it is paramount to ensure the resuscitation area is prepared and all necessary equipment is immediately available and functional.

    A. Essential Equipment and Supplies :
  • Personal Protective Equipment:
    • Surgical gloves (minimum for resuscitator).
    • Other PPE (gowns, masks, eye protection) as per institutional policy.
  • Warmth Management:
    • Radiant warmer or heat lamp (integrated into the resuscitation table).
    • Pre-warmed towels or blankets.
    • Temperature probe/sensor (to monitor infant's temperature).
    • Plastic wrap/bag (for extremely preterm infants).
  • Airway and Suction:
    • Bulb syringe.
    • Suction catheters (e.g., 6F, 8F, 10F) with mechanical suction apparatus (set to 80-100 mmHg).
    • Meconium aspirator (if meconium is present and baby is non-vigorous, though routine use has decreased).
  • Ventilation Equipment:
    • Self-inflating bag, flow-inflating bag, or T-piece resuscitator.
    • Face masks (various sizes: preterm, term, full-term/neonate).
    • Oxygen source (blender if available to provide specific FiO2, flowmeter).
    • Nasal prongs/cannula (for oxygen administration post-resuscitation).
  • Intubation Equipment:
    • Laryngoscope with straight blades (e.g., Miller 0, 1 for term/preterm).
    • Spare laryngoscope handle and bulbs.
    • Endotracheal tubes (ETTs): range of sizes (e.g., 2.5, 3.0, 3.5, 4.0 mm internal diameter).
    • Stylet (for ETT insertion).
    • CO2 detector (colorimetric or capnography) for confirming ETT placement.
    • Scissors, tape/ETT holder for securing ETT.
    • Naso-gastric/oro-gastric tube (e.g., 8F) for gastric decompression after prolonged PPV.
  • Circulation and Medication Equipment:
    • Syringes (various sizes: 1mL, 3mL, 5mL, 10mL, 20mL).
    • Needles/blunt fill devices.
    • Umbilical venous catheterization tray (for rapid vascular access if medications are needed).
    • Sterile water and normal saline (for flushing).
    • Pediatric stethoscope.
  • Medications (Prepared and Labeled):
    • Adrenaline (Epinephrine) 1:10,000 solution:
    • Volume Expanders: 0.9% Normal Saline or Ringer's Lactate.
    • Dextrose 10%: For hypoglycemia management post-resuscitation.
    • Sodium Bicarbonate 4.2%: For prolonged resuscitation with documented metabolic acidosis.
  • Monitoring and Documentation:
    • Timer (clock watch).
    • Pulse oximeter with neonatal probe (pre-ductal placement, right hand/wrist).
    • Displayed charts for resuscitation steps (e.g., NRP algorithm).
    • Mothers' chart/patient notes.
    • B. Resuscitation Environment:
    • Resuscitation table: Stable, readily accessible, with radiant warmer.
    • Light source: Adequate, adjustable lighting.
    • Proximity: Situated near the delivery area for immediate access.
    II. Immediate Assessment at Birth: The "Golden Minute"

    Upon delivery, a rapid assessment is made to determine if the newborn requires routine care or resuscitation. This assessment should take no longer than 30 seconds to allow for timely intervention within the first minute of life.

    A. Three Key Questions for Rapid Assessment:

    The decision to proceed with routine care or to initiate resuscitation is based on answering these three questions quickly:

    1. Is the baby term gestation? (i.e., ≥ 37 weeks)
    2. Does the baby have good tone? (i.e., flexed limbs, active movement)
    3. Is the baby breathing or crying? (i.e., strong, regular respiration, not gasping or apneic)
    B. Decision Pathway:
    • YES to all three questions: Proceed with Routine Care (provide warmth, dry, skin-to-skin, observe).
    • NO to any of these questions: Proceed immediately to the Initial Steps of Stabilization.
    III. Steps for Resuscitation: The T-A-B-C's of Resuscitation

    If the newborn does not meet the criteria for routine care, the following initial steps of stabilization must be performed quickly and effectively, ideally within the first 30-60 seconds after birth (the "Golden Minute").

    A. Step 1: Temperature (T)
  • Provide Warmth and Dry:
    • Place the naked newborn under a pre-heated radiant warmer.
    • Dry the baby thoroughly with pre-warmed towels/blankets. This removes amniotic fluid, which prevents evaporative heat loss, and provides tactile stimulation.
    • Remove any wet cloth after drying.
    • B. Step 2: Airway (A)
  • Position and Clear Airway:
    • Position baby’s head in a neutral or slightly extended “sniffing position”.
    • Place a small towel roll under the baby’s shoulders to help maintain this position, ensuring the airway is open.
    • Clear the airway (if necessary): Suction blood or mucus from the mouth and then the nose using a bulb syringe or suction catheter ONLY if secretions are obstructing breathing or the baby is gasping.
    • C. Step 3: Breathing (B)
  • Assess Breathing and Heart Rate: After completing the initial steps of warmth, drying, positioning, and suctioning (if needed), reassess the newborn.
    • Look for effective breathing (regular, sustained respiratory effort, no gasping).
    • Assess Heart Rate (HR): Auscultate the chest with a stethoscope or palpate the umbilical cord stump for 6 seconds and multiply by 10.
  • Intervention for Breathing Issues:

    If the baby is apneic (not breathing) or gasping, OR if the Heart Rate is less than 100 bpm despite initial steps: Begin Positive-Pressure Ventilation (PPV).

    • Stand at the baby's head.
    • Apply an appropriately sized mask to the baby’s face, ensuring it covers the mouth and nose to form a good seal.
    • Give five initial inflation breaths (each 2-3 seconds duration). This aims to establish functional residual capacity in the lungs.
    • Observe response by looking for chest movements (chest rising) and listen for increasing heart rate.
    • Troubleshooting: If the chest does not rise, reapply the mask, reposition the baby’s head, and consider suctioning again (MR. SOPA mnemonic: Mask adjustment, Reposition airway, Suction mouth and nose, Open mouth, Pressure increase, Alternate airway).
    • Continue ventilating at a rate of 30-40 breaths per minute.
    • Intubation consideration: If PPV with a mask is ineffective, prolonged, or if specific conditions require it, intubation should be considered earlier than 20 minutes. Intubation provides a more secure airway for ventilation and allows for direct tracheal suction if needed.

    • D. Step 4: Circulation (C) / External Cardiac Massage (Chest Compressions)
  • Indication for Chest Compressions:
    • Chest compressions should be initiated if the heart rate is less than 60 beats per minute (bpm) AFTER at least 30 seconds of effective positive-pressure ventilation (PPV).
  • Technique:
    • The preferred method is the Two-Thumb Encircling Technique: Wrap your hands around the baby’s torso, placing both thumbs over the lower third of the sternum (just below an imaginary line between the nipples).
    • Alternatively, the two-finger technique can be used if one resuscitator is present or if the encircling method is not feasible.
  • Rate and Ratio:
    • Chest compressions are performed at a rate of 90 compressions per minute, coordinated with 30 ventilations per minute.
    • This provides a ratio of 3 compressions to 1 ventilation, aiming for 120 "events" (compressions + breaths) per minute.
  • Depth:
    • Compress the chest approximately one-third of the anterior-posterior diameter of the chest. Allow for complete recoil after each compression.
    • E. Step 5: Drugs (D)
  • Indication for Medications:
    • Medications are generally reserved for when the heart rate remains below 60 bpm despite effective ventilation and chest compressions.
    • Establish vascular access ( umbilical venous catheter - UVC) prior to medication administration.
  • Adrenaline (Epinephrine):
    • Indication: Heart rate remains < 60 bpm despite at least 30 seconds of effective PPV and at least 60 seconds of effective chest compressions coordinated with PPV.
    • Dose: 0.01 to 0.03 mg/kg IV (intravenous) or IO (intraosseous) of a 1:10,000 solution.
    • Repeat: May be repeated every 3-5 minutes if needed.
  • Volume Expanders (e.g., Normal Saline 0.9%):
    • Indication: Suspected hypovolemia (e.g., pallor, poor perfusion, weak pulse, lack of response to resuscitation efforts) and heart rate remains < 60 bpm despite ventilation, compressions, and epinephrine.
    • Dose: 10 mL/kg IV over 5-10 minutes.
  • Dextrose 10%:
    • Indication: Not typically given during acute resuscitation unless documented hypoglycemia. Administered after stabilization if blood glucose is low (<2.5 mmol/L).
    • Dose: 2 mL/kg of 10% dextrose solution IV.
  • Sodium Bicarbonate 4.2%:
    • Indication: For prolonged resuscitation or documented metabolic acidosis. Not a first-line drug.
    • Dose: 2 mEq/kg (equivalent to 4 mL/kg of 4.2% solution) IV slowly.
    • F. Post-Resuscitation Monitoring and Ongoing Care:
  • Continue to monitor response to resuscitation closely. (This includes heart rate, breathing, oxygen saturation, and clinical appearance).
  • APGAR Score: The Apgar score is assessed at 1 and 5 minutes after birth, and every 5 minutes thereafter if the score is less than 7, until 20 minutes of age. It's a snapshot of the baby's condition and response to resuscitation.
  • If the baby responds to resuscitation and stabilizes, keep the baby warm and transfer to a special care unit (e.g., NICU, SCN) for ongoing monitoring and supportive care.
  • If the baby is breathing well and stable:
    • Encourage skin-to-skin contact with the mother.
    • Encourage breastfeeding.
    • Provide reassurance to the mother and family.
  • Discontinuation of Resuscitation:
    • If there is no detectable heart rate after 10-20 minutes of complete and adequate resuscitation efforts, discontinuation of resuscitation should be considered in consultation with the medical team and family.
    • Principles and Techniques of Positive-Pressure Ventilation (PPV)

    Positive-Pressure Ventilation (PPV) is the most critical and frequently performed intervention in neonatal resuscitation. Its primary goal is to establish functional residual capacity (FRC) in the lungs and provide oxygenation and ventilation to newborns who are apneic (not breathing), gasping, or have a heart rate below 100 beats per minute (bpm) despite initial steps. Effective PPV can rapidly improve heart rate, oxygen saturation, and clinical condition, often preventing the need for more advanced interventions like chest compressions or medications.

    I. Principles of Effective PPV

    The success of PPV hinges on three key principles:

    1. Effective Mask Seal: The mask must form a tight, leak-free seal around the baby's mouth and nose to ensure that the delivered positive pressure enters the lungs and does not escape.
    2. Open Airway: The baby's airway must be properly positioned (sniffing position) to allow air to flow freely into the trachea and lungs. Obstructions (e.g., secretions, incorrect head position) will render PPV ineffective.
    3. Adequate Pressure and Rate: Sufficient pressure is needed to inflate the lungs, but excessive pressure must be avoided to prevent lung injury. The rate of ventilation must be appropriate to ensure both oxygenation and CO2 removal.
    II. Indications for PPV

    PPV is indicated when a newborn is:

    • Apneic: Not breathing at all.
    • Gasping: Irregular, ineffective breaths.
    • Heart Rate < 100 bpm: Despite the initial steps of warmth, drying, positioning, and clearing the airway (if necessary).
    III. Equipment for PPV

    The primary equipment used for PPV includes:

    1. Ventilation Device:
      • Self-inflating Bag: The most common device. It refills automatically after each squeeze and requires an oxygen source for supplemental oxygen. It will deliver room air if no oxygen is attached.
      • Flow-inflating Bag (Anesthesia Bag): Requires a compressed gas source and a tight mask seal to inflate. Allows for precise control of pressure and oxygen concentration but requires more skill.
      • T-piece Resuscitator (e.g., Neopuff): A gas-powered, flow-controlled device that delivers consistent peak inspiratory pressure (PIP) and positive end-expiratory pressure (PEEP). Often preferred for its precision and consistency.
    2. Face Mask:
      • Proper size is crucial. Masks are available in various sizes (preterm, term/neonate). The mask should cover the bridge of the nose, the mouth, and the chin without extending over the eyes or compressing the neck.
      • Transparent masks allow for visualization of the baby's mouth and color.
    3. Oxygen Source:
      • Oxygen blender (if available) allows for delivery of specific oxygen concentrations (FiO2).
      • Flowmeter (usually set to 5-10 L/min for resuscitation).
    4. Pulse Oximeter:
      • Essential for monitoring oxygen saturation (SpO2) and heart rate during PPV. The probe should be placed on the right wrist or hand (pre-ductal site).
    IV. Techniques for Administering PPV
    A. Positioning the Baby and Mask Application:
    1. Position the baby: Place the baby on their back under the radiant warmer, with the head in a neutral or slightly extended "sniffing position" (as detailed in Objective 3). A rolled towel under the shoulders can help.
    2. Select the correct mask size: Ensure it covers the nose and mouth without touching the eyes or overhanging the chin.
    3. Apply the mask:
      • Position yourself at the baby's head.
      • Place the mask gently but firmly on the baby's face.
      • Use the "C-E grip" (or similar): The "C" is formed by the thumb and index finger pressing the mask edges to the face, while the "E" is formed by the remaining fingers lifting the jaw forward to maintain an open airway. Avoid pressing on the baby's soft tissues under the chin, which can obstruct the airway.
    B. Initial Breaths (Inflation Breaths / Ventilating Breaths):
    1. Initial Breaths: Begin with 5 breaths, each lasting 2-3 seconds. These are sometimes called "inflation breaths" or "ventilating breaths" as they are crucial for clearing fluid from the lungs and establishing functional residual capacity.
    2. Pressure: The initial pressure required can vary.
      • For a term baby, initial pressures of 20-25 cm H2O may be sufficient.
      • For preterm babies or those with very stiff lungs, higher pressures (e.g., 25-30 cm H2O) may be needed to achieve initial chest rise.
      • Many devices have pressure gauges; familiarize yourself with how to achieve the target pressure.
    3. Observe for Chest Rise: The most important indicator of effective ventilation is a gentle, symmetrical rise and fall of the chest with each breath.
      • If no chest rise: Immediately re-evaluate the mask seal, reposition the airway, and consider clearing secretions (MR. SOPA mnemonic - discussed below).
    C. Ongoing PPV:
    1. Rate: After the initial 5 breaths, continue PPV at a rate of 30-40 breaths per minute (approximately one breath every 1.5-2 seconds).
    2. Pressure: Adjust pressure as needed to achieve gentle chest rise. Once the lungs are open, less pressure is often required.
    3. Oxygen Concentration (FiO2):
      • For term infants: Start with 21% (room air).
      • For preterm infants (<35 weeks): Start with 21-30% oxygen.
      • Adjust oxygen based on pulse oximetry readings. Target SpO2 values increase over the first 10 minutes of life (e.g., 60-65% at 1 min, 80-85% at 5 min, 85-95% at 10 min).
    D. Assessing Response to PPV:

    Reassess the baby approximately every 30 seconds during PPV.

    1. Heart Rate (HR): The most important indicator. PPV is effective if the HR is increasing, especially if it rises above 100 bpm.
    2. Breathing: Look for spontaneous breathing efforts.
    3. Oxygen Saturation (SpO2): Monitor with a pulse oximeter.
    4. Color: Observe the baby's color (pinker is good).
    5. Tone: Increased activity and muscle tone.
    V. Troubleshooting Ineffective PPV (MR. SOPA)

    If PPV is not resulting in a rising heart rate or visible chest movement, quickly go through the following troubleshooting steps:

    • M - Mask adjustment: Reapply the mask to achieve a better seal.
    • R - Reposition airway: Adjust the head position to ensure an open airway.
    • S - Suction mouth and nose: Clear any secretions that may be blocking the airway.
    • O - Open mouth: Gently open the baby's mouth, sometimes just a finger's width, to facilitate airflow.
    • P - Pressure increase: Gradually increase the inspiratory pressure (e.g., by 5-10 cm H2O increments) until chest rise is observed.
    • A - Alternate airway: If PPV remains ineffective despite all the above, consider advanced airway interventions such as endotracheal intubation.
    VI. Discontinuing PPV

    PPV can be gradually discontinued when the baby meets the following criteria:

    • Heart rate is consistently > 100 bpm.
    • The baby is breathing spontaneously and effectively.
    • Oxygen saturation is within the target range for age on minimal or no supplemental oxygen.

    Discontinuation can be done by gradually decreasing the rate of PPV while observing the baby's spontaneous breathing, or by stopping completely if the baby is breathing strongly and effectively.

    Principles and Techniques of Chest Compressions in Neonatal Resuscitation

    Chest compressions are an intervention in neonatal resuscitation, indicated when a newborn's heart rate remains dangerously low despite effective positive-pressure ventilation (PPV). The primary goal of chest compressions is to maintain blood flow to the vital organs, particularly the heart and brain, until the baby's own heart can resume an effective rhythm. This intervention is always performed in conjunction with PPV.

    I. Principles of Effective Chest Compressions

    For chest compressions to be effective, several principles must be adhered to:

    1. Correct Indication: Compressions are only started after a defined period of effective PPV has failed to raise the heart rate.
    2. Proper Location: Compressions must be delivered over the correct anatomical landmark (sternum) to be effective and minimize injury.
    3. Adequate Depth: Compressions must be deep enough to create adequate blood flow but not so deep as to cause trauma.
    4. Appropriate Rate: The rate must be fast enough to maintain perfusion, but allow for proper coordination with ventilations.
    5. Complete Recoil: Allowing the chest to fully recoil between compressions is essential for adequate cardiac filling and coronary perfusion.
    6. Coordination with Ventilation: Chest compressions must be perfectly coordinated with PPV to ensure both circulation and oxygenation.
    II. Indications for Chest Compressions

    Chest compressions are indicated when:

    • The newborn's heart rate is below 60 beats per minute (bpm).
    • This low heart rate persists despite at least 30 seconds of effective positive-pressure ventilation (PPV), confirmed by visible chest rise.
    III. Techniques for Administering Chest Compressions

    There are two main techniques for performing chest compressions in newborns:

    1. Two-Thumb Encircling Technique (Preferred):
      • Position: The resuscitator stands at the foot end of the baby (or to the side if more convenient for the team). Both hands encircle the baby's torso.
      • Hand Placement: Place both thumbs side-by-side or one over the other (depending on baby size and hand size) on the lower third of the sternum, just below an imaginary line connecting the nipples.
      • Compression: Use the pads of the thumbs to compress the sternum. The fingers support the baby's back, providing counter-pressure and stability.
      • Advantages: This technique generally produces higher peak systolic blood pressure, better coronary artery perfusion pressure, and less fatigue for the resuscitator compared to the two-finger technique. It also allows for continuous ventilation.
    2. Two-Finger Technique (Alternative):
      • Position: The resuscitator is positioned to the side of the baby.
      • Hand Placement: Place the tips of the index and middle fingers (or middle and ring fingers) of one hand on the lower third of the sternum, just below an imaginary line connecting the nipples.
      • Compression: Use the tips of these two fingers to compress the sternum. The other hand can be placed under the baby's back for support.
      • Advantages: This technique is often used if there is only one resuscitator or if vascular access is being obtained via the umbilical cord while compressions are ongoing.
      • Disadvantages: Can be more tiring, may produce less effective blood flow, and may interfere with effective ventilation if not coordinated properly.
    IV. Location, Depth, Rate, and Coordination
    A. Location of Compressions:
    • On the lower third of the sternum, just below an imaginary line connecting the nipples. Avoid compressing over the xiphoid process (bottom tip of the sternum) as this can cause liver injury.
    B. Depth of Compressions:
    • Compress the sternum to a depth of approximately one-third of the anterior-posterior (AP) diameter of the chest.
    • This depth ensures adequate cardiac output while minimizing the risk of injury. Allow for complete release and recoil of the chest wall after each compression to allow for cardiac refilling.
    C. Rate of Compressions:
    • Compressions should be delivered at a rate of 90 compressions per minute.
    • This requires a rapid, rhythmic pace: "One-and-two-and-three-and-breathe..."
    D. Coordination with Ventilation (3:1 Ratio):
    • Chest compressions are always coordinated with PPV. The established ratio is 3 compressions to 1 ventilation.
    • This means 90 compressions and 30 ventilations per minute, totaling 120 "events" (compressions + breaths) per minute.
    • Technique: "One-and-two-and-three-and-BREATH..." The "BREATH" should coincide with the release phase of the third compression. The resuscitator performing compressions should pause briefly (for approximately 0.5-1 second) to allow the ventilation to be delivered effectively.
    V. Assessing Response to Chest Compressions
    • Heart Rate: Reassess the heart rate after 60 seconds of coordinated chest compressions and PPV.
      • If the heart rate is ≥ 60 bpm, chest compressions can be discontinued, and PPV can be continued until the heart rate is ≥ 100 bpm and the baby has effective spontaneous breathing.
      • If the heart rate remains < 60 bpm despite 60 seconds of coordinated compressions and PPV (which have been deemed effective), then medications (epinephrine) should be considered and administered as per Objective 3.
    VI. Discontinuing Chest Compressions
    • Chest compressions should be discontinued once the newborn's heart rate is consistently 60 bpm or greater.
    • Continue PPV until the heart rate is consistently ≥ 100 bpm and the baby has effective spontaneous breathing.
    Role and Administration of Medications in Neonatal Resuscitation

    Medications are the final step in the neonatal resuscitation algorithm and are rarely needed when ventilation and chest compressions are performed effectively. The primary goal of medication administration in this context is to support cardiovascular function and improve heart rate when other resuscitative efforts have failed. Access for medication administration is established via the umbilical vein.

    I. General Principles of Medication Administration
    1. Last Resort: Medications are indicated only after adequate ventilation and effective chest compressions have been performed for a sufficient duration (usually at least 60-90 seconds after starting compressions) and the heart rate remains below 60 bpm.
    2. Vascular Access: Rapid and reliable vascular access is crucial. The preferred route is the umbilical venous catheter (UVC). Intraosseous (IO) access can be an alternative if UVC placement is delayed or unsuccessful. Intratracheal (IT) administration of epinephrine is less effective and not the preferred route, but may be used as a temporizing measure if vascular access is not immediately available.
    3. Dilution and Administration: Medications should be prepared in appropriate concentrations and administered swiftly but carefully. Always flush the line after administration.
    4. Team Communication: Clear communication among the resuscitation team regarding medication preparation, dosage, route, and time of administration is essential to avoid errors.
    II. Key Medications in Neonatal Resuscitation
    A. Epinephrine (Adrenaline)
  • Role: A catecholamine that increases heart rate, myocardial contractility, and peripheral vasoconstriction. It is the primary drug used to improve heart rate during neonatal resuscitation.
  • Indication:
    • Heart rate remains < 60 bpm despite at least 30 seconds of effective positive-pressure ventilation (PPV).
    • AND at least 60 seconds of effective chest compressions coordinated with PPV.
  • Preparation:
    • Concentration for IV/IO use: 1:10,000 solution (0.1 mg/mL).
  • Dosage:
    • Intravenous (IV) / Intraosseous (IO): 0.01 to 0.03 mg/kg.
      • This corresponds to 0.1 to 0.3 mL/kg of the 1:10,000 solution.
    • Intratracheal (IT) (if no IV/IO access): 0.05 to 0.1 mg/kg.
      • This corresponds to 0.5 to 1.0 mL/kg of the 1:10,000 solution. Note: The IT route is less reliable, and higher doses are needed due to poor absorption. It should be considered a temporizing measure while obtaining IV/IO access.
  • Administration: Administer rapidly (over 1-3 seconds) via IV/IO route, followed by a flush (e.g., 0.5-1 mL normal saline).
  • Repeat Dosing: May be repeated every 3-5 minutes if the heart rate remains < 60 bpm.
    • B. Volume Expanders (e.g., Normal Saline 0.9% or Ringer's Lactate)
  • Role: Used to treat hypovolemic shock (low blood volume) and improve blood pressure and perfusion.
  • Indication:
    • Suspected acute blood loss (e.g., placental abruption, fetomaternal hemorrhage).
    • Signs of shock (pallor, poor perfusion, weak pulses, persistent bradycardia) that do not respond to other resuscitative measures, especially if accompanied by evidence of hypovolemia.
  • Preparation: Normal Saline 0.9% or Ringer's Lactate.
  • Dosage:
    • IV/IO: 10 mL/kg.
  • Administration: Administer slowly over 5-10 minutes. Rapid administration can lead to complications.
  • Repeat Dosing: May be repeated once or twice if signs of hypovolemia persist and the heart rate remains low.
    • C. Sodium Bicarbonate (4.2%)
  • Role: Used to correct severe metabolic acidosis, which can develop during prolonged resuscitation and impair cardiac function.
  • Indication:
    • Prolonged resuscitation with documented metabolic acidosis.
  • Preparation: 4.2% Sodium Bicarbonate (0.5 mEq/mL).
  • Dosage:
    • IV/IO: 2 mEq/kg (which is 4 mL/kg of the 4.2% solution).
  • Administration: Administer very slowly, over at least 5-10 minutes, to avoid rapid shifts in pH and hyperosmolality. Administer only after adequate ventilation has been established.
    • D. Dextrose (10%)
  • Role: To correct hypoglycemia (low blood sugar).
  • Indication:
    • Hypoglycemia is not typically an acute issue during the immediate resuscitation phase.
    • Indicated if hypoglycemia is suspected or confirmed after resuscitation, or if the baby has risk factors for hypoglycemia (e.g., prematurity, small for gestational age, maternal diabetes).
  • Preparation: 10% Dextrose solution.
  • Dosage:
    • IV/IO: 2 mL/kg.
  • Administration: Administer over 5-10 minutes.
    • III. Medications Generally Not Recommended for Acute Neonatal Resuscitation
  • Naloxone:
    • Role: An opioid antagonist.
    • Why not recommended in acute resuscitation: While it reverses opioid-induced respiratory depression, its onset of action is delayed compared to PPV. PPV is the primary treatment for respiratory depression regardless of cause. Administering naloxone too early or to an opioid-dependent infant can precipitate acute withdrawal and seizures. It should only be considered after successful resuscitation for suspected opioid depression if the baby has a good heart rate but poor respiratory effort.
  • Calcium Gluconate:
    • Role: Used to treat hypocalcemia.
    • Why not recommended: Rarely indicated in acute neonatal resuscitation. Its use is reserved for specific conditions like documented hypocalcemia, hyperkalemia, or magnesium toxicity, which are typically not acute issues in the delivery room.
  • Atropine:
    • Role: Anticholinergic, can increase heart rate.
    • Why not recommended: Not used in neonatal resuscitation. Bradycardia in newborns is almost always due to hypoxia, and correcting hypoxia with PPV is the treatment.
    • IV. Securing Vascular Access: Umbilical Venous Catheter (UVC)
  • Procedure: A sterile procedure performed when medications or volume expanders are indicated.
    1. Cleanse the umbilical cord stump.
    2. Cut the cord cleanly about 1-2 cm from the skin.
    3. Identify the umbilical vein (larger, thin-walled, usually at the 12 o'clock position) and the two smaller, thick-walled umbilical arteries.
    4. Insert a catheter (e.g., 3.5F or 5F) into the umbilical vein for a short distance (2-4 cm) until blood can be aspirated easily. Advance no further than necessary to get a free flow of blood, to avoid advancing into the portal circulation.
    5. Secure the catheter.
  • Importance: Provides a rapid and reliable route for medication administration and volume expansion during ongoing resuscitation.
    • Post-Resuscitation Care and Monitoring of the Newborn

    Post-resuscitation care is a phase aimed at stabilizing the newborn, preventing secondary complications, and optimizing long-term outcomes. Even after successful resuscitation and stabilization of vital signs, newborns remain at risk for various issues related to the initial hypoxic-ischemic event and the interventions performed. Therefore, meticulous monitoring and supportive care are essential.

    I. Immediate Post-Resuscitation Stabilization (First Hours)

    Once resuscitation efforts lead to stable vital signs (heart rate >100 bpm, effective spontaneous breathing, SpO2 within target range), the focus shifts to maintaining this stability.

    A. Thermal Regulation:
    • Maintain normothermia: Continue to monitor temperature closely and use appropriate warming devices (radiant warmer, incubator). Avoid both hypothermia (which increases oxygen consumption and metabolic acidosis) and hyperthermia.
    • Target Temperature: Maintain core body temperature between 36.5°C and 37.5°C.
    B. Respiratory Support:
    • Weaning from PPV/Oxygen: If the baby is breathing effectively, gradually wean from supplemental oxygen as tolerated, guided by pulse oximetry.
      • Goal SpO2: Aim for age-appropriate target oxygen saturations (e.g., 90-95% by 10 minutes, then >92% once stable).
    • Monitor for Respiratory Distress: Observe for signs of tachypnea, grunting, retractions, nasal flaring, and cyanosis. Provide continuous positive airway pressure (CPAP) or mechanical ventilation if needed.
    • Chest X-ray: Consider a chest X-ray to assess lung expansion, rule out pneumothorax, or confirm endotracheal tube (ETT) position if intubated.
    C. Cardiovascular Support:
    • Continuous Cardiac Monitoring: Monitor heart rate and rhythm continuously.
    • Blood Pressure: Monitor blood pressure. Hypotension may require volume expansion or inotropic support.
    • Perfusion: Assess capillary refill time, skin color, and peripheral pulses as indicators of systemic perfusion.
    D. Fluid and Electrolyte Management:
    • Intravenous Fluids: Begin IV fluids (e.g., Dextrose 10% at 60-80 mL/kg/day) to prevent hypoglycemia and dehydration, especially if oral feeding is delayed.
    • Electrolytes: Monitor electrolytes and correct any imbalances.
    E. Glucose Management:
    • Blood Glucose Monitoring: Perform frequent blood glucose checks (e.g., every 1-2 hours initially) to detect and manage hypoglycemia or hyperglycemia.
    • Treatment of Hypoglycemia: Administer IV dextrose bolus (2 mL/kg of 10% dextrose) followed by a continuous infusion if needed.
    F. Acid-Base Balance:
    • Arterial Blood Gas (ABG): Obtain ABG to assess acid-base status, oxygenation, and ventilation. Correct significant acidosis as needed, although resolution often occurs with adequate ventilation and perfusion.
    II. Ongoing Monitoring and Assessment (First 24-72 Hours)

    Newborns who have undergone resuscitation require close observation and specialized care in a Neonatal Intensive Care Unit (NICU) or Special Care Nursery (SCN).

    A. Neurological Assessment:
    • Hypoxic-Ischemic Encephalopathy (HIE): This is a major concern. Assess for signs of neurological injury:
      • Level of consciousness: Lethargy, irritability, seizures.
      • Muscle tone and reflexes: Hypotonia, hypertonia, abnormal reflexes.
      • Feeding difficulties.
    • Therapeutic Hypothermia: If criteria for moderate to severe HIE are met in term or near-term infants, therapeutic hypothermia (cooling) should be initiated within 6 hours of birth. This neuroprotective intervention aims to reduce brain injury.
    B. Organ System Monitoring:
    • Renal: Monitor urine output, creatinine, and electrolytes for signs of acute kidney injury.
    • Gastrointestinal: Monitor for feeding intolerance, abdominal distension, and signs of necrotizing enterocolitis (NEC), especially in preterm infants or those with severe hypoxia-ischemia.
    • Hematologic: Monitor for coagulation abnormalities (DIC) and anemia.
    C. Infection Control:
    • Newborns who undergo resuscitation may be at higher risk for infection, particularly if invasive procedures (e.g., UVC placement) were performed.
    • Monitor for signs of sepsis and consider antibiotic therapy if clinically indicated.
    III. Documentation and Communication
    • Detailed Documentation: Maintain meticulous records of the resuscitation event, including:
      • Time of birth and start/end of resuscitation.
      • Initial assessment.
      • All interventions (PPV, compressions, medications: dose, route, time).
      • Baby's response to interventions (HR, SpO2, breathing, tone).
      • Personnel involved.
    • Communication with Parents: Provide timely, empathetic, and clear communication with the parents about the events, the baby's condition, ongoing care plan, and prognosis. Answer their questions honestly.
    APGAR Score Reference
    SCORE 0 points 1 point 2 points
    Appearance (Skin color) Cyanotic / Pale all over Peripheral cyanosis only Pink
    Pulse (Heart rate) 0 <100 100-140
    Grimace (Reflex irritability) No response to stimulation Grimace or weak cry when stimulated Cry when stimulated
    Activity (Tone) Floppy Some flexion Well flexed and resisting extension
    Respiration Apneic Slow, irregular breathing Strong cry
    IV. Apgar Scoring
  • Purpose: The Apgar score is a rapid method to summarize the newborn's condition at 1 and 5 minutes after birth. It is a guide to the baby's response to the birth process and resuscitation, not an indicator of long-term neurological outcome.
  • Scoring:
    • Appearance (color)
    • Pulse (heart rate)
    • Grimace (reflex irritability)
    • Activity (muscle tone)
    • Respiration (breathing effort)
  • Interpretation:
    • Scores of 7-10 are generally reassuring.
    • Scores of 4-6 indicate moderate depression.
    • Scores of 0-3 indicate severe depression.
  • Repeat Scoring: If the 5-minute Apgar score is < 7, the score should be repeated every 5 minutes until 20 minutes of age, or until the score is consistently > 7.
    • V. Transfer and Referral
    • If comprehensive NICU care or specific therapies (like therapeutic hypothermia) are not available at the birth facility, prompt and safe transfer to an appropriate higher-level facility is crucial.

    Resuscitation Read More »

    Obstetric Anatomy

    Obstetric Anatomy Q & A

    Obstetric Anatomy Q & A

    Obstetric Anatomy, Obstetrics is the field of study concentrated on pregnancy, childbirth and the postpartum period
    Question 1
     

    (a) Describe the vagina.

    (b) Outline indications of vaginal examination.

    (c) What information must you note on vaginal examination?

    (d) List contraindications of vaginal examination

    SOLUTIONS.

    1. A vagina is a muscular fibrous canal which forms the part of the internal female reproductive organs

    Situation

    It is a canal which extends from the vestibule below to the cervix above running in an upward and backward direction between the planes of the pelvic brim.

    Shape

    It is a potential tube which runs upwards and backwards with its walls in close contact but can be separated during coitus, menstruation, vaginal examination and child birth.

    Size

    The anterior wall measures 7.5cm

    The posterior wall is longer and it measures 10cm.This is because the uterus enters the vagina at an angle of 90 degrees and bends forwards towards the anterior wall hence it encroaches on it

    Structure 

    Gross structure

    Superiorly; the upper end of the vagina is known as the vault, where the cervix protrudes into the vault it forms circular recess known as fournices.

    The vagina is made up of four fournices that is to say; The anterior fornix which is smaller and fairly deep The 2 lateral fournices which are shallow

    The posterior fornix which is the longest and deepest

    The lower end of the vagina is narrow and inferiorly we find the vulva_hymen enclosing the vaginal opening only present in virgins. If hymen is ruptured it leaves tags of membranes referred to as carunculae mytiformes. Vaginal orifice is also called introitus.

    Microscopic structure

    It is made up of four layers;

    1. Squamous epithelium arranged in folds known as rugae and makes the inner most layer of the vagina, the rugae increase the surface area and offer the vagina ability to stretch when need be for example during coitus and child
    2. Vascular connective tissue layer which is rich in blood vessels, nerves and lymphatics and is found just beneath the epithelium.
    3. Muscular layer. This is thin but a strong layer which is divided into two; the weak inner circular and strong outer longitudinal fibres.
    4. The pelvic fascial which is made up of loose connective It forms the outer protective coat and is continuous with the pelvic fascia.

    Blood supply (arterial)

    obstetric anatomy blood supply

    The vagina is supplied by the branches of internal iliac artery which include vaginal artery and uterine artery

    Venous drainage

    By the corresponding veins ie branches of internal iliac veins which include vaginal veins and uterine veins.

    Lymphatic drainage

    Into the inguinal, the iliac and the sacro glands

    Nerve supply

    By the sympathetic and parasympathetic nerves which are branches from the lee Franken lanser plexus

    Contents of the vagina

    It doesn‘t contain any glands but its kept moist by cervical mucus and a transudation from the underlying blood vessels through the epithelium.

    Its media is acidic (PH 3.8 to 4.5) and this is made possible by presence of lactic acid after action of doderleins bacilli on glycogen

    Relationships of the vagina

    obstetric anatomy relation

    Anteriorly

    Below, the base of the bladder rests on the upper ½ of the vagina and the urethra is embedded in the lower ½.

    Posteriorly

    Pouch of Douglas above, the rectum medial and perineal body below Laterally

    Pubococcygeous muscles below and pubic fascial containing the uterus above Inferiorly

    The structure of the vulva Superiorly

    The cervix and the fournices

    Functions of the vagina

    1. Exit from menstrual flow
    2. Entrance for spermatozoa
    3. Exit for products of conception
    4. Supports the uterus
    5. Prevents ascending infection due to acidic PH
    6. For assessing the pelvis
    7. Drug administration

    PART B

    Indications of vaginal examination

    Indications can be divided into during pregnancy, labour and puerperium

    During pregnancy

    • To confirm pregnancy using hegars, jacquemiers and osianders signs
    • To rule out abnormalities in genital organs g. polyps, cervical erosion and cancer of the cervix
    • To rule out causes of bleeding in early weeks

    During labour

    First stage of labour

    • To diagnose onset of labour
    • To determine progress of labour by finding out degree of cervical dilatation
    • To note state of membranes
    • To confirm presentation, position and engagement of head
    • To assess moulding
    • To exclude cord prolapse when membranes rupture
    • To note dilatation before giving a narcotic

    Second stage of labour

    • To confirm second stage of labour
    • To note cause of delay in second stage of labour
    • To confirm presentation of second twin before rupturing membranes

    Third stage of labour

    • To determine cause of postpartum haemorrhage
    • Incase of retained placenta, to detect cause of retained placenta and exclude construction ring
    • To detect condition of birth canal following child birth

    During puerperium

    • To rule out cause of secondary PPH
    • At 6-8weeks after delivery, to detect if the reproductive organs have gone back to their pregravida state.
    1. Information to note on vaginal examination

    On inspection

    State of the vulva, note any abnormal discharges like pus, blood, abnormal growths like warts,  oedema and scars.

    On examination

    Note condition of the vagina

    Normally the vaginal walls feel warm and moist and dilatable. If dry may be a sign of infection or obstruction.

    State of the cervix

    If thin, thick, whether soft or rigid and whether its well applied to the presenting part.

    Note dilatation and cervical effacement.

    State of the membranes

    Whether intact or ruptured. If ruptured check colour and smell of liquor

    Presentation and presenting part

    Note level of presenting part in the pelvis

    Confirm position by finding or palpating sutures and fontanelles and relate them to the maternal pelvis.

    Note moulding.

    Do internal pelvic assessment and note

    • -sacro promontary if protruding
    • -hollow of the sacrum if well curved
    • -sciatic notches if well rounded
    • -ischial spines if prominent
    • -sub pubic arch-if it accommodates 2 ½ to 3 fingers
    • -inter tuberous diameter if it accommodates 4 knuckles

    Contraindications of vaginal examination

    • Ante partum haemorrhage
    • Threatened abortion
    • Elective caesarean section

    a) Describe

    b) Outline the formation of the

    c) List variations of the placenta

    SOLUTIONS

    1. Describe Fertilization

     Fertilization is the fusion of the male gamete (sperm) and female gamete (ovum)

    Fertilization occurs when the female gamete fuse to form a zygote during the time of intercourse, about 300 million spermatozoa are deposited into the vagina.

    Some sperms cannot survive the acidic media of the vaginal secretions so the weak ones die and only the strong ones survive.

    The surviving sperms continue moving forwards this is made possible by the special arrangement of the mucus lining of the cervix (arborvitae) which prevents back flow of sperms.

    Sperms continue their journey but still the weak ones continue to die off. Movement is slowed down by the presence of hair like projections called cilia and more eradication of weak sperms continues. And if ovulation had taken place within 48 hours and the ovum is still viable the two gametes will meet in the ampulla and fusion will take place hence fertilization.

    b) Outline the Formation of the Placenta 

    Placenta is a vital organ of communication between the mother and the fetus.

    It‘s a maternal-fetal organ which begins developing at implantation of the blastocyst and is delivered with the fetus at birth.

    Formations of the placenta

    • Maternal surface

    This is the surface next to the uterus

    Its dark red in color due to presence of maternal blood and it has 18-20 lobes which are collections of chronic villi each cotyledon is separated from the other by tissues.

    •       Fetal surface

    This is the surface next to the fetus

    It has a shiny surface due to presence of amniotic membrane

    c). List variations of the placenta / abnormalities of the placenta

    • Succenturiate lobe

    This occurs due to abnormalities in development and it is the most significant abnormality. The additional lobule separates from the main part of the placenta.

    • Circumvallated placenta

    It is an opaque ring seen on the fetal surface of the placenta and this is due to doubling back of the chorion and amnion

    • Bi-partite placenta or bi-lobed placenta

    This placenta has two complete and separate parts each with a branch of umbilical cord vessels which later join to form one cord.

    • Battledore insertion of the cord

    In this the placentas cord is inserted at the edge/margin of the placenta and the placenta has an appearance of a table tennis bat in shape.

    1. Velamentous insertion of the cord

    The cord is inserted into the fetal membranes some distance away from the edge of the placenta.

    The diagram below shows the different variations of the placenta discussed above.

    placenta variations

    a) Describe the non-pregnant

    b) What changes take place in this organ during pregnancy?

     

    Description of the non pregnant uterus

    • This is a hollow muscular pear /ovacado shaped

    Situation

    • It is situated in the true pelvis between the urinary bladder and the

    Size

    • It is 5cm, long 5cm wide, and 2.5cm thick so each wall is 1.25cm thick.

    Position

    • The uterus is anteverted (bends forward) and anteflexed (bends on itself)

    Shape

    •  The uterus is pear shaped (avocado) with the upper part bigger than the lower part .

    Description of the non pregnant uterus

     
      

    Gross structure

    This is made up of the following

    • The body.

     This forms the upper part of the whole uterus.

    • Fundus

     This is a raised area between the insertion of the uterine tubes.

    • Cornua

    Upper outer angles of the uterus where the uterine tubes are inserted. This is made up of the following

    • Cavity

    This is a potential space between the anterior and posterior uterine walls.

    It is triangular in shape.

    • Isthmus

    This is a narrow area between the body of the uterus and the cervix.

    • Cervix or neck

    This forms other lower third of the whole uterus into the

    Microscopic structure

    Endometrium

    • this is a layer of ciliated mucus
    • It changes constantly with the menstrual cycle
    • It lines the uterine cavity and shades off during menstruation up to the basal
    • The cervical endometrium does not change during menstruations

    Myometrium

    • Middle layer and is formed by different muscle fibres.
    • Longitudinal fibres ;mainly found in the upper part of the uterus .
    • Oblique muscle fibres ;mainly found in the fundus
    • Circular muscle fibres which are located at the cornua and they prevent contractions extending to the uterine tubes.
    • Some are found around the cervix which help in dilatation during labour.

    Perimetrium

    • It is a serous membrane which is a continuation of the peritoneum
    • It covers the outer aspect of the uterus.
    • It bends upwards to form the uterovesco pouch anteriorly and the pouch of dauglous posterioly

    Blood supply

    • By uterine arteries which are the branches of the internal iliac artery and they supply the lower ovarian arteries the branches of the abdominal aorta and supply the upper parts.

    Nerve supply

    • By sympathetic and parasympathetic
    • Lymph drains into internal illiac glands

    Supports

    • The uterus is supported by pelvic floor muscles and maintained in position by ligaments.
    • Transverse ligament
    • Utero sacral ligament
    • Pubo cervical ligament
    • Broad ligament
    • Round ligament and,
    • Ovarian ligament.

    Relations of the Body of the Uterus

     

    • Anteriorly:The bladder and vesco-uterine pouch.
    • Posteriorly: The pouch of douglas
    • Laterally: The broad ligament on each side uterine tubes and ovaries.
    • Superiorly: intestines
    • Inferiorly :vagina

    Functions of the uterus

    • It shades the endometrium during menstruation
    • To prepare a bed for the fertilized ovum
    • It shelters the fetus during pregnancy
    • It expels the products of conception at term
    • To involute following childbirth

    (B) THE PHYSIOLOGICAL CHANGES THAT OCCUR IN UTERUS DURING PREGNANCY

    Pregnancy

     Is the growth and the development of a fertilized ovum from the time of conception until its expulsion. In normal pregnancy expulsion of the fetus takes place at term. Thus, 38-42 weeks of gestation with an average of 40 weeks.

    • Physiological changes that take place during and pregnancy are associated with and caused by the effects of specific hormones.
    • These are temporary adaptations of the body that helps to meet the demands of the fetus.
     
      

    CHANGE IN THE UTERINE SIZE DURING PREGNANCY.

    The body of the uterus

     After conception, the body develops to provide a nutritive and a protective environment into which the fetus will grow and develop.

    Size: 7.5x5x2.5- 30×23 x20 (cm) 

    Weight: changes from 60 to 1000gm 

    Uterine shape and situation.

    • The uterus changes to a globular shape to accommodate the growing fetus, increasing amounts of liquor and placental tissues.
    • The lowest part of the uterus elongates 3 times its original length during the first trimester, giving the appearance of a stalk below the globular segment. This is the beginning of the upper and lower uterine
    • By 12th week of pregnancy, the uterus rises out of the pelvis and becomes upright. It is no longer anteverted and ante flexed. It is about the size of a grape fruit and may be palpated abdominally above the symphysis pubis.
    • By 16th week, the conceptus has grown enough to put pressure on the isthmus, causing it to open out so that the uterus become more globular n shape.
    • By 20th week of pregnancy, the uterus becomes spherical in shape and has a thicker, and more rounded fundus. As the uterus continues to rise in the abdomen, the uterine tubes, being ristricted by attachments to the broad ligaments, become progressively more At 20th week the fundus of the uterus may be palpated at or just below the umblicus.
    • At 30th week, the lower uterine segment can be It is the portion of the uterus above the internal os of the cervix. The fundus can be palpated midway between the umblicus and the xiphisternum.
    • The uterus reaches the level of the xisphisternum by the 38th A reduction in fundal height , known as lightening, may occur at the end of pregnancy when the fetus sinks into the lower pole of the uterus.

    Decidua

     The decidua is the name given to the endometrium during pregnancy. Estrogen and progesterone produced by the corpus luteum, causes decidua to become thicker and richer and more vascular at the fundus and in the upper body of the uterus, which are the usual site for implantation.

    The decidua provides a glycogen rich environment for the blastocyst until the placenta is formed.

     

    Myometrium.

    • It is made up of smooth muscle fibres, held together by connective These muscle fibres grow up to 15 to 20 times their non pregnant length.
    • The hypertrophy and hyperplasia of the uterine muscle is due to the effect of estrogen and
    • The uterus continues to grow in this way for the first three months, after which the growth is related to the distension by the growing
    • The wall of the myometrium become thicker during the first few months of pregnancy, and as gestation advances, the walls become thinner owing to the gross enlargement of the uterus being only 5 cm thick or less at term.
    • These prelabor contractions are associated with the ―ripening of the cervix‖ and eventually becomes the contractions of labor as the effects of estrogen supersede those of progesterone e. progesterone normally suppresses myometrial activity.
    • During pregnancy, the muscle layers become more differentiated and organized and organized for their part in expelling the fetus.
    • The thickness of the upper uterine acts as a piston to force the fetus into the receptive, passive lower uterine segment.

    Contractions of these muscles fibres is necessary to entrap and enmesh bleeding vessels and ligate them after the placenta is delivered.

    • The inner circular layer is thin and forms sphincters around the openings at the cornua, and around the lower uterine segment and

    Blood vessels

     

    • The uterine blood vessels increase in diameter and new vessels develop under the influence of estrogen. the blood supply through the uterine and ovarian arteries increase to about 750mls per minute at term to keep pace with its growth and also to meet its needs of the functioning placenta.

    The cervix

    • The cervix remains tightly closed during pregnancy , providing protection to the fetus and resistance to the pressure from above when the woman is in a standing up
    • The mucus secreted by the endo cervical cells become thicker and more viscous during The thicken mucus then forms a plug called the operculum, which provides protection from ascending infections.
    • Cervical vascularity increases during pregnancy, giving the cervix a bluish color if viewed through a speculum.
    • The cervix remains 5cm long throughout pregnancy.
    • In late pregnancy, softening or ripening of the cervix occurs making it more distensible. The muscles of the fundus enhance tension in the outer longitudinal layer of muscles of the cervix contributing to the process of effacement.

    Obstetric Anatomy Q & A Read More »

    Ectopic Pregnancy

    Ectopic Pregnancy

    ECTOPIC PREGNANCY

    Ectopic pregnancy is a gestation that implants outside of the endometrial cavity. 

    Ectopic pregnancy is an implantation of a fertilized ovum outside the uterine cavity.

    An ectopic pregnancy most often occurs in a fallopian tube. This type of ectopic pregnancy is called a tubal pregnancy.

     

     An ectopic pregnancy is estimated to occur in 1 of every 80 spontaneously conceived pregnancies.

    Ectopic Pregnancy anatomical location

    ANATOMICAL LOCATION OF ECTOPIC PREGNANCY

    Tubal (99%)

    • Ectopic Pregnancy occurs anywhere in the fallopian tube.
    • The most common site is the ampulla.
    • Interstitial (cornual) pregnancies occur in the most proximal tubal segment, which runs through the uterine cornua. This type of ectopic pregnancy can grow to be quite large, and rupture may cause massive haemorrhage.

    Ovarian (0.5%)

    • Ectopic Pregnancy occurs in the ovary.

    Abdominal (less than 0.1%)

    • Ectopic Pregnancy occurs in the abdomen.
    • With possible adherence to the peritoneum, visceral surfaces, or omentum

    Cervical (0.1%)

    • Ectopic Pregnancy occurs in the cervix.
    • A cervical ectopic, in which the pregnancy implants on the cervix itself, is very rare. Most cervical pregnancies will result in miscarriage. The risk of bleeding, either with spontaneous miscarriage, or for those which require surgical intervention, is much higher

    Heterotopic Pregnancy

    • This is a very rare type of multiple pregnancy, in which one viable pregnancy develops within the uterus, and another fertilised egg is implanted elsewhere as an ectopic pregnancy. 
    • It occurs in less than 1 in 30,000 naturally occurring pregnancies, and is slightly more common in couples who conceive through assisted conception.
    • Both intrauterine and ectopic pregnancies may occur concomitantly.

    Caesarean Scar Pregnancy

    • Rarely, the ectopic pregnancy can be located at the site of the scar from a previous Caesarean section. This occurs in 1 in 1,800 pregnancies.

    Cornual/Interstitial

    • Interstitial ectopic pregnancies are those which occur in the tissue of the Fallopian tube that lies within the muscular wall of the uterus. 
    • It can be quite difficult to diagnose through ultrasound, and may need laparoscopic (keyhole) surgery to confirm the diagnosis.

    Other less common sites of ectopic implantation are the ovary,  or a rudimentary uterine horn. Rarely, an ectopic may be intraligamentous or in the peritoneal cavity

    CAUSES AND RISK FACTORS FOR ECTOPIC PREGNANCY

    CAUSES AND RISK FACTORS FOR ECTOPIC PREGNANCY

    The occurrence of ectopic pregnancy has been associated with abnormal function of the fallopian tubes. Normally, the tubes facilitate collection and transport of the oocyte and embryo into the uterus. The integrity of the fimbria, lumen, and ciliated mucosa appears to be important for transport. Conditions thought to prevent or retard migration of the fertilized ovum to the uterus increase the risk for an ectopic pregnancy.

    Abnormal Function of Fallopian Tubes: 

    • Normal function of the fallopian tubes, involving the integrity of fimbria, lumen, and ciliated mucosa, is crucial for the proper transport of the oocyte and embryo into the uterus.
    • Conditions hindering migration of the fertilized ovum to the uterus elevate the risk of ectopic pregnancy.

    Pelvic Inflammatory Disease (PID):

    • Inflammation and scarring from PID affect intra and extra luminal structures, impairing normal tubal function.
    • Severe damage may result in complete tubal blockage and infertility.

    Tubal Surgery and Related Procedures:

    • Tubal surgeries, bilateral tubal ligation, and tubal reanastomosis may lead to scarring, narrowing, or false passage formation.
    • Other pelvic and abdominal surgeries may cause peritubal adhesions, although not directly associated with ectopic pregnancy.

    Chlamydia, Gonorrhea, Endometriosis, and Salpingitis:

    • Infections, especially Chlamydia and gonorrhoea, which causes PID, contribute to inflammation and scarring.
    • Conditions like endometriosis and salpingitis increase the risk of ectopic pregnancy.

    Artificial Reproductive Techniques:

    • In-vitro fertilization and gamete intrafallopian transfer have been linked to an increased risk of ectopic pregnancy.
    • Retrograde embryo migration is considered a possible mechanism.

    Delayed Fertilization:

    • Possible transmigration of the oocyte to the contralateral tube and slowed tubal transport can delay the passage of the morula to the endometrial cavity.

    Chromosomal and Structural Anomalies of the Conceptus:

    • Anomalies in the chromosomes or structure of the conceptus may predispose individuals to ectopic pregnancy.

    Developmental Abnormalities of the Tube:

    • Abnormalities like diverticula, accessory ostia, and hypoplasia in the tube can elevate the risk of ectopic pregnancy.
    • Exposure to diethylstilbestrol increases the risk four to five times.

    RISK FACTORS FOR ECTOPIC PREGNANCY:

    • Increased Maternal Age: Advanced maternal age is identified as a risk factor for ectopic pregnancy.
    • History of Previous Ectopic Pregnancy: Individuals with a history of ectopic pregnancy have a 15% to 20% risk of recurrence in subsequent pregnancies, in either the same or opposite tube.
    • History of Infertility: Infertile couples exhibit an increased proportion of ectopic pregnancies compared to the total number of pregnancies, regardless of the cause of infertility.
    • Contraceptive Methods: Certain contraceptive methods carry a higher risk, including Progestasert IUD (15%), intrauterine devices (5%), and diaphragms. Oral contraceptives have a 1% risk, while intrauterine devices are highly effective at preventing intrauterine pregnancy, making any pregnancy in an IUD user more likely to be tubal.
    • Progestin-only Contraceptives: Users of progestin-only oral contraceptives and injectable progestins face an increased risk of ectopic pregnancy if pregnancy occurs, possibly due to altered tubal motility.
    • Peritubal Adhesions: Adhesions following post-abortal or puerperal infections, appendicitis, or endometriosis contribute to the risk of ectopic pregnancy.
    • Cigarette Smoking: Studies indicate that cigarette smoking causes tubal ciliary dysfunction, contributing to the risk of ectopic pregnancy.
    • Endometriosis: Endometriosis can make the uterus unsuitable for implantation, increasing the likelihood of ectopic pregnancy.

    WHY AN ECTOPIC PREGNANCY HAPPENS?

    Pathophysiology of an Ectopic Pregnancy.

    • Fertilization occurs at the usual distal third of the fallopian tube.
    • After the union, zygote begins to divide and grow.
    • However, due to an obstruction by several factors (see Risk Factors), the zygote cannot travel through the length of the tube.
    • It lodges on that constricted part and implantation takes place at that area instead of the uterus.

    In a normal pregnancy, an egg is fertilized by sperm in one of the fallopian tube which connect the ovaries to the womb .The fertilized egg moves and implants itself into the womb lining endometrial ,where it grows and develops 

    So for an ectopic pregnancy, it occurs when a fertilized egg implants itself outside the womb.

    CLINICAL PRESENTATION OF ECTOPIC PREGNANCY

    An ectopic pregnancy does not cause noticeable symptoms and is only detected during routine pregnancy testing. However, most women do have symptoms and these usually become apparent between 5 to 14 weeks of gestation.

    The Classic Triad of symptoms of ectopic pregnancy consists of

    • Amenorrhea,
    • Vaginal bleeding, and
    • Lower abdominal pain. 

    Acutely ruptured ectopic pregnancy.

     This clinical scenario represents a surgical emergency. The patient who has experienced rupture of her ectopic pregnancy will most likely have:

    On History Taking:

    • History of amenorrhoea 6 – 10 weeks.
    • Patient complains of a feeling of fainting, dizziness, thirst, light vaginal bleeding and pelvic pain.
    • Abdominal distension, Guarding and rebound tenderness.
    • Patient complains of acute abdominal pain localized in the iliac fossa which is colicky in nature.
    • She may also complain of ipsilateral shoulder pain from phrenic nerve irritation due to hemoperitoneum from the blood in her abdomen and it occurs in up to 25% of patients.

    On Examination:

    • Signs of pregnancy are present.eg darkening of areolar.
    • Signs of shock e.g. cold clammy skin, rapid thread pulse, low blood pressure and low temperature
    • Patient is anxious and restless
    • Pallor of mucous membranes

    On Palpation:

    • Abdominal tenderness especially on the affected side.
    • Abdominal muscles become rigid due to mother guarding against pain.
    • Abdominal distention due to presence of blood in the abdominal cavity.

    On Vaginal Examination:

    • Amount of bleeding does not correspond to the mother’s condition.
    • Tenderness on movement of the cervix and a mass is felt in the lateral fornix.
    • Painful mass in the pouch of Douglas.
    • Dark brown blood on the examining finger.

    DIAGNOSIS OF ECTOPIC PREGNANCY

    Ultrasound Confirmation: Utilization of ultrasound imaging as a primary diagnostic tool(golden standard).

    •  An ultrasound would reveal an empty uterus and free fluid (blood) in the peritoneal cavity. The diagnosis of ectopic pregnancy may be confirmed by the absence of intrauterine pregnancy (IUP) on ultrasound in a woman with a level of HCG sufficient to normal pregnancy, the absence of intrauterine pregnancy on ultrasound examination is diagnostic for ectopic pregnancy if the gestational age is known for certain or if the HCG level is >2500 IU per ml.
    • Cordocentesis(Percutaneous umbilical cord blood sampling) , Aspiration of fluid from the cul-de-sac for evidence of intra-abdominal bleeding. It is a technique by which a needle attached to a syringe is inserted transvaginally through the posterior vaginal fornix into the pouch of Douglas to detect any fluid within the peritoneal cavity.

    • Laparoscopy: Commonly performed surgical procedure for diagnosis. Follows symptoms of bleeding and a positive pregnancy test.
    • Positive Pregnancy Test: Presence of human chorionic gonadotropin (hCG) in the blood or urine.
    • Cullen’s Sign: Specific clinical manifestation suggesting a ruptured ectopic pregnancy. Periumbilical bruising due to blood tracking from the ruptured fallopian tube.

    Cullen's Sign ectopic

    • Magnetic Resonance Imaging. This is also another way to detect the presence of ectopic pregnancy and it is safer than undergoing a CT scan for pregnant women.
    • Hematocrit and Haemoglobin Levels: Routine blood tests to assess for signs of anaemia due to internal bleeding.

    DIFFERENTIAL DIAGNOSIS OF ECTOPIC PREGNANCY.

    Gynecologic problems

    • Threatened or incomplete abortion 
    • Ruptured corpus luteum cyst 
    • Endometriosis
    • Gestational trophoblastic diseases 
    • Ruptured corpus luteal cyst
    • Dysfunctional uterine bleeding
    • Acute pelvic inflammatory disease 
    • Adnexal torsion 
    • Degenerating leiomyoma (especially in pregnancy)
    • Salpingitis

    Non Gynecologic Problems 

    • Acute appendicitis
    • Pyelonephritis 
    • Pancreatitis

    MANAGEMENT OF ECTOPIC PREGNANCY.

    Management has two modalities:

    • Surgical approach.
    • Medical approach.

    In maternity center

    Aims

    1. To prevent shock
    2. To relieve pain
    3. To reassure the patient
    • Admission: The patient is admitted temporarily in a gynecological ward in a well-made warm bed.
    • Histories: These are taken including personal, social, surgical, medical, obstetrical history, how the condition started etc
    • Examination: This is carried out from head to toe to rule out anaemia, dehydration, shocketc
    • Observation:  Temperature, pulse, respiration and blood pressure are taken and recorded to assess functioning of vital organs.  The foot of the bed should be raised to allow blood to move to vital centres.
    •  Send for transport as soon as possible and inform the patient and relatives about the decision made and why it is necessary.

    Treatment

    • Put up intravenous infusion of normal saline to prevent or treat shock.. This is to elevate low blood pressure.
    • Administer morphine or pethidine to relieve pain as prescribed.
    • Nursing care: The vulva is swabbed and a clean pad is applied.
    • Send the patient to hospital with a written note stating when the patient reported to the centre, condition on admission and at time leaving and treatment given.

    In the Hospital

    Aims:

    • To treat anaemia
    • To prevent or treat shock
    • To reassure the patient
    • To prevent complications

    It  is a gynaecological emergency, requiring swift action. 

    Management

    Admission: Admit the patient to a well-ventilated room and a warm admission bed. Establish a good nurse-patient relationship.

    Histories: Take comprehensive history, including personal data, presenting complaints, and obstetrical and medical history.

    General Examination: Perform a head-to-toe examination to rule out anaemia, shock, dehydration, etc.

    Observations: Monitor vital signs like temperature, pulse, respiration, and blood pressure. Inform the doctor about the patient.

    Investigations: Conduct investigations as required by the doctor, including Hb, grouping and cross-match, ultrasound scan, and urinalysis.

    Resuscitation:

    • Administer intravenous fluids (e.g., normal saline) and maintain a fluid balance chart.
    • Consider blood transfusion based on haemoglobin results.
    • Provide pain relief with analgesics like morphine as prescribed by the doctor.
    • The doctor will determine the operation.

    Preparation for Theatre:

    1. Explain the nature of the operation and obtain informed consent.
    2. Reassure the patient to allay anxiety.
    3. Inform theatre staff.
    4. Pass an intravenous line for infusion.
    5. Perform vulva swabbing to minimize infections.
    6. Catheterization is done, and a fluid balance chart is started.
    7. Pass a naso-gastric tube for aspiration of gastric contents or administer an anti-acid like magnesium trisilicate to alkalize stomach contents and prevent aspiration into the lungs.
    8. Pre-medication is given, such as atropine to dry secretions.
    9. Repeat vital observations and compare with baseline observations, recording all findings.
    10. Compile clinical charts and notes, dress the patient in a gown, and transport her carefully to the theatre.
    11. In the theatre, give a full report to the theatre nurse about the patient.
    12. Book about 1-2 units of blood.
    SURGICAL APPROACH

    Surgical treatment of ectopic pregnancy has the advantage of taking care of the ectopic immediately. It is suitable for emergency care of ectopic pregnancy.  It is critical to establish large-bore intravenous lines and to start fluid resuscitation.  

    Salpingectomy, the removal of the fallopian tube containing the ectopic pregnancy, is the treatment of choice in the following situations:

    • Future childbearing is not desired.
    • The tube is severely damaged.
    • Bleeding cannot be controlled.
    • The ectopic is in a fallopian tube where an ectopic occurred previously.

    Linear salpingostomy, the removal of the gestation through a linear incision in the fallopian tube, may be performed if future fertility is desired.

    • This procedure is associated with a persistent ectopic pregnancy rate of 3% to 20%.
    • Therefore, serial quantitative HCG values must be followed to ensure resolution.

    Operative laparoscopy may be performed to confirm the diagnosis of ectopic pregnancy and to remove the abnormal gestation via salpingectomy or salpingostomy.  This method is used in hemodynamically stable patients. Advantages of this technique over laparotomy include:

    • Shorter hospital stay
    • Faster postoperative recovery
    • Better cosmetic result
    • Potentially shorter operative time

    Laparotomy is reserved for hemodynamically unstable patients who require emergent surgery for a ruptured ectopic pregnancy. This method may also be appropriate when laparoscopy is contraindicated or technically challenging because of extensive adhesive disease from prior surgery.

    Cornual resection, may be performed when an interstitial pregnancy occurs. The interstitial portion of the tube is removed via wedge resection into the uterine cornua. Cornual ectopic pregnancies have a higher failure rate with methotrexate and a surgical approach may be more effective.

    Oophorectomy is indicated only when an ovarian ectopic pregnancy occurs and salvage of the affected ovary is not possible.

    Post-Operative Care:

    Post-operative Bed Preparation: Set up the bed with all necessary accessories ready to receive the patient.

    Patient Transfer: Inform ward staff, and two qualified nurses go to the theatre to collect the patient. In theatre, receive a full report from the anaesthetist and theatre nurse in a recovery room, reporting the patient’s condition.

    Confirm the Report:

    • Check airway, breathing, and circulation.
    • Take vital observations.
    • Observe the site of operation for bleeding.
    • Observe the catheter to see if it is draining well and in a good position.

    Patient Transfer to Ward: After confirming, gently wheel the patient to the ward in a recumbent position with the head turned to one side, observing the airway.

    On Ward: Lift the patient from the trolley carefully to a well-made post-operative bed near the nurse’s station for close observations.

    • Place the patient in a recumbent position with the head turned to one side for drainage of secretions and to prevent the falling back of the tongue.
    • Conduct observations and record vital signs (temperature, respiration, blood pressure, and pulse) every 1/4, 1/2, 1, 2 hours as per surgeon’s instructions. Adjust the duration based on patient stabilization. Continue observations until the patient is discharged.
    • Observe the site of operation for bleeding.
    • Observe the catheter for drainage, color, and the quantity of urine passed.
    • Maintain a fluid balance chart and balance it every 24 hours to rule out renal failure.
    • On regaining consciousness, welcome the patient from the theatre, sponge the face, change the theatre gown, conduct mouthwash to remove the anesthetic smell, and offer a pillow.

    Fluid/Hydration:

    • Continue intravenous fluid (e.g., 0.9%) to replace lost fluids.
    • Observe IV infusion, including cannular site for swelling and drip rate; correct any issues.
    • Monitor fluid intake and output to avoid overhydration.
    • Stop IV fluids when bowel sounds are heard, and the patient can take by mouth.
    • Remove the cannula when necessary, e.g., if the patient has completed intravenous drugs.

    Drug Therapy:

    • Administer prescribed strong analgesics (e.g., pethidine for 48 hours, then switch to mild analgesics like diclofenac 50-100mg tds).
    • Administer prescribed antibiotics (e.g., x-pen 2mu qid for 72 hours, then change to oral antibiotics if necessary, such as amoxyl 250-500mg tds for 5 days).
    • Monitor the patient for side effects of the drugs given.
    • Provide supportive drugs like ferrous and folic acid to prevent anemia.

    Wound Care:

    • Observe the wound for bleeding and add more dressing if needed. Change the dressing if soiled and check for signs of infections.
    • Conduct daily wound dressing.
    • Remove stitches on the 7th and 8th day alternately.

    Physiology:

    • Encourage the patient to do deep breathing exercises to prevent chest complications like hypostatic pneumonia.
    • Encourage passive exercises, such as limb movement, and later active exercises like walking around to prevent deep vein thrombosis.
    • Provide psychotherapy for continuous reassurance.

    Diet:

    • Conduct a digestion test, and if positive with bowel sounds heard, start the patient on small sips of water.
    • Introduce soft foods according to tolerance, rich in proteins for tissue repair, roughages to prevent constipation, and carbohydrates for energy.
    • Note: The nasogastric tube is removed as long as the patient can take orally without any complaint.

    Hygiene:

    • Conduct a bed bath on the first day of operation when the patient is still weak, and later assist her to the bathroom.
    • Conduct mouth care to prevent neglected mouth complaints like stomatitis, halitosis, etc.
    • Ensure that the patient’s clothing, bed linen, and the surrounding environment are clean.

    Bowel and Bladder Care:

    • If urine is clear in 24-48 hours, remove the urethral catheter and encourage the patient to pass urine.
    • Encourage the patient to pass stool, offer privacy, and provide foods rich in roughages to prevent constipation.
    • In case of constipation and failed conservative measures, give purgatives such as bisacodyl 5-10mg o.d or nocte.

    Rest and Sleep:

    • Keep the patient in a quiet, well-ventilated room.
    • Restrict visitors, avoid bright light to create a conducive environment for the patient to sleep and rest.

    Advice on Discharge: When the patient is fit for discharge, advise on:

    • Having enough rest at home.
    • Avoiding heavy lifting to prevent straining the abdominal muscles.
    • Coming back for review on appointed dates.
    • Attending ANC clinics when pregnant.
    • Bringing the husband for treatment if the cause of ectopic pregnancy was PIDs.
    • Completing the prescribed medications.

    In case of Unruptured Ectopic Pregnancy, Medical Approach can be used.

    MEDICAL APPROACH

    Methotrexate, a chemotherapeutic agent, has been used successfully to treat small, unruptured ectopic pregnancies. This approach has the advantage that it avoids surgery, but the patient must be counselled that it may take 3 to 4 weeks for the ectopic to resolve with methotrexate therapy. Early diagnosis is very paramount for successful management. 

    Mechanism of action

    • Methotrexate is a folic acid antagonist that interferes with DNA synthesis. Its action is principally directed at rapidly dividing cells, such as trophoblastic cells.
    • Once an ectopic pregnancy has been confirmed, 50 mg/m2 is administered intramuscularly in a single or multiple doses with folic acid.
    • Serial HCG levels are followed every 2 to 4 days after treatment until the HCG level starts to decrease. This is to ensure resolution of the pregnancy
    • If a 15% reduction is not achieved during the first week, or in subsequent weeks a plateau occurs, then an additional injection of Methotrexate is given or surgical exploration is advocated.
    • Decreased success has been noted with ectopic pregnancies of greater than 3.5 cm, with fetal cardiac activity, or with high HCG levels (greater than 5000).
    • After treatment failures, surgical management is usually necessary. 
    • After an ectopic gestation, pregnancy should be avoided for at least 3 months to allow for the fallopian tube architecture to normalize.
    • Contraception should be provided

    Side effects (approximately 5% of patients).

    1.  Mild gastrointestinal symptoms such as nausea, vomiting, diarrhoea, and stomatitis are typical. 
    2. Potential life-threatening complications include pneumonitis, thrombocytopenia, neutropenia, elevated liver function tests, and renal failure.

    Contraindications,

    • Women who are breastfeeding 
    • Immunodeficiency, 
    • Liver disease, renal disease, 
    • Blood disorders, 
    • Peptic ulcer disease,
    • Active pulmonary disease should not receive methotrexate.

    Criteria for medical management of ectopic pregnancy

    Criteria for receiving methotrexate(MTX) (Absolute indications)

    Contraindications to medical therapy (Absolute contraindications)

    • Hemodynamically stable without active bleeding or signs of hemoperitoneum 

    • Non Laparoscopic diagnosis 

    • Patient desires future fertility 

    • General anaesthesia poses a significant risk 

    • Patient is able to return for follow-up care 

    • No contraindications to MTX

    Relative indications

    • Unruptured mass ≤3.5 cm at its greatest dimension 

    • No fetal cardiac motion detected 

    • Patients whose hCG level does not exceed a predetermined value (6000-15,000 mIU/Ml

    • Breastfeeding 

    • Laboratory evidence of immunodeficiency 

    • Alcoholism, alcoholic liver disease, or other chronic liver disease 

    • Preexisting blood dyscrasias, such as bone marrow hypoplasia, leukopenia, thrombocytopenia or significant anaemia 

    • Known sensitivity to MTX 

    • Active pulmonary disease 

    • Peptic ulcer disease  Hepatic, renal, or hematologic dysfunction

    Relative contraindications

    • Gestational sac =3.5 cm 

    • Embryonic cardiac motion

    COMPLICATIONS OF ECTOPIC PREGNANCY

    The most common complication is rupture with internal haemorrhage which may lead to hypovolemic shock. Death from rupture is rare in women who have access to modern medical facilities.

    • Infertility
    • Recurrence 
    • Severe haemorrhage leading to shock 
    • Anaemia due to bleeding.
    • Infections following operation.
    • Adhesions due to scar formation during healing process.
    • Re-occurrence of another ectopic pregnancy.
    • Infertility if both tubes are affected.

    Nursing Diagnosis

    1. Risk for Deficient Fluid Volume related to bleeding from a ruptured ectopic pregnancy.
    2. Fatigue related to early loss of pregnancy secondary to ectopic pregnancy.

    Nursing Interventions

    1. Upon arrival at the emergency room, place the woman flat in bed.
    2. Assess the vital signs to establish baseline data and determine if the patient is under shock.
    3. Maintain accurate intake and output to establish the patient’s renal function.

    Evaluation

    1. The goal of the evaluation is to ensure that maternal blood loss is replaced and the bleeding would stop.
    2. The patient must maintain adequate fluid volume at a functional level as evidenced by normal urine output at 30-60mL/hr and a normal specific gravity between the ranges of 1.010 to 1.021.
    3. Vital signs, especially the blood pressure and pulse rate, should be stable and within the normal range.
    4. Patient must exhibit moist mucous membranes, good skin turgor, and adequate capillary refill.

    Ectopic Pregnancy Read More »

    Family Planning Counseling

    Family Planning Counseling

    Family Planning Counseling

    Family Planning Counseling is a continuous process that you as health care provider, as a counselor provide to help clients and people in the community or health facility make and arrive at informed choices about the size of their family (i.e. the number of children they wish to have)

    Counseling is a face to face communication that you have with your client or couple in order to help them arrive at involuntary and informed decisions.

    Informed choice is defined as involuntary choice or decision based on the knowledge relevant to the choice or decision.

    In order to allow people to make an informed choice about family planning, you must make them aware of all available methods and advantages and disadvantages plus side effects of each .

    They should know how to use the chosen method safely and effectively as well as understanding possible side effects.

    Aims of Counseling 

    • The primary objective of counseling in the context of family planning is to help people decide the number of children they wish to have and when to have them.
    • To help clients choose voluntarily, the method that is personally and medically appropriate to them.
    • To ensure they understand how to use their chosen method correctly for safe and effective contraceptive protection  
    • To clear rumors and misconceptions a client may have about family planning methods

    Types of Family Planning Counseling.

    There  are varieties of approaches for different types of family planning counseling:

    • Individual counseling 
    • Couple counseling 
    • Group counseling and information sharing
    Individual counseling 

    This is a counseling approach that involves only one client. it involves individual privacy and confidentiality during communication or counseling with you.

    It is mostly important when dealing with confidential matters that relate to family planning and other reproductive health issues . E.g.in HIV couples, the woman wants to use family planning but the husband does not.

     

    Couple counseling 

    Couples counseling refers to counseling sessions in which a woman and her partner are present in discussions with the provider. 

    However, it must be recognized that couples counseling requires special sensitivity and skills to deal with gender related issues.

     

    Group counseling and information sharing

    This is counseling approach involving a group of many people.

    It is used when individual counseling is not possible or there are people in the village who are more comfortable in a group.

    It is a cost effective of information sharing and answering general questions but people are not likely to share their more personal concerns with you in this situation.

    General principles of counseling

    • Privacy-find a quiet place to talk
    • Take sufficient time
    • Maintain confidentiality
    • Conduct a discussion in a helpful atmosphere
    • Keep it simple-use words people in your village will understand
    • First things first –do not cause confusion by giving too much information 
    • Say if again –repeat the most important instructions
    • Use available visual aids like posters and flip charts etc.

    Characteristics of a good counselor

    The most important characteristics of a good counselor are:

    • Respect the dignity of others
    • Respect the clients’ concerns and ideas
    • Be non-judgmental and open 
    • Show that you are being an active listener
    • Be empathetic and caring
    • Be honest and sensitive

    Overview of stages of counseling

    General counseling

    This is the first contact of family planning counseling .it involves counseling on general issues to address the client’s needs and concerns.

    The counselor needs to talk about the following:

    • To give general information about family planning methods
    • To clear up any mistaken belief or myths about specific family planning methods 
    • Give information on other sexual and reproductive health issues like; STD’s, HIV and infertility

    All these will make the client arrive at the informed decision on the best contraceptive method to use.

    Method-specific counseling

    The information is given about the chosen method.

    The following points are considered:

    • Examination for fitness (screening) (Blood pressure, weights, age and other health parameters)
    • Instruct on how and when to use given method
    • Tell the client when to return for follow-up and ask them to repeat what you have said on key information.

    BRAIDED,

    Family planning counseling the BRAIDED approach, the acronym BRAIDED can help to remember what to talk about when counseling clients on specific methods.

    It stands for:

    B-Benefits of the method

    R-Risks of the method including consequences of the method failure

    A-Alternative to method, including abstinence and no method

    I-Inquiries about the method (Individual rights and responsibilities to ask)

    D-Decision to withdraw from a method without a penalty

    E-Explanation of the method chosen

    D-Documentation of the session for your own records

    Return follow-up 

    Follow-up counseling should always be arranged after the counseling process.

    The aims;

    • To discuss and manage any problem and side effects related to the given contraceptive method
    • It gives the opportunity to encourage the continued use of the chosen method unless problems exist.
    • It helps to find out whether the client has other concerns  and questions 

    Steps in family planning counseling GATHER approaches  

    The counseling process should follow a step-by –step process.

    GATHER acronym will help you remember the 6 steps for family planning counseling.

    G-Greet the client respectfully

    A-Ask them about their family planning needs

    T-Tell them about different contraceptive options and methods

    H-Help them to make decisions about choices of methods

    E-Explain and demonstrate how to use the methods 

    R-Return /Refer, schedule and carryout a return visit and follow-up

    It is important to give more emphasis to the points during counseling steps 

    Greet the client 

    • In the first case give your full attention to your client
    • Greet them in respective manner and introduce yourself to them often offering seats
    • Ask them how you can help them 
    • Tell them that you will not tell others what they have told you.
    • If the counseling takes place in health facility you have to explain what will happen during the visit describing physical examinations and laboratory tests if necessary
    • Conduct counseling in a place where no one can overhear your conversation

    Ask

    • Help them to talk about their needs, doubts, concerns, and any question they might have
    • If they are new ,use a standard check list or from your health management information system to write down their names, age ,marital status ,number of pregnancies ,number of births, number of living children ,current and past family planning use  and basic medical history
    • Explain that you are asking them the information in order to help you provide appropriate care
    • Keep questions simple and brief, and look at them as you speak

    Many people do not know diseases, ask specific questions,  say<< have you had any headache in the past 2 weeks? or have you had any genital itching? Or do you experience any pain when urinating?>> do not say <<have you had any disease in the recent past?>>

    If you have seen the client previously, ask if anything has changed since the last visit.

    Tell

    • Tell them about family planning method 
    • Tel them which methods available
    • Ask them which methods interest them and what they know about the method 
    • Briefly, describe each method of interest and explain how it works, its advantages, disadvantages and possible side effects.

     Help

    • Help them to choose a method of contraception, ask them about their plans and family situation, if they are uncertain about the future start with the present situation
    • Ask what the spouse /partner likes and wants to use
    • Ask if there is anything they cannot understand and repeat information when necessary
    • When the chosen method is not safe for them explain clearly why the method may not be appropriate and help them choose another method.
    • Check whether they have a clear decision and ask what method have you decided to use?

     

    Explain

    • Explain how to use a method after it has been chosen
    • Give supply if appropriate 
    • If the method cannot be given immediately, explain how, when and where it will be provided 
    • For the method like voluntary sterilization the client will have to sign consent form .the form says that; they want the method, have been informed about it, and understand the consent form.
    • Explain how to use the method 
    • Ask the client to repeat the instructions
    • Describe and possible side effects and warning signs and tell them what to do if they occur.
    • Ask them to repeat this information back to you 
    • Give them printed material about the method to take home if it is available
    • Tell them when to come back for a follow-up visit and to comeback sooner if they wish, or if side effects or warning signs occur

    Appoint a return visit follow-up at the follow-up visit

    • Ask the client if she is or they are still using a method or whether there have been any side effects or problems
    • Refer for treatment if severe side effects are present
    • Re assure the clients’ concerning minor side effects are not dangerous and suggest what can be done to relieve them 

    Rights of the client

    1. Information : to learn about their reproductive health ,contraception and abortion options
    2. Access : to obtain services regardless of religion, ethnicity, age, marital or economical status 
    3. Choice : to decide freely whether to use contraception and which method
    4. Safety : to have a safe abortion and to practice safe, effective contraception
    5. Privacy : to have a private environment during counseling process
    6. Confidentiality : to be assured that any personal information will remain confidential
    7. Dignity : to be treated with courtesy ,consideration and effectiveness 
    8. Comfort : to feel comfortable when receiving services 
    9. Continuity : to receive follow-up care and contraceptive services and supplies for as long as needed
    10. Opinion : to express views on the service offered. 

    Factors influencing family planning counseling outcomes

    Factor related to the health care provider

    • Effective communication
    • Technical knowledge and skills, attitudes and behaviors can influence in effectiveness of counseling process

    Factors related to the client

    • Client’s level of knowledge and understanding, what they choose to do may also be affected by the extent to which they trust and respect a service provider.
    • Personnel situation (e.g. .if the spouse or another family member has a difference to them)
    • External programmatic factors
    • In most health facilities the space or rooms for provision of family planning is integrated with other reproductive health services .This can make it very difficult for you to find a place where privacy and confidentiality can be maintained .

    Family Planning Counseling Read More »

    Hormonal Contraceptive Methods

    Hormonal Contraceptive Methods

    HORMONAL CONTRACEPTIVE METHODS

    Hormonal family planning refers to the use of hormonal methods to prevent pregnancy. 

    Hormonal contraceptive refers to birth control methods that act on the endocrine system (hormones).

    These methods involve the use of hormones, usually synthetic versions of those naturally produced by the body, to regulate a woman’s menstrual cycle and prevent ovulation (the release of an egg from the ovaries). By preventing ovulation, hormonal methods make it difficult for sperm to fertilize an egg and thus prevent pregnancy.

    These include;

    1. Oral contraceptive pills
    2. Implants
    3. Injectable contraceptive
    4. Emergency contraceptive pills

    Hormonal Methods:

    i. Oral Pills:

    Method

    Description

    Combined Oral Contraceptives

    Pills containing both oestrogen and progestin hormones

    Progesterone-Only Pills

    Pills containing only progestin hormone

    Emergency Contraceptive Pills

    Pills taken after unprotected sex to prevent pregnancy

    ii. Implants:

    Method

    Description

    Implanon (1 Rod Capsule)

    Subdermal contraceptive rod

    Jadelle (2 Rod Capsules)

    Subdermal contraceptive rods

    Norplant (6 Rod Capsules)

    Subdermal contraceptive rods

    iii. Injectable Contraceptives:

    Method

    Description

    Depo Provera

    Injectable contraceptive administered every three months

    Injector Plan

    Injectable contraceptive

    Sayana Press

    Injectable contraceptive

    Noristrate

    Injectable contraceptive

    iii. Emergency Contraceptives:

    Emergency Contraceptive

    Mechanism of Action

    Lofemenal/Microgynon 4BD for 1 day (Low Dose COC)

    Inhibits ovulation, thickens cervical mucus

    Eugynon (High Dose COC) 2BD for 1 day

    Inhibits ovulation, thickens cervical mucus

    Regular POP (Ovrette/Microval) at Recommended Dose

    Alters cervical mucus, inhibits sperm function

    Levonorgestrel 2 stat

    Delays ovulation, inhibits fertilization

    Postinar 2 BD for 1 day

    Alters cervical mucus, inhibits sperm function

    Vikela/Levonelle-2/Norlevo Plan B

    Delays ovulation, inhibits fertilization

    Oral Contraceptive Pills

    Oral Contraceptive Pills

    There are two main types of hormonal oral contraceptive formulations:

    1. Combined hormonal contraceptive methods which contain both oestrogen and progestin thus, they are called combined oral contraceptives (COCs)
    2. One which contains only progesterone or one of its synthetic analogues (Progestins) thus, it is called progestogen-only pills (POPs) method.

    Combined Oral Contraceptive Pills (COC)

    (i) Combined Oral Contraceptive Pills (COC)

    Combined oral contraceptives contain both oestrogen and progesterone. It achieves effects of both hormones. Oestrogen suppresses ovulation and progesterone creates unfavourable conditions for egg transport and thickening of the cervical mucus to impair sperm entrance into the canal.

    Examples
    • Lo-femenal
    • Pill Plan (Duofen)
    • Microgynon

    Mechanism of Action:

    Combined methods work by:

    • Suppressing ovulation (estrogenic effect)
    • Thickening cervical mucus, making it difficult for sperm to penetrate the uterus
    • Making the endometrium unsuitable for implantation of a fertilized egg (thin and atrophic due to constant progestogenic action)
    • Reducing sperm transport in the upper genital tract (fallopian tubes).

    Effectiveness:

    • 92 – 99.9% effective, depending on user compliance.
    • In very young women, typical effectiveness can be as high as 95.3%.
    • Failure rates decline with the duration of use and age of the user.
    • Failures may be due to method failure, client error, incomplete information from service providers, drug interactions, severe vomiting/diarrhoea, or expired pills.

    Advantages:

    • Very effective if taken correctly.
    • Effective immediately.
    • Easily reversible.
    • Few side effects.
    • Convenient and easy to use.
    • Does not interfere with intercourse.
    • Causes regular and predictable periods.
    • May improve anemia.
    • Reduces dysmenorrhea and premenstrual tension.
    • Protects against ovarian and endometrial cancer, and some causes of PID.
    • Reduces the risk of ovarian cysts, benign breast disease, and ectopic pregnancy.
    • Can be provided by trained non-medical staff.

    Disadvantages:

    • Effectiveness depends on daily pill intake, requiring strong motivation.
    • Increases chances of promiscuity.
    • Can cause Candida vulvitis and vaginitis.
    • May lead to thromboembolism and benign/malignant liver tumors.
    • Requires regular and dependable supply.
    • Reduces breast milk, especially in the first 6 months after delivery.
    • Not the most appropriate choice for lactating women unless no other method is available and there is a high risk of pregnancy.

    Indications:

    • Women requiring a highly effective method.
    • Women wanting an easily reversible method.
    • Non-breastfeeding women or breastfeeding women after 6 months.
    • Women who are anaemic with heavy menstrual bleeding.
    • Women with a history of ectopic pregnancy.
    • Nulliparous women.
    • Women with a history of benign, functional ovarian cysts.
    • Women with a family history of ovarian cancer.
    • Women with menstrual cycle symptoms or irregular menstrual cycles.

    Contraindications:

    • Absolute contraindications include cardiovascular diseases, liver disease, pregnancy, undiagnosed per vaginal bleeding, and oestrogen-dependent neoplasms.
    • Relative contraindications include obesity, varicosities, epilepsy, asthma, mood disorders, nursing mothers in the first 6 months, smoking, and gallbladder disease.

    Side Effects:

    • Major side effects include hypertension, venous thromboembolism, and cholestatic jaundice.
    • Minor side effects can be due to oestrogen, progestin, or both, including nausea, vomiting, headache, leg cramps, weight gain, chloasma & acne, breakthrough bleeding, hypomenorrhea, amenorrhea, leucorrhea, and decreased libido.

    Danger Signs of COCs:

    • Acute abnormal pain.
    • Severe headaches with blurred vision.
    • Pain in the chest with difficulty in breathing.
    • Pain in the calf muscles.

    Indications for Withdraw:

    • Severe migraine.
    • Visual disturbance.
    • Sudden chest pain.
    • Severe cramps.
    • Excessive weight gain.
    • Severe depression.
    • Patient wanting pregnancy.
    • Awaiting major surgery.

    Drug Interaction:

    • Decreases effectiveness of methyldopa, oral anticoagulants, and oral hypoglycemics.
    • Increases effectiveness of B blockers, corticosteroids, diazepam, aminophylline, and alcohol.
    • Other drugs that increase COC metabolism include phenobarbitone, antiepileptics (except sodium valproate and clozapine), rifampicin, griseofulvin, spironolactone, and ketoconazole.

    WHO Medical Eligibility Criteria for Contraceptive Use. 

    Category 1: A condition for which there is no restriction for use of the contraceptive 

    Category 2: A condition where the advantages of using the method generally outweigh the theoretical or proven risks

    Category 3: A condition where the theoretical or proven risk outweigh the advantages of using the method.

    Category 4: A condition that represents unacceptable health risk if the contraceptive is used.

    Who can use only if more appropriate methods are not available (WHO class3) 

    • Women with high BP (greater than 160/100 but less than 180/110) and no vascular disease.
    • Women with symptomatic gall bladder disease.
    • Women age 35 yrs or older and light smokers (under 20 cigarettes a day)
    • Women taking drugs for epilepsy or anti-TB.
    • Women with unexplained vaginal bleeding (only if serious problem suspected)
    • Women who are fully b/feeding (6 wks to 6 months postpartum)
    • Women who are not b/feeding who are less than 3 weeks postpartum.
    • Women with h/o breast cancer and no current evidence of the disease.

    Who should not use COCs (WHO Class 4)

    • Women with hypertension: blood pressure diastolic above 110 mm Hg. The health risk/benefit ratio is dependent upon the severity of the condition
    • Women with current or history of cardiac disease (heart disease or stroke). Among women with underlying vascular disease due to thrombosis, the increased risk of thrombosis with COCs should be avoided; 
    • Women with thrombo-embolic disease (current and a history of or major surgery with prolonged immobilization). The increased risk of venous thromboembolism associated with COCs should have little impact on healthy women, but may have a big impact on women otherwise at risk for it;
    • Women within 2 weeks of child birth (Postnatal) and within 4 weeks or elective surgery;
    • Women with known or suspected cervical cancer. Theoretical concern that COC use may affect prognosis of the existing disease. In general, treatment of these conditions renders a woman sterile; 
    • Women who are pregnant. As no method is indicated, any health risk is considered unacceptable. However, there is no known harm from COCs; 
    • Women with undiagnosed breast lumps or breast cancer. Breast cancer is a hormonally sensitive tumor. The risk for progress of the condition may be increased among women with current or past history of breast cancer;
    • Women who are taking long-term drugs that could affect the pill’s efficacy. Commonly used liver enzyme inducers are likely to reduce the efficacy of COCs. Drugs which affect liver enzymes are the antibiotic rifampicin (note that other antibiotics will not affect pill efficacy), other drugs where another method should be used are:  —griseofulvin, and anticonvulsants (such as phenytoin, carbamazepine, barbiturates, and primidone).
    • Women with severe headache (recurrent, including migraine with focal neurological symptoms). Focal neurological symptoms may be an indication for an increased risk of stroke( or cerebrovascular accident (CVA) is sudden damage to brain  tissue caused either by a lack of blood supply or rupture of a blood vessel . The affected brain cells die and the parts of the body they control or receive sensory messages from ceaseto function.)
    • Women who are retarded or forgetful.
    • Women with sickle cell disease, as they have increased risk of thrombosis;
    • Women with trophoblast disease (current trophoblastic tumor)
    • Women who are to undergo major elective surgery with prolonged bed rest.

    Client Information

    • Start between 1st and 7th day of monthly period
    • Take pills daily at the same time – at bed time if possible
    • Do not miss taking the pill any day
    • If you start after the 7th day of monthly period; you need to use another FP method such condoms or to abstain from sex for one week.
    • Contraception is 7 days after initiation
    • You will have your monthly period when you are taking the brown pills. Do not stop taking the pills.

    If a client misses, they should do the following:

    • If you miss one white pill, take it as soon as you remember, then continue normally.
    • If you miss 2 white or more days in a row; take two pills each day until all missed pills are taken and you are back on schedule. You must also use a condom for the next 7 days.
    • If you miss the brown pill, no worry. Just skip and continue
    • If you keep forgetting – may need to change method
    Progesterone Only Pills (POP)

    ii)  Progesterone Only Pills (POP)

    Progestin-Only Pills are oral contraceptive pills which contain synthetic progestin and are taken orally every day at the same time of day to prevent pregnancy. 

    Mechanism of Action:

    • Reduces the frequency of ovulation.
    • Thickens cervical mucus, making it difficult for sperm to penetrate the uterus.
    • Partially inhibits ovulation.

    Types of POPs available in Uganda:

    1. Microval: 35 white pills, each containing 0.03 mg Levonorgestrel.
    2. Ovrette: 28 yellow pills, each containing 0.075 mg Norgestrel.

    Effectiveness:

    • Depends on user compliance.
    • Very effective if used correctly (83%-99%).
    • Crucial to take POPs at the same time every day, as effectiveness decreases even with a few hours’ delay.
    • In lactating women, POPs are nearly 100% effective, and they do not alter the quantity of milk.

    Advantages of POPs:

    • Do not suppress lactation.
    • No estrogenic side effects.
    • Suitable for women with hypertension, thrombotic, cardiac, and sickle cell diseases.
    • Can be started at any time of the menstrual cycle and in the early postpartum period.
    • Decreased menstrual cramps.
    • Decreased amount of bleeding during periods.
    • Decreased severity of anaemia.
    • Do not increase blood clotting.
    • Some protection against pelvic inflammatory disease (progestins make cervical mucus thicker, reducing the likelihood of infection reaching the uterus and tubes).

    Disadvantages of POPs:

    • Amenorrhea.
    • Must be taken at the same time every day.
    • Irregular periods, including spotting or bleeding between periods.
    • Prolonged or heavy vaginal bleeding.
    • For women who have had ectopic pregnancy, POPs do not prevent ectopic pregnancy as well as intrauterine pregnancy.
    • For women with a history of ovarian cysts, POPs do not protect against the development of future ovarian cysts.

    Indications:

    • Women of any reproductive age or parity seeking pregnancy protection.
    • Breastfeeding women (6 weeks or more postpartum).
    • Post-abortion women (may start immediately).
    • Women who smoke.
    • Women with high blood pressure, blood clotting problems, or sickle cell disease.
    • Women unable to take Combined Oral Contraceptives (COCs) but want to take Pills.

    Who should not use POPs (Class 3):

    • Women breastfeeding and less than 6 weeks postpartum.
    • Women with jaundice.
    • Women taking anti-epileptic and anti-TB medication.
    • Women with unexplained vaginal bleeding.
    • Women with breast cancer.
    • Women concerned about changes in their menstrual bleeding pattern.
    • Women unable to remember taking a pill every day (no more than 3 hours late).

    Who should not use POPs (Class 4):

    • Women known or suspected to be pregnant.
    • Women who are known or suspected to be pregnant. POPs should not be initiated if a woman is pregnant. However, there is no known harm to mother or fetus if POPs are used during pregnancy;
    • Signs of problems from POPs warranting immediate return to clinic
    • Severe lower abdominal pain.
    • Heavy bleeding (twice as long and as much).
    • Migraine headaches, repeated very painful headaches, or blurred vision.

    Signs of problems from POPs warranting immediate return to clinic:

    • Severe lower abdominal pain.
    • Heavy bleeding (twice as long and as much).
    • Migraine headaches, repeated very painful headaches, or blurred vision.

    Client Instructions:

    1. Start between the 1st and 7th day of the monthly period.
    2. If started after the 1st day of bleeding, abstain from intercourse or use another method for the next 48 hours.
    3. Take pills daily at the same time.
    4. Do not miss taking the pill any day.
    5. Return to the clinic for more pills before finishing the last pack.
    6. Severe diarrhoea or vomiting reduces pill effectiveness. Use a backup method or abstain from sex while taking the pills and for 48 hours after.
    7. If client misses taking pills:
    • If more than 3 hours late, take it as soon as remembered and the next pill at the usual time. Use a backup method or abstain for the next 48 hours.
    • If miss two or more days, take one as soon as remembered, continue as usual, and use a backup method or abstain for the next 48 hours.
    • If consistently forgetting, consider another method and seek counseling.

    Contraindications:

    1. Pregnancy: Progestin-Only Pills (POPs) should not be initiated if a woman is pregnant. 
    2. Unexplained vaginal bleeding: POPs are contraindicated in cases of unexplained vaginal bleeding, and immediate medical attention is advised to determine the cause.
    3. Recent history of breast cancer: Women with a recent history of breast cancer are advised against using POPs due to potential hormonal interactions that could affect cancer progression.
    4. Arterial diseases: Individuals with arterial diseases, such as a history of stroke or cardiovascular issues, should avoid POPs as they may pose additional risks to vascular health.
    5. Thromboembolic diseases: Those with a history of thromboembolic diseases, involving blood clotting, are at an increased risk when using POPs, making it a contraindicated option.
    6. Active hepatic diseases: Presence of active liver diseases is a contraindication, as POPs can impact liver function, and their use might exacerbate hepatic conditions.
    7. Hypertension: Women with hypertension are advised against using POPs, as the hormonal components may contribute to increased blood pressure.

    Side Effects:

    1. Amenorrhea: Some women may experience amenorrhea (absence of menstruation) as a side effect of POPs, which is generally considered a normal response to hormonal changes.
    2. Spotting: Spotting, or irregular bleeding between periods, can occur, and individuals should be aware that this is a common side effect that usually diminishes with time.
    3. Prolonged or heavy bleeding: While some may experience prolonged or heavy bleeding, this side effect should be discussed with a healthcare provider to ensure it is not indicative of an underlying issue.
    4. Lower abdominal pain: Lower abdominal pain may occur.
    5. Weight gain or loss: Changes in weight, either gain or loss, may be observed.
    6. Jaundice: Jaundice, characterized by yellowing of the skin or eyes, is a rare but serious side effect.
    7. Nausea and vomiting: Nausea and vomiting may occur initially but often subside. 
    8. Headache with blurred vision: Headaches with blurred vision may be experienced.
    9. Excessive hair growth: Some individuals may notice changes in hair growth patterns.
    10. Breast fullness or tenderness: Breast fullness or tenderness is a common side effect that usually resolves over time.
    11. High blood pressure: An increase in blood pressure may occur in some individuals

    Implants

    Implants are small, flexible rods or capsules that are inserted under the skin of a woman’s upper arm.

     These implants release a steady, low dose of hormones (usually a progestin hormone) into the bloodstream over an extended period. The most common types of contraceptive implants include Implanon, Jadelle, and Norplant.

    Implants are considered a reversible form of contraception, and their effectiveness is not dependent on user compliance once inserted. They are suitable for women who want a reliable, long-term birth control option without the need for daily or frequent intervention.

    Types:

    1. Implanon: A single rod capsule effective for 3 years.
    2. Jadelle: Two rods of levornogestrel each 75mg capsules providing protection for 5 years.
    3. Norplant: Consists of 6 rods each with 36mg levornogestrel capsules labelled for 5-7 years.

    Modes of Action:

    The hormonal release from these implants serves to prevent pregnancy by thickening the cervical mucus within 24 hours, hindering sperm entry into the uterus, inhibiting ovulation (the release of eggs from the ovaries), and altering the uterine lining to make it less receptive to a fertilized egg. Implants are highly effective and offer long-term contraception, ranging from three to seven years, depending on the specific type.

    Implants

    Insertion: Inner aspect of non dominant arm, 6 – 8 cm above elbow fold under local anesthesia. This is at day1, immediate after abortion or 3weeks postpartum.

    Removal: Approximately 3 to 5 years

    Advantages:

    • Very effective within 24 hours after insertion.
    • Easily reversible with no delay in returning to fertility after removal.
    • Reduces frequency and intensity of sickle cell crises.
    • Highly effective for long-term contraception.
    • Shares benefits with Depo Provera.

    Common Side Effects and Disadvantages:

    • Changes in menstruation patterns.
    • Spotting.
    • Rare instances of heavy bleeding.
    • Amenorrhea.
    • Does not protect against STIs, including HIV/AIDS.
    • Discomfort in the hand after insertion.
    • Possible weight changes (overweight or weight loss).
    • Minor surgical procedure required for both insertion and removal.

    Indications:

    • Breastfeeding post-partum mothers.
    • Adolescents.
    • Post-abortion contraception.
    • Women with sickle cell disease.
    • Women awaiting surgical contraception.
    • Women on treatment, e.g., ARVs.

    Contraindications:

    • Serious problems with the heart or blood vessels.
    • Breast cancer history.
    • Liver diseases leading to jaundice.
    • Pregnancy.

    Signs and Problems Requiring Medical Attention:

    1. Soreness at the site of insertion.
    2. Capsules coming out.
    3. Severe headaches.
    4. Heavy bleeding, exceeding the usual amount and duration.
    5. Pregnancy.
    6. Missed period after several regular cycles.

    Injectable Contraceptives

    Examples

    • Depo Provera (Depo Medroxyprogesterone acetate (DMPA), single dose of 150 mg I.M every 12 weeks. (Injecta Plan)
    • Sayana Press 104mg, 0.65ml Subcutaneously
    • Noristerat (Norethisterone) 200mg every 8 weeks for 24 weeks, then every 12 weeks.
    • Norigynon/Mesigyna (50 mg norethindrone enanthate plus 5 mg estradiol valerate) ; Both given monthly.

    These contraceptives contain a single type of hormone, progestin.

    Injectable Contraceptives depo

    Depo Provera

    Depo Provera is a hormone used for contraception. It is given by injection and its effects will last for three months at a time.

    Mode of Action

    • Inhibits ovulation.
    • Thickens cervical mucus, hindering sperm entry.
    • Thins the uterine lining, reducing chances of fertilized egg implantation.

    Indications

    • Breastfeeding mothers after 6 weeks or immediately if not breastfeeding.
    • Women needing long-term contraception.
    • Known/suspected HIV-positive women.
    • Women with sickle cell disease.
    • Women unable to use COC due to oestrogen content.
    • Women awaiting surgical contraception.

    Advantages

    • Very effective.
    • Does not suppress lactation.
    • Easy to remember return dates.
    • Private usage.
    • No oestrogen-related side effects.
    • Reduces sickle cell crisis frequency.
    • Non-interference with sex.

    Disadvantages

    • Changes in menstrual bleeding.
    • Spotting (common in the first 3 months).
    • Amenorrhea (common after 1st injection and after 9-12 months).
    • Prolonged heavy vaginal bleeding.
    • Weight changes.
    • Irreversible injection.
    • Delayed return of fertility.
    • Loss of libido.
    • Does not protect against STIs/HIV/AIDS.

    Management

    • Depo Provera 150mg deep IM into deltoid or buttock muscle.
    • No rubbing to avoid increased absorption.
    • Advise abstinence or backup FP method for the first 7 days after injection.
    • Return for the next dose 12 weeks after the injection.

    Injectable Contraceptives sayana

    Sayana Press

    Sayana Press is a contraceptive injection that women can give to themselves to prevent pregnancy. It’s given under the skin, at the front upper thighs or abdomen. The injection releases medication that runs through your bloodstream over a period of 13 weeks.

    • Sayana press ® is a single-dose container with 104 mg Medroxyprogesterone acetate (MPA) in 0.65ml suspension (104mg) formulated for subcutaneous.
    • It is administered subcutaneously into the anterior thigh or abdomen or arm.
    • The efficacy of Sayana press depends on adherence to the recommended dosage schedule of administration.

     

    Composition

    • Single-dose container with 104 mg Medroxyprogesterone acetate (MPA) in 0.65ml suspension.

    Administration

    • Subcutaneously into the anterior thigh, abdomen, or arm

    Mechanism of Action

    • Suppresses ovulation.
    • Renders endometrium unsuitable for implantation.
    • Increases cervical mucus viscosity, impeding sperm penetration.

    Indications

    Nearly all women can use it safely & effectively including women:-

    • Women whose partners have undergone vasectomy until vasectomy is effective.
    • Have or have not had children.
    • Any age including adolescents & women over 40 years old.
    • Have just had an abortion/miscarriage.
    • Breastfeeding women 6 weeks postpartum.
    • HIV infected whether or not on ART.

    Advantages and Non contraceptive benefits.

    • New formulation for S/C injection.
    • 30% low side effects compared to Depo-Provera.
    • Do not interfere with sex.
    • Private & no one else can tell that a woman is using it.
    • May help women gain weight.
    • Do not require daily action.
    • Prevents pregnancy.
    • Protects against endometrial cancer, uterine fibroids.
    • Reduces sickle cell crisis among women with sickle cell anaemia.
    • Protects against symptomatic PID & iron deficiency anaemia.

    Disadvantages

    • Weight changes.
    • No protection against STIs/HIV/AIDS.
    • Delayed fertility return.
    • Potential side effects like hypersensitivity reactions, decreased/increased appetite, loss of libido, dizziness, headache, and more.

    Problems that may need medical attention

    • Loss of bone mineral density.
    • Menstrual irregularities.
    • Thromboembolic disorders.
    • Anaphylaxis & anaphylactoid reactions.
    • Sudden partial or complete loss of vision.
    Disadvantages & Side effects
    • Weight gain or loss
    • Does not protect against STI/HIV/AIDs
    • Delayed fertility return
    • Hypersensitivity reactions
    • Decreased/increased appetite
    • Loss of libido & irritability
    • Dizziness, headache & migraine
    • Thromboembolic disorders
    • Nausea & vomiting
    • Jaundice
    • Alopecia & urticaria
    • Loss of bone mineral density
    • Back & leg pains
    • Mood changes
    • Abdominal bloating & discomfort
    Emergency Contraception / Post-Coital Contraception

    Emergency Contraception / Post-Coital Contraception

    Emergency contraception (EC) serves as a preventive measure for unintended pregnancies following unprotected sexual intercourse, condom rupture, missed pills, or sexual assault.
     It should be regarded as an emergency measure and not as a routine contraceptive method. EC does not terminate pregnancy. It encompasses hormonal, anti-progestin, and other methods.
    Types
    1. Emergency Contraceptive Pills (ECP)
    2. Progesterone-Only Pills Regimen
    When to Start?
    EC should be initiated within 3 -5 days or 72 -120 hours, with earlier administration being more effective, following unprotected sexual intercourse. Intrauterine contraceptive devices (IUCDs) with copper introduction, within a maximum period of 5 days, can prevent conception after accidental unprotected sexual exposure.
    Mechanism of Action
    • Prevents implantation
    • Failure rate is about 1%
    • Effectiveness is over 99% in preventing pregnancy
    NOTE:
    • Post-coital contraception is solely for emergency use and is not effective if used regularly, except for copper IUCDs.
    • Women seeking emergency contraception should also be counselled about regular contraceptive options, promoting consistent and correct usage. 
    • Referral to relevant services, such as HIV counselling, testing, post-exposure prophylaxis (PEP), and treatment for sexually transmitted infections (STIs), is essential. 
    • Specialized services for sexual and gender-based violence should also be considered.
    Basic Steps of Client Care for ECP
    1. Greet and introduce yourself.
    2. Maintain a respectful attitude.
    3. Ensure confidentiality of the discussion.
    4. Explain different ECP options, including usage, side effects, and the need for referral or follow-up.
    5. Encourage questions from the client.
    6. Discuss regular contraception options.
    7. Conduct counselling with active client involvement, reassurance of confidentiality, and in a private and supportive environment.
    Examples of ECP:
    • Ethinyl estradiol 2.5mg b.d X 5/7
    • Conjugated oestrogen 15mg b.d X 5/7
    • Levonorgestrel 0.75mg stat and after 12 hours.
    • Mifepristone 600 mg stat – single dose.
    • Copper IUDs inserted within 5 days.
    • Others: Postinor, Microgynon, Eugynon.
    Indications
    • Unprotected sexual intercourse
    • Rape survivors
    • Contraceptive method failure
    • Missed contraceptive pills or injections
    • Delay in taking pills
    • Sexual assault or first-time intercourse
    Contraindications
    • Pregnancy
    • After 120 hours or 5 days of unprotected sex

    Emergency Contraceptive

    Dosage

    Mechanism of Action

    Lofemenal/Microgynon 4BD for 1 day (Low Dose COC)

    4 tablets once

    Inhibits ovulation, thickens cervical mucus

    Eugynon (High Dose COC) 2BD for 1 day

    2 tablets twice

    Inhibits ovulation, thickens cervical mucus

    Regular POP (Ovrette/Microval) at Recommended Dose

    As recommended

    Alters cervical mucus, inhibits sperm function

    Levonorgestrel 2 stat

    2 tablets at once

    Delays ovulation, inhibits fertilization

    Postinar 2 BD for 1 day

    2 tablets twice

    Alters cervical mucus, inhibits sperm function

    Vikela/Levonelle-2/Norlevo Plan B

    As recommended

    Delays ovulation, inhibits fertilization

    NON HORMONAL METHODS click here

    Hormonal Contraceptive Methods Read More »

    Want notes in PDF? Join our classes!!

    Send us a message on WhatsApp
    0726113908

    Scroll to Top
    Enable Notifications OK No thanks